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ABSTRACT 
In Saccharomyces cerevisiae DNA postreplication repair (PRR) functions to 
bypass replication-blocking lesions to prevent damage-induced cell death. PRR employs 
two different mechanisms to bypass damaged DNA. While translesion synthesis (TLS) 
has been well characterized, little is known about the molecular events involved in error-
free bypass although it has been assumed that homologous recombination (HR) is 
required for such a mode of lesion bypass. We undertook a genome-wide, synthetic 
genetic array (SGA) screen for novel genes involved in PRR and observed evidence of 
genetic interactions between error-free PRR and HR. We were screening for synthetic 
lethality which occurs when the combination of two mutations leads to an inviable 
organism, however, either single mutation allows for cell viability. In addition, we 
screened for conditionally synthetic lethal interaction which occurs when the 
combination of two mutations is inviable only in the presence of a DNA-damaging agent. 
This screen identified and assigned four genes, CSM2, PSY3, SHU1 and SHU2, whose 
products form a stable Shu complex, to the error-free PRR pathway. Previous studies 
have indicated that the Shu complex is required for efficient HR and that inactivation of 
any one of these genes is able to suppress the severe phenotypes of top3 and sgs1. We 
confirmed and further extended some of the reported observations and demonstrated that 
error-free PRR mutations are also epistatic to sgs1. Based on the above analyses, we 
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propose a model in which error-free PRR utilizes the Shu complex to recruit HR to 
facilitate template switching, followed by double-Holliday junction resolution by Sgs1-
Top3.  
Null mutations of HR genes including rad51, 52, 54, 55 and 57 are known to 
confer characteristic synergistic interactions with TLS mutations. To our surprise, null 
mutations of genes encoding the Mre11-Rad50-Xrs2 (MRX) complex, which is also 
required for HR, are epistatic to TLS mutations. The MRX complex confers an 
endo/exonuclease activity required for the detection and processing of DNA double-
strand breaks (DSBs). Our results suggest that the MRX complex functions in both TLS 
and error-free PRR and that this function requires the nuclease activity of Mre11. This is 
in sharp contrast to other known HR genes that only function downstream of error-free 
PRR. Furthermore, we found that inactivation of SGS1 significantly inhibits proliferating 
cell nuclear antigen (PCNA) monoubiquitination and is epistatic to mutations in TLS, 
suggesting that Sgs1 also functions at earlier steps in DNA lesion bypass. We also 
examined the roles of Sae2 and Exo1, two accessory nucleases involved in DSB 
resection, in PRR. We found that while Sae2 is primarily required for TLS, Exo1 is 
exclusively involved in error-free PRR. In light of the distinct and overlapping activities 
of the above nucleases in the resection of DSBs, we propose that the distinct single-strand 
nuclease activities of MRX, Sae2 and Exo1 dictate the preference between TLS and 
error-free PRR for lesion bypass.  
While both PRR pathways are dependent on the ubiquitination of PCNA, error-
free PRR utilizes non-canonical Lys63-linked polyubiquitinated PCNA to signal lesion 
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bypass. This mechanism is dependent on the Mms2-Ubc13 complex being in close 
proximity to PCNA, a process thought to be dependent on Rad5. Rad5 is a member of the 
SWI/SNF family of ATPases that contains a RING finger motif characteristic of an E3 
Ub ligase. Previous in vitro experiments demonstrated the ability of Rad5 to promote 
replication fork regression, a function dependent on its helicase/ATPase activity. We 
therefore created site-specific mutants defective in either Rad5 RING finger or 
helicase/ATPase activity, or both, in order to examine their genetic interactions with 
known TLS and error-free PRR genes. Our results indicate that both the Rad5 RING 
finger motif and the helicase/ATPase activity are exclusively involved in error-free PRR. 
To our surprise, like the Rad5 RING finger, lack of the helicase/ATPase activity also 
abolishes the Lys63-linked PCNA polyubiquitin chain formation, suggesting that either 
the Rad5 helicase/ATPase-promoted replication fork regression signals PCNA 
polyubiquitination or this domain has a yet unidentified activity.  
In summary, results obtained from this thesis dissertation have revealed novel 
mechanisms of yeast PRR in S. cerevisiae, a mechanism that appears to be evolutionarily 
conserved throughout eukaryotes, from yeast to humans. 
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CHAPTER ONE 
INTRODUCTION 
 
Deoxyribonucleic acid (DNA) contains the instructions for life, and as such must 
be preserved. At the core of the DNA helix structure are two nucleotides joined together 
by hydrogen bonds which align in a Watson-Crick base pairing scheme where A aligns 
with T, and C aligns with G in a stepwise manner. External to the DNA nucleotides are 
two phosphate-deoxyribose backbones upheld by phosphodiester bonds. DNA is 
organized into chromosomes that must be correctly duplicated before cellular division 
may occur. During normal DNA replication DNA fidelity is maintained by the 
polymerase selection of correct base pairing and an associated 3`-5` proofreading 
exonuclease. Although DNA mutations are required for evolutionary changes a balance 
between genomic stability and instability must be maintained for cell survival and 
inheritance. Cellular DNA is quite dynamic and is subject to constant assault as it readily 
reacts with a variety of agents both internal and external to the cell. Therefore, in order to 
maintain genomic integrity living organisms have developed a comprehensive set of 
highly conserved mechanisms to deal with DNA damage. Depending on the source, DNA 
damage can be predominantly divided into two categories: endogenous DNA damage 
referring to damage occurring from within the cell, while the second category pertains to 
both physical and chemical DNA damage originating from outside the cell.  
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1.1 – DNA Damage 
1.1.1 – Spontaneous DNA Damage 
Cellular metabolism, although vital to cell survival also results in accidental 
spontaneous DNA damage from a variety of sources. DNA constantly reacts with 
oxygen, water, and UV radiation from the sun, all essential requirements to life, but have 
the potential devastating ability to alter and spontaneously damage DNA. Oxygen is one 
trigger of spontaneous DNA damage. Although oxygen is required for life, reactive 
oxygen species (ROS) formed as byproducts of aerobic metabolism are highly toxic to 
cells as they readily react with DNA at an estimated rate of 10
4
-10
6
 oxidized 
adducts/cell/day (Ames and Gold, 1991). Such adducts may occur on any of the four 
DNA nucleotides and on deoxyribose. Predominantly, intracellular ROS emanate from 
errors in the electron transport chain during mitochondrial respiration (Friedberg et al., 
2006). However, additional ROS may originate from extracellular sources such as 
radiation, redox cycling compounds, various drugs and chemicals. ROS are a major 
source of spontaneous DNA damage in numerous intracellular macromolecules including 
proteins, lipids, carbohydrates, and nucleic acids (Friedberg et al., 2006), and are known 
to cause more than 80 products of DNA nucleotide damage (Bjelland and Seeberg, 2003).  
The leading source of DNA damage caused by ROS is thought to be the 
formation of Fenton oxidants that are the result of H2O2 reacting with iron-complexed 
DNA (Fenton, 1894; Friedberg et al., 2006). It was later confirmed that the oxidant 
produced in this reaction was indeed the hydroxyl radical (●OH) (Haber and Weiss, 1939; 
Koppenol, 2001). Once the reactive hydrophilic hydroxyl radicals are formed near DNA 
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they are highly reactive (Breen and Murphy, 1995), and as such predominantly add 
excessive hydrogen atoms to the double-bonds of DNA nucleotides, or remove hydrogen 
from the deoxyribose sugar in DNA resulting in fragmentation, nucleotide loss, and or 
single- and double-strand breaks .  
Not only is genomic DNA subject to hydroxyl radicals, but also its precursors. 
The ROS induced lesion 7, 8-dihydro-8-oxoguanine (8-oxoG) is one such example. 8-
oxoG can be incorporated into the parent strand of DNA following oxidation, but 
additionally the daughter strand can have a precursor 8-oxoG incorporated. 8-oxoG is 
usually incorrectly base-paired with an A residue resulting in a transverse mutation 
(Cheng et al., 1992; Kuchino et al., 1987; Shibutani et al., 1991). Should these mutations 
not be removed subsequent rounds of replication can incorporate the error thereby 
compounding the initial DNA damage (Friedberg et al., 2006). Cells typically maintain a 
balance between biochemical antioxidants and enzymes to breakdown ROS; however, if 
the balance is upset by an increase in ROS, redox active chemicals, or oxygen availability 
the results can be devastating. 
Cells have multiple mechanisms to protect against reactive oxygen species. These 
mechanisms include maintaining a decreasing oxygen gradient from extracellular to 
intracellular levels, compartmentalization of DNA to the nucleus away from oxygen 
metabolism, DNA protection via histones, the ability to trigger cell cycle arrest, 
degradation of damaged macromolecules, and induction of apoptosis in eukaryotes, all of 
which contribute to the cells ability to protect against spontaneous DNA damage via 
reactive oxygen species. Despite the vast ability of cells to protect against damage, 
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spontaneous DNA damage by oxygen and cellular metabolism is still inevitable. In 
humans, oxidative stress has been implicated in neurodegenerative disorders, 
atherosclerosis, cancer, alcohol-induced liver damage, as well as a contributing factor to 
the ageing process (Friedberg et al., 2006). Although potentially devastating, cells have 
the ability to use ROS to their advantage in the innate immune response against bacterial 
pathogenesis (Segal and Shatwell, 1997; Vazquez-Torres et al., 2001). 
In addition to ROS, deamination, or loss of an exocyclic amino group from 
cytosine, adenine, guanine, or 5-methylcytosine, which readily occurs at physiological 
pH and temperature, results in the affected nucleotide being converted to uracil, 
hypoxanthine, xanthine or thymine, respectively, and is a prevalent form of spontaneous 
DNA damage. Mammalian cells under physiological conditions reportedly deaminate 
cytosine residues to uracil at a rate of 100-500 times/day (Adelman et al., 1988; Albert 
and Burns, 1977; Ames et al., 1993; Friedberg et al., 2006). 
DNA nucleotides are continually lost from nucleic acids resulting in abasic sites. 
Abasic, or AP (apurinic or apyrimidinic) sites can be spontaneously formed when the N-
glycosyl bond between the DNA nucleotide and sugar is cleaved leaving behind an intact 
sugar-phosphate chain. Spontaneous depurination in human cells is thought to occur at a 
rate of approximately 9,000 bases/cell/day (Prise et al., 1994), and even cells maintained 
at a physiological temperature reportedly lose 18,000 purine residues everyday due to 
hydrolysis of the N-glycosyl bond in DNA (Allen and Tresini, 2000; Alvarez et al., 1998; 
Friedberg et al., 2006). Fortunately, repair of the damage caused by depurination is 
quickly initiated by ubiquitous AP endonucleases at a rate that is greater than the 
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spontaneous damage can occur (Lindahl, 1993). However, AP sites also arise as an 
intermediate during base excision repair (BER) (discussed later). Although AP sites 
formed in this manner are short lived, deficiencies in BER will result in the accumulation 
of AP sites (Friedberg et al., 2006). Cells completely lacking AP repair enzymes in S. 
cerevisiae are rendered inviable (Guillet and Boiteux, 2003).  
   It has also been stated that DNA replication alone introduces enough 
spontaneously induced errors to overwhelm a cell with potentially devastating outcomes 
(Friedberg et al., 2006). This may be the result of a misinsertion of nucleotides during 
syntheses, which is a plausible result even though replicative DNA polymerases typically 
function with high fidelity. Although errors introduced during replication are generally 
resolved immediately by associated exonucleases, should errors persist beyond this point 
they are excised and corrected post-replicatively by mismatch repair.  
 There are a seemingly overwhelming number of ways in which DNA can be 
spontaneously damaged, and the above sources are only a portion of ways by which DNA 
can be damaged. Exogenous DNA damage is also a major contributing factor to cellular 
DNA damage.  
 
1.1.2 – Exogenous DNA Damage 
1.1.2.1 – Physical DNA-damaging Agents 
 Ionizing radiation (IR) is a naturally occurring external source of physical damage 
to DNA, and results in excited and ionized molecules that have the ability to randomly 
cause damage to all cellular components, including DNA lesions (Friedberg et al., 2006). 
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Typically people living in the United States of America are exposed to 1-2 mSv per year, 
with an additional dose of 0.5 mSv possibly due to artificial radiation sources utilized in 
the medical profession for diagnostics and treatment such as X-rays (Friedberg et al., 
2006). In addition, elevation and time spent at high-altitudes can greatly increase 
exposure to IR, suggesting that individual exposures can vary considerably. IR has the 
ability to physically damage DNA both directly and indirectly. Direct damage is a result 
of the absorption of radiation by DNA and results in the ionization of DNA nucleotides 
and sugars, whereas species formed from the radiolysis of water are a major source of 
indirect DNA damage by IR. However, both direct and indirect damage may result in the 
same intermediate reactive products, and one of the reactive intermediates is the hydroxyl 
radical. Hence, DNA damage as a result of IR can be deemed similar to that of ROS to a 
certain extent. However, the most lethal affects caused by IR result from single and 
double-strand breaks (DSBs) (Friedberg et al., 2006). Single-strand breaks can result 
from the abstraction of a hydrogen atom from deoxyribose and may occur either directly 
from IR, or indirectly from hydroxyl radicals formed from IR exposure (Friedberg et al., 
2006). DSBs resulting from IR are an important example of multiple damage sites, and 
may result because a single track of IR produces a cluster of ionizations allowing two or 
more hydroxyl radicals to abstract hydrogen atoms from both DNA strands (Friedberg et 
al., 2006). Therefore, oxidative damage can also result from an exogenous source like IR, 
in addition to the endogenous sources mentioned earlier. However, exogenous oxidative 
damage may also result from metal ions and barbiturates for example (Buonocore and 
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Bellieni, 2010). Nonetheless, it is the cellular response to DNA damage that determines 
the lethality of DNA damage.  
 In addition to IR, DNA is also damaged by Ultraviolet (UV) radiation. UV 
radiation can be divided by three wavelength ranges: UV-A (320 to 400 nm), UV-B (295-
320 nm), and UV-C (100-295 nm), where solar radiation consists mainly of UV-A and 
UV-B waves as UV-C waves are filtered out by the ozone (Friedberg et al., 2006). 
However, in seeming contrast, most UV radiation studies in laboratories involve the 
study of UV-C radiation for ease of treatment. However, UV-C radiation does induce the 
same lesions as UV-A and UV-B, but is slightly more specific for DNA specific lesions. 
One of the major lesions induced by UV radiation is cyclobutane pyrimidine dimers 
(CPD), a phenomenon where adjacent pyrimidines become covalently linked by a four-
member ring structure (Friedberg et al., 2006). 6-4 photoproducts (6-4 PP) are another 
major form of UV-induced lesions. 6-4 PP link the C6 position of the 5’ pyrimidine to an 
adjacent C4 position of the 3’ pyrimidine and thus distort the DNA helix. UV radiation 
may also result in spore photoproducts, photoinduced lesions involving purines, 
pyrimidine hydrates, thymine glycol lesions, crosslinking of DNA to proteins, and strand 
breaks most likely caused from the biological processing of the UV radiation-induced 
damage (Friedberg et al., 2006). UV-induced lesions are typically repaired by nucleotide 
excision repair (NER) (discussed later) before they hinder DNA replication.  
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1.1.2.2 – Chemical DNA-damaging Agents 
 Alkylating agents include a wide variety of chemicals, most of which are 
suspected carcinogens and can cause such extreme consequences as death. For example, 
mustard gas has been used in chemical warfare in World Wars. However, alkylating 
agents also have the ability to act as anticancer chemotherapeutic drugs. All four DNA 
nucleotides have been shown to have reactive sites for alkylating agents, albeit to varying 
degrees (Friedberg et al., 2006). The two major consequences of alkylating agents are 
replication blocks (3-methyladenine for example (3-meA), and mutagenesis (O
6
-
methylguanine (O
6
-meG)) (Friedberg et al., 2006). However, to a lesser extent, alkylation 
of DNA nucleotides may weaken the N-glycosyl bond, and result in alkali-labile AP sites 
(Friedberg et al., 2006; Loeb and Preston, 1986). Alkylating agents can be either 
monofunctional and covalently bound with one nucleophilic center in DNA, or 
bifunctional and react with two sites in DNA, which forms crosslinks. In the laboratory 
the most commonly used monofunctional alkylating agents for studying DNA repair 
include methylnitrosourea (MNU), N-methyl-N’-nitro-N-nitrosoguanidine (MNNG), 
methyl methanesulfonate (MMS), ethylnitrosourea (ENU) and ethyl methanesulfonate 
(EMS). 
 Crosslinking agents are important components to chemical DNA damage as well. 
Crosslinking agents have the ability to construct complete blocks in DNA hindering both 
DNA replication and transcription, and crosslinks formed by alkylating agents are 
virtually irreversible (Kozekov et al., 2003). The ability of a bifunctional alkylating agent 
to bind to two nucleophilic centers on opposing DNA strands results in an interstrand 
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crosslink. However, if the nucleophilic centers are on the same DNA strand it is referred 
to as an intrastrand crosslink. Notable crosslinking agents include nitrogen mustard, 
cisplatin and mitomycin C (MMC); the latter two are employed as chemotherapeutic 
agents (Kozekov et al., 2003). Crosslinking can refer to DNA-DNA crosslinking, but 
evidence has shown that DNA-protein crosslinks by aldehydes such as formaldehyde are 
also plausible (Kurtz and Lloyd, 2003). We are continually exposed to aldehydes and 
related compounds via tobacco smoke, car exhaust and endogenously from oxidative 
degradation of unsaturated lipids (Friedberg et al., 2006). In addition to the chemicals 
that can cause DNA crosslinks, IR (Love et al., 1986; Marmur and Grossman, 1961) and 
UV radiation (Lett et al., 1961) also have the ability to form intermolecular DNA 
crosslinks (Friedberg et al., 2006).  
Crosslinks may also be formed during photosensitized reactions. For example, 
psoralenes can intercalate into DNA upon exposure to UV-A radiation thereby producing 
covalent adducts to pyrimidines (Hearst et al., 1984), typically across the 5-6 double-
bond of thymine, and also cause helix distortion and unwinding of the DNA (Friedberg et 
al., 2006; Pearlman et al., 1985). Although potentially harmful, psoralenes provide a 
mechanism for studying the repair of interstrand DNA crosslinks, as well as a treatment 
for patients suffering from psoriasis, a skin disease (Friedberg et al., 2006).  
In addition to the chemical damage discussed so far, canonical cellular 
metabolism has the ability to create DNA-damaging agents. A variety of relatively 
unreactive chemical compounds readily undergo metabolic activation by enzymes 
attempting to protect the cell from cytotoxic agents and potentially detrimental effects by 
 10 
 
breaking down these chemicals to water-soluable excretable forms. Unfortunately, 
sometimes this results in an activated electrophilic form that may readily react with 
DNA, which converts these cytotoxic chemicals into genotoxic compounds. Well known 
chemicals that act in this manner are N-2-Acetyl-2-Aminofluorene, Benzo[a]pyrene, 
aflatoxins, MNNG, and 4-Nitroquinoline 1-Oxide (4-NQO). Benzo[a]pyrene is one of the 
most carcinogenic compounds known and is readily found in cigarette smoke, vehicle 
exhaust, and charred foods. While aflatoxins are mycotoxins produced by certain fungi 
and contaminate cereal grains consumed by humans, alfatoxin-B1 is taken up into the cell 
by passive diffusion and metabolized to aflatoxin B1-8,9-epoxide, which then attacks 
certain guanine residues in duplexed DNA, resulting in a weakened N-glycosyl bond and 
AP sites (Friedberg et al., 2006). In addition to the above chemicals, metabolism of the 
natural hormone estrogen can result in reactive electrophilic metabolites. The 
consequences can be DNA adducts, AP sites, ROS, oxidized DNA nucleotides and DNA 
strand breaks, to name a few.  
DNA damage from DNA strand breaks can be induced by chemicals such as 
bleomycin, IRs, as well as from alteration of enzymatic activities in the cell such as 
topoisomerase inhibitors. Bleomycin, although used as an antitumor antibiotic, abstracts 
hydrogen from DNA, resulting in nucleotide modification, AP sites and strand breaks 
(Friedberg et al., 2006; Povirk, 1996). DNA strand breaks may also result from 
topoisomerases. Topoisomerases are nicking and closing enzymes that function while 
covalently attached to DNA ends. DNA ends are subsequently re-joined when the 
topoisomerase is released from the DNA. However, in the presence of a topoisomerase 
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inhibitor (camptothecin for example), the topoisomerase remains covalently attached to 
the broken DNA end resulting in DSBs with DNA-protein crosslinks (Ferguson and 
Baguley, 1996; Froelich-Ammon and Osheroff, 1995). Human cells resolve such DNA-
protein crosslinks with the enzyme TDP1 (Friedberg et al., 2006). 
 Although many forms of DNA damage have been mentioned thus far, it should be 
noted that DNA damage is also dependent on the higher order structure of DNA 
organization into nucleosomes and chromosomes. For example, CPD DNA damage has 
no preferential distribution in chromatin. Alternatively, 6-4 PP accumulate in the linker 
region and distribute randomly in the nucleosome core to a lesser extent (Friedberg et al., 
2006).  
It is easy to see that DNA damage is an inevitable component to life, and as such 
poses a major challenge to the cell to be able to identify many types of DNA damage. 
The devastating results from spontaneous DNA damage alone has the potential to 
overwhelm a cell, not to mention DNA damage induced by environmental factors. It is no 
wonder why cells have evolved numerous mechanisms to repair and bypass DNA 
damage.  
 
1.2 – DNA Repair Pathways 
 Given the multitude of mechanisms that constantly assault cellular DNA, it is no 
surprise that cells have responded with an equally large array of mechanisms to not only 
repair but also bypass DNA damage to allow for cell survival. In the strict sense of the 
term, as defined by Friedberg et al. 2006, DNA repair is defined as “cellular responses to 
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DNA damage that result in the restoration of normal nucleotide sequence and DNA 
structure.”, and as such two mechanisms exist for DNA repair, reversal and excision of 
DNA damage (Friedberg et al., 2006). In addition to the DNA repair and tolerance 
mechanisms discussed below it should be mentioned that cell cycle progression and 
transcription also play important roles in responding to DNA damage for the preservation 
of genomic stability.  
 
1.2.1 – Direct Reversal of Damage 
 Direct reversal of DNA damage is thought to be the simplest, most efficient, most 
direct, and most accurate way to repair DNA damage, and is typically thought to be error-
free. Reversal of DNA damage is thought to be efficient as only a single gene product is 
required resulting in a presumably rapid repair mechanism; however, the repercussion is 
a requirement of high energy (Friedberg et al., 2006). Although direct reversal occurs in a 
very limited manner by photoreactivation or methyl transfer, it was the discovery of 
photoreactivation in 1949 (Kelner, 1949) that initiated the field of DNA repair. 
Photoreactivation, a one-step enzymatic reaction by a photolyase, is a light requiring 
reaction (Cleaver, 2003; Sancar, 2003) that reverses covalently joined adjacent 
pyrimidines characterized by both CPDs and 6-4 PPs. In addition to photoreactivation 
other forms of direct reversal are available to cells to deal with at least four different 
kinds of alkylation base damage which are regulated by the adaptive response to 
alkylation damage (Friedberg et al., 2006). Therefore, mutagenic alkylating agents such 
as MNNG, MNU, and to a smaller extent, MMS, which react with DNA to produce many 
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O-alkylated and N-alkylated products are reversed. In addition to photoreactivation and 
direct reversal of alkylation damage single-strand DNA (ssDNA) breaks (SSBs), without 
end group damage, may be repaired in a direct reversal mechanism via the enzyme DNA 
ligase in which the ends are simply rejoined (Jacobs et al., 1972).   
 
1.2.2 – Base Excision Repair (BER) 
 BER is thought to be the most utilized mechanism of DNA repair in nature, and it 
is conserved from bacteria to humans (Friedberg et al., 2006). BER is defined and 
initiated by the presence of DNA glycosylases. DNA glycosylases are found in bacteria, 
yeast and human cells, and typically maintain function specificity for a particular class of 
base damage such as inappropriate base incorporation, or mispairing (Friedberg et al., 
2006).  
 The essential component of a DNA glycosylase is the catalytic release of free 
bases as a product of their reaction with DNA (Friedberg et al., 2006). Many DNA 
glycosylases are categorized in the helix-hairpin-helix superfamily. These DNA 
glycosylases have a helix-hairpin-helix DNA binding motif found in many DNA binding 
proteins (Doherty et al., 1996). There are six families under the helix-hairpin-helix 
superfamily which are defined by the modified nucleotide they excise. They are: 
alkyladenine-DNA glycosylase, N-methylpurine-DNA glycosylase II, A/G specific 
adenine glycosylase/mismatch glycosylase, endonuclease III, 8-oxoG-DNA glycosylase 
I, and 8-oxoG-DNA glycosylase II. In addition to the helix-hairpin-helix superfamily, 
uracil-DNA glycosylase has the ability to remove uracil from DNA (Friedberg et al., 
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2006). Although the specificity that DNA glycosylases maintain is a great benefit to 
BER, it would be a daunting task for the cell to maintain DNA glycosylases specific for 
each plausible type of DNA damage; instead DNA glycosylases with broader catalytic 
selectivity are also present in the cell, some of which are able to remove alkylation 
damage for example. Unfortunately, the consequence of utilising less specific enzymes is 
a more energy exhaustive repair mechanism. Glycosylases typically function by 
dispersing along the minor groove of DNA until DNA damage is encountered. The DNA 
glycosylase then compresses the DNA backbone and the abnormal nucleoside is flipped 
out to allow for specific recognition of the altered nucleotide and subsequent cleavage by 
hydrolysis of the N-glycosyl bond that links the damaged or altered nucleotide to the 
DNA backbone. The result is an AP site. DNA glycosylases may be monofunctional, and 
result in an AP site, or bifunctional as some of them also cleave the backbone 3’ end of 
the AP site; the latter class is designated DNA glycosylase/AP lyases. Regardless, the 
resultant AP sites must be repaired by AP endonucleases and finally correct nucleotides 
are incorporated via DNA polymerases through a “short patch” (often one nucleotide) or 
a “long patch” (two to eight nucleotides) BER pathway. Finally joining of DNA ends by 
DNA ligases, as in other forms of DNA repair and recombination processes, complete 
BER (Friedberg et al., 2006). Because BER is a multistep process, the intermediates 
formed have the potential to be either mutagenic or reactive if BER is initiated and 
subsequently left incomplete. Results have shown that repair of single or clustered DNA 
lesions by DNA glycosylases that are initiated but either aborted or failed result in lethal 
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DSBs (Blaisdell and Wallace, 2001; Demple and DeMott, 2002; Sutherland et al., 2002; 
Wallace, 2002).  
 
1.2.3 – Mismatch Repair (MMR) 
 Mismatched DNA nucleotides may arise from the misincorporation of DNA 
nucleotides during canonical DNA replication, from insertion of an extra nucleotide, 
deletion of a nucleotide, formation of a heteroduplex, and deamination of 5-
methylcytosine, to name a few. MMR functions to correct nucleotide errors that arise 
during DNA replication and have escaped the proofreading activity of DNA polymerases. 
MMR repairs mismatched or unpaired nucleotides, mispairings arising during replication, 
and mispairings that result from the incorporation of damaged nucleotide precursors 
(Earley and Crouse, 1998), for example the incorporation of d8oxoGTP resulting in DNA 
damage. In additional nucleotides being incorporated or deleted due to replication 
slippage. MMR is similar to BER and NER, discussed below, in terms of their molecular 
mechanisms of functioning. MMR functions by recognizing the lesion, discriminating 
between the newly synthesized DNA strand containing an error and the parental strand, 
excision, and finally ligation. Although MMR may remove DNA damage in the example 
of 8oxoG-A mismatches in yeast, in the case of O6meG-T mismatches, dTMP is 
removed and the DNA damage remains (Friedberg et al., 2006).  
 In Escherichia coli, MMR distinguished the parent strand from the daughter 
strand by the methylation state of adenine in a d(GATC) sequence (Modrich and Lahue, 
1996), and although MMR is highly conserved from prokaryotes to eukaryotes, it has not 
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yet been determined how this distinction is made in eukaryotes. Regardless of the 
organism MMR is initiated by MutS, or MutS homologue, binding to DNA mismatches 
via a conserved DNA binding domain. In prokaryotes this is achieved via the MutS 
homodimer, while S. cerevisiae encodes six MutS homologues Msh1-6 (Friedberg et al., 
2006). Msh1 in S. cerevisiae is thought to function independently as a homodimer (Chi 
and Kolodner, 1994) in the repair of mitochondrial DNA (Dzierzbicki et al., 2004; 
Reenan and Kolodner, 1992) while Msh2, Msh3, and Msh6 function to maintain the 
nuclear genome (Johnson et al., 1996; Marsischky et al., 1996) leaving Msh4 and Msh5 
to function during meiotic recombination (Friedberg et al., 2006; Hollingsworth et al., 
1995; Ross-Macdonald and Roeder, 1994). MutS and MutS homologs undergo an ATP-
dependent conformation change allowing MutS to move along the DNA backbone in 
vitro (Blackwell et al., 1998; Gradia et al., 1999; Iaccarino et al., 2000). Subsequently, 
MutS binds to MutL at the site of mismatch (Grilley et al., 1989) in a second ATP-
dependent step (Friedberg et al., 2006). MutL, a homodimer in prokaryotes, is comprised 
of the heterodimer Mlh1-Pms1 (Prolla et al., 1994a; Prolla et al., 1994b; Wang et al., 
1999) in S. cerevisiae. S. cerevisiae encodes a total of four MutL orthologues; however, 
the heterodimers of Mlh1-Mlh3, Mlh1-Mlh2 are thought to play more specialized roles, 
for example in the repair of frameshift mutations (Flores-Rozas and Kolodner, 1998; 
Harfe et al., 2000). In E. coli subsequent steps involve recruitment of MutH opposite a 
dam methylated GATC parent DNA sequence. Alternatively, in Bacillus subtilis, which 
does not have dam-directed methylation, MutS has been shown to colocalize with 
replication foci. Yet, in mammalian cells studies have suggested the involvement of 
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proliferating cell nuclear antigen (PCNA) (Friedberg et al., 2006). Subsequently four 
exonucleases have been implicated for MMR in E. coli, while Exo1 has been 
demonstrated to be involved in MMR in S. cerevisiae and demonstrated co-localization 
with PCNA (Tishkoff et al., 1997). During meiosis in S. cerevisiae MMR also maintains 
an antirecombinational function thereby preventing heteroduplex formation particularly 
between divergent DNA sequences (Alani et al., 1994; Borts et al., 2000). Defects in 
MMR are thought to cause an increase in the spontaneous mutation rate by up to a 1000-
fold, and in humans it is associated with cancer thus signifying the importance of MMR 
in maintaining genomic stability.   
 
1.2.4 – Nucleotide Excision Repair (NER) 
 Alternative to BER and MMR, DNA repair may also be accomplished by 
nucleotide excision repair. Following the discovery of enzymatic photoreactivation DNA 
repair was differentiated as either light dependent repair (photoreactivation) or dark 
repair (repair independent of light and photoreactivation), which led to the discovery of 
NER by autoradiographic experiments in E. coli. NER is defined as a process where 
damaged nucleotides are excised from the genome as part of an oligonucleotide 
(Friedberg, 1988), and should not be confused with BER that excises damaged 
nucleotides from the genome. Although a complex process, NER can simply be 
explained as the recognition of a damaged nucleotide, incision on either side of the 
affected DNA nucleotide, excision of the oligonucleotide, DNA synthesis to fill the DNA 
gap, and finally DNA ligation.   
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 In E. coli, NER is carried out by three proteins, UvrA, UvrB and UvrC that act in 
a sequential manner (collectively referred to as UvrABC endonuclease). UvrAB genes are 
under the control of the SOS regulon and as such are DNA damage inducible genes. In 
addition, UvrB appears to have an SOS-independent induction mechanism as well. 
Mutations in any one of the uvrABC endonuclease genes render E. coli cells sensitive to 
UV radiation and numerous chemical agents including nitrogen mustard and MNNG. 
UvrA is an ATPase and a dimeric DNA binding protein, and recognizes various types of 
DNA nucleotide damage. Following UV radiation the UvrABC endonuclease generally 
hydrolyses the eighth phosphodiester bond 5’ to CPD or 6-4 PP; however, the 3’ incision 
is more variable, and is surmised to account for the variability in DNA conformation as a 
result of different nucleotide damage allowing NER to handle numerous types of DNA 
damage (Friedberg et al., 2006).  
 In eukaryotes inactivation of RAD1, RAD2, RAD3, RAD4 and RAD10 genes 
causes an increased sensitivity to UV radiation and chemicals which produce bulky 
nucleotide adducts, and renders NER completely defective in vivo (Friedberg et al., 
2006). Humans defective in NER suffer from xeroderma pigmentosum (XP), a condition 
in which the repair of UV damage from sunlight is inadequate, and typically results in 
skin cancer at a young age (Friedberg et al., 2006).   
 
1.2.5 – Homologous Recombination (HR) 
 In 1974 Game and Mortimer published a paper establishing the X-ray sensitivity 
of the rad50-rad57 mutants (Game and Mortimer, 1974), and since then mutations of the 
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RAD50-RAD59 genes have been shown to have a characteristic sensitivity to ionizing 
radiations and chemicals that cause strand breaks (Friedberg et al., 2006). Strand breaks, 
specifically unrepaired DSBs are thought to be the main reason for cell killing following 
IR. However, DSBs may also arise endogenously during cellular metabolism or 
exogenously as a result of exposure to DNA-damaging chemicals. Regardless of how 
they arise, DSBs must be repaired to avoid mutations, loss or rearrangement of 
chromosomes, cell death and, in higher eukaryotes cancer. DSBs are essentially repaired 
by one of two mechanisms; non-homologous end joining (NHEJ), or HR. 
 Homologous recombination is accomplished by the RAD52 epistasis group (Table 
1.1) in S. cerevisiae and is known to play several vital roles in maintaining genomic 
stability by removing DSBs and interstrand crosslinks in both prokaryotes and 
eukaryotes. In addition, HR functions in preserving replication forks, telomere 
maintenance and chromosome segregation in meiosis I (Friedberg et al., 2006). Because 
HR requires an extensive region of DNA homology from undamaged sister chromatid or 
homologous chromosomes in order to function it is thought to be largely an error-free 
process. HR is characterized by the requirement of recombinases, of which there are two 
in eukaryotes, Rad51 (which shares 30% sequence identity with the bacterial RecA 
protein (Symington, 2002)) and Dmc1. While Dmc1 functions only in meiosis Rad51 is 
required for mitotic and meiotic events requiring HR. Deletion of RAD51 renders S. 
cerevisiae cells highly sensitive to DNA-damaging agents, while in higher eukaryotes 
deletion of RAD51 renders cells inviable and in vertebrates, as studied in mice causes 
embryonic lethality (Symington, 2002; Tsuzuki et al., 1996). In S. cerevisiae DSBs are 
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detected and bound by the MRX complex, which is required for efficient DSB resection. 
Mutants of the MRX complex maintain persistent strand breaks that are not processed 
appropriately (Friedberg et al., 2006). The ssDNA left behind is rapidly bound by RPA 
(replication protein A) allowing Rad52 to recruit Rad51 to the RPA-ssDNA complex. It 
is thought that RPA binding to ssDNA is inhibitory to Rad51 binding, therefore Rad52 
and the Rad55-Rad57 heterodimer function to recruit and stabilize Rad51 binding to 
ssDNA (Fung et al., 2009). Rad51 is known to self-interact as well as interact with 
Rad52, Rad54, Rdh54/Tid1 and Rad55 (Symington, 2002). Although the interaction 
between Rad51 and Rad52 is quite stable in yeast, the interactions between Rad51, 
Rad52 and Rad54 are thought to be highly dynamic in higher eukaryotes. The Rad51 
nucleofiliment protein initiates strand invasion into a homologous sequence to form a D-
loop. Antagonistic to HR is the Srs2 protein which contains both helicase and ATPase 
activities in vitro (Rong and Klein, 1993). Srs2 disassembles the Rad51 presynaptic 
filament allowing for the ssDNA to once again be coated with RPA and abolishing 
further Rad51 binding (Krejci et al., 2003; Veaute et al., 2003). It is thought that Rad54 
promotes chromatin remodeling, DNA unwinding and strand annealing between the 
donor DNA and the incoming Rad51-nucleofiliment protein (Friedberg et al., 2006). By 
displacing the original paired DNA strands a Holliday junction intermediate is formed 
that must be resolved. Two scenarios exist for HR, one in which the second DNA end is 
captured resulting in two Holliday junctions being formed (Double-strand break repair or 
DSBR), and the second where synthesis-dependent strand annealing (SDSA) is required  
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(Figure 1.1). Depending on how the double-Holliday junction is resolved in DSBR, it 
may result in crossover or non-crossover events.  
 In addition to HR and NHEJ cells can utilize several other mechanisms to survive 
DSB that are alternative to HR, yet still require some form of homologous pairing to 
function. One such mechanism is single-strand annealing (SSA) (Figure 1.1), a result of 
the annealing of direct repeats that were revealed by resection of the DSB to ssDNA. The 
genetic requirements for SSA differ from HR in that in S. cerevisiae Rad51 is dispensable 
whereas Rad52 and its homolog Rad59 are required (Friedberg et al., 2006). Although 
SSA can repair DSBs the unfortunate consequence is the deletion of what can be a large 
portion of DNA. In addition to SSA is the break-induced repair (BIR) of DSBs. BIR also 
assumes the invasion of a 3` ssDNA overhang; however, as in SDSA the displaced strand 
does not pair back but instead serves as the lagging-strand template of a newly formed 
replication fork (Friedberg et al., 2006). 
NHEJ acts directly on the ends of DSBs allowing for the direct ligation of the 
ends (Figure 1.1). Various studies have suggested the existence of two NHEJ pathways. 
One NHEJ pathway is dependent on DNA end binding protein Ku which prevents the 
DNA ends from degradation (Feldmann et al., 2000; Gottlich et al., 1998; Liang and 
Jasin, 1996), while the second is Ku-independent and mutagenic. In contrast to the error-
free mechanisms of HR, NHEJ is typically thought of as mutagenic due to the potential 
loss of DNA at free DNA ends since the two DSBs may be reannealed by NHEJ whether 
their ends are complimentary or not. Free DNA ends are susceptible to nuclease 
degradation and this method is therefore error prone as some genetic material may be lost  
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Figure 1.1 – Overview of Eukaryotic DSB Repair Pathways. DSBs may be resealed by 
NHEJ, or alternatively DSB may be resected to form 3`overhangs thus initiating HR. 
Strand invasion can result in the formation of a replication fork and an extended gene 
conversion tract for break induced repair (BIR). Following limited DNA synthesis (shown 
in gold) the invading strand may reanneal without crossover events which is referred to as 
synthesis dependent strand annealing (SDSA). Should HR continue following strand 
invasion Holliday junctions are formed and subsequently resolved. Alternatively single-
strand annealing (SSA) results from the annealing of direct repeats.  Friedberg et al., 2006 
(Copyright granted for republish or display in a thesis/dissertation).  
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(Pfeiffer, 1998). Although NHEJ and HR occur in all eukaryotes, yeast cells prefer HR, 
while mammalian somatic cells prefer NHEJ.  
 Studies in S. cerevisiae have shown that BER, NER, and HR have overlapping 
functions in repairing spontaneous and exogenous oxidative DNA damage (Doetsch et 
al., 2001; Gellon et al., 2001; Swanson et al., 1999; Vance and Wilson, 2001). However, 
should these mechanisms fail, DNA damage tolerance functions to maintain cell survival.  
 
1.3 – DNA Damage Tolerance 
 Although most DNA damage can be removed and repaired by BER, MMR, NER, 
HR and NHEJ as previously discussed, certain damage may elude DNA repair, 
overwhelm DNA repair mechanisms, or present a replication blockage thus hindering 
replicative DNA polymerases. Therefore, in order to preserve genomic stability and 
viability, cells possess mechanisms that allow the cell to tolerate DNA damage, these 
mechanisms are thought to be as biologically significant as DNA repair mechanisms 
(Friedberg et al., 2006). This is collectively termed DNA damage tolerance (DDT).  
 
1.3.1 – DNA Damage Tolerance and Translesion DNA Synthesis in E. coli 
The notion that cells produce physiological responses to DNA damage was 
initially discovered in E. coli. The majority of cellular responses to DNA damage in E. 
coli are centrally controlled by the SOS regulatory network. During the early phases of 
the SOS response accurate DNA repair is achieved; however, should these mechanisms 
fail or damage exceeds repair, the SOS response is activated to initiate a series of DNA 
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damage tolerance mechanisms. The SOS regulon genes respond to ssDNA. The RecA 
protein recognizes ssDNA and thus promotes two parallel pathways; recombination-
mediated bypass which constitutes the majority of lesion bypass in E. coli, and TLS. 
Current ideology suggests that it is ssDNA generated from attempted replication of 
damaged template DNA or as a result of interrupted DNA replication that serves as a 
DNA damage signal. It is the ternary complex formed amongst the RecA protein, a 
nucleoside triphosphate, and ssDNA (also referred to as a RecA nucleoprotein filament) 
that activates the RecA protein (Craig and Roberts, 1980; Little et al., 1981). It is these 
nucleoprotein filaments, or active RecA that interact with LexA and induce autocleavage 
of the LexA protein, a homodimer repressor of the SOS regulon at the SOS boxes, thus 
allowing for transcriptional activation of more than 40 genes required for DNA repair and 
cell survival (Courcelle et al., 2001; Friedberg et al., 2006; Little, 1984). In particular the 
SOS response induces both DinB and UmuDC that encode polymerases PolIV and PolV, 
respectively, both of which are involved in TLS. Activated RecA has the ability to 
facilitate UmuD self-cleavage and the resulting product forms an active heterotrimer 
UmuD’2C (Bruck et al., 1996; Woodgate et al., 1989), which is the highly mutagenic 
form of PolV. PolV is thought to replace the replicative polymerase (PolIII) and allow for 
lesion bypass. Although DNA repair and DNA damage tolerance in E. coli seem to be 
centered on RecA, this mechanism does not appear to be evolutionarily conserved in 
eukaryotes.  
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1.3.2 – Radiation Repair Epistasis Groups in S. cerevisiae 
 The yeast genome was first suggested to be a radiation-sensitive target in the late 
1940’s (Laterjet and Ephrussi, 1949); however, it was in the late 1960’s (Nakai and 
Matsumoto, 1967) that the first investigation for radiation-sensitive yeast mutants began 
(Friedberg, 1988). Since then over 30 RAD (RADiation sensitive) genes have been 
identified that contribute to the resistance of killing by UV and/or IR. Subsequently many 
rad mutants have been shown to display enhanced sensitivity to other chemicals 
(Friedberg, 1988). Since then RAD genes have been organized into essentially three 
epistasis groups representing three classes of cellular responses to DNA damage in S. 
cerevisiae. An epistatic interaction can be operationally defined as the presence of two 
mutations in different genetic loci resulting in a phenotype quantitatively equal to one of 
the single mutations. An epistatic interaction thus suggests that the genes being studied 
are involved in sequential steps of a multistep biochemical pathway or their products are 
in the same multimeric complex. Alternatively, if the two mutations produce an additive 
or synergistic phenotype, they are placed in different epistasis groups (Friedberg et al., 
2006). In S. cerevisiae the RAD3 epistasis group and RAD52 group consist of NER and 
HR genes, respectively, and repair the majority of radiation-induced DNA lesions. In 
addition, lesions induced by oxidative and alkylating agents may be dealt with by BER. 
Should any or all of the above pathways fail the third radiation repair epistasis group, 
represented by RAD6, is thought to function by reinitiating replication without removing 
the lesion itself. This is termed, though somewhat misleadingly, DNA PRR. The genes 
that are known to be allocated to each epistasis group are listed in Table 1.1.   
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Table 1.1 - S. cerevisiae Radiation Repair Epistasis Groups 
Friedberg et al. 2006, and Friedberg et al. 1991.  
Copyright granted for republish or display in a thesis/dissertation 
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1.3.3 – DNA Postreplication Repair (PRR) in Yeast 
The RAD6 epistasis group is one of the initial radiation repair epistasis groups 
found in S. cerevisiae. Historically, genes that were not assigned to either the RAD3 or 
RAD52 epistasis groups were placed into the RAD6 group. While the first two epistasis 
groups remove and repair DNA-damaging lesions, PRR functions to allow replication to 
bypass lesions without removing the lesion itself. Consequently, PRR functions to avoid 
potentially lethal effect with or without increased mutagenesis. Genes required for PRR 
were initially identified by alkaline sucrose gradients that demonstrated the inability of 
yeast mutants to fill single-stranded gaps following UV radiation in an NER deficient 
background (di Caprio and Cox, 1981; Prakash, 1981). Experimental results showed that 
ssDNA gaps persisted in rad6 and rad18 mutants (Prakash, 1981). Since then, the stable 
complex formed by Rad6 and Rad18 have been shown to centrally control the PRR 
pathways, and while Rad6 has diverse functions outside of PRR, Rad18 functions 
exclusively in PRR. Like E. coli, PRR in S. cerevisiae can be subdivided into two 
pathways. However, in S. cerevisiae it is the sequential ubiquitination of PCNA that 
satisfactorily explains the current genetic observations with regards to how the RAD6 
pathway operates to bypass DNA damage in eukaryotes and shuffles DNA lesion bypass 
to either a TLS (error-prone) or an error-free pathway.  
 
1.3.3.1 – Ubiquitination 
  Ubiquitin (Ub) is a 76 amino acid protein which can be found either freely or 
covalently attached to a substrate in the cell. Conjugation of Ub to other proteins occurs 
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through a cascade of reactions as depicted in Figure 1.2 (adapted from (Matyskiela et al., 
2009)). Ubiquitination is known to be highly conserved among diverse eukaryotes. To 
begin, the -carboxyl group of Ub, which is essential for all Ub-dependent processes, 
must be activated. This allows for Ub to be linked to an E1 (Ub-activating) enzyme in an 
ATP-dependent fashion. Following ATP hydrolysis a thioester bond is formed between 
Ub and the E1. In the second step Ub is passed from the E1 to an E2 (Ub-conjugating) 
enzyme via transthiolation (Hochstrasser, 1996). The E2 family of enzymes is defined by 
a conserved catalytic core (Ubc) domain that contains an active-cysteine residue. From 
the E2, Ub may then be transferred to an E3 (Ub-ligase), however this step is not 
essential and ubiquitination may occur in the absence of an E3. Regardless, the final step 
creates an isopeptide bond between the C-terminal glycine residue of Ub and a lysine 
residue on the target protein, resulting in a monoubiquitinated substrate. It is also possible 
that substrates can be monoubiquitinated at several lysine residues resulting in a 
multiubiquitinated substrate. In addition, covalently bound Ub can be further modified by 
the sequential addition of Ub resulting in polyubiquitin chains. In 1980 it was proposed 
that selective conjugation of Ub to proteins marked these substrates for degradation 
(Hershko et al., 1980), and in 1987 Hough et al. purified a protease capable of degrading 
a multiubiquitin-protein substrates (Hough et al., 1987). Subsequently Ub has become 
best known for its role in covalent modification of substrates to signal them for 
degradation by the 26S proteasome (Hochstrasser, 1996), which breaks down the 
substrate but recycles the Ub protein. Predominantly short-lived regulatory proteins are   
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Figure 1.2 – Ubiquitination. Ubiquitination occurs via a cascade of reactions. An E1 
(ubiquitin-activating) enzyme is attached to a Ub moiety by a thioester bond in an 
ATP-dependent manner. The Ub is then transferred from the E1 to an E2 (Ub-
conjugating) enzyme, and subsequently, Ub is transferred to an E3 (Ub-ligase) 
enzyme, although not absolutely required. In a final step Ub is attached to a substrate. 
The final result is a monoubiquitinated substrate. Subsequent rounds of ubiquitination 
may allow for the substrate to be multiubiquitinated at several lysine residues. In 
addition, covalently bound ubiquitin can be further modified by the sequential 
addition of ubiquitin resulting in polyubiquitin chains. Ub chains may be formed in a 
Lys48-dependent manner and signal for proteosomal degradation, or in a non-
canonical Lys63-dependent manner and signal for DNA damage response. 
Monoubiquitination 
Multiubiquitination Polyubiquitination 
Additional rounds of  
ubiquitination 
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degraded via the Ub-dependent proteasome pathway (Pickart, 1997). Substrates that are 
best recognized by the 26S proteasome are typically those conjugated to Lys48 
polyubiquitin chains, a signal which has an affinity for the specific length of the Lys48 
chain. Since intracellular proteolysis is essential for all organisms, including bacteria, the 
importance of the Lys48 chains is only further exemplified by the finding that the Ub-
K48R point mutation causes lethality in S. cerevisiae (Finley et al., 1994). However, 
substrates covalently modified by a single Ub or unmodified substrates have also been 
shown to be degraded by the 26S proteasome. It should also be noted that Ub can target 
proteins for degradation by the lysozyme. Although Lys48-linked Ub chains may be the 
most abundant it has become clear that there are additional Ub chain modifications found 
in vivo. Studies have shown that polyubiquitination can occur on seven Lys sites on Ub 
itself; Lys48, Lys63, Lys11, Lys29, Lys33, Lys27, and Lys6 (Arnason and Ellison, 1994; 
Peng et al., 2003). 
A study which examined all six Lys residues on Ub found that it was a Ub-K63R 
mutant that showed sensitivity to DNA-damaging agents such as MMS and UV but did 
not affect protein turnover, therefore suggesting that this Lys63 residue was not involved 
in degradation and instead functioned in the DNA repair pathway (Spence et al., 1995). 
Since then the Lys63-linked chains have been linked to DNA damage tolerance 
(Hofmann and Pickart, 1999; Ulrich, 2002), the inflammatory response (Sun and Chen, 
2004), protein trafficking (Hicke and Dunn, 2003) and ribosomal protein synthesis 
(Spence et al., 2000). It is the monoubiquitination, and non-canonical Lys63-linked 
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polyubiquitin chains that play a vital role in PRR, both TLS and error-free PRR, 
respectively.  
 
1.3.3.2 – Translesion DNA Synthesis (TLS) 
Post-translational modification of PCNA by Ub plays a vital role in coordinating 
DNA damage tolerance processes in yeast. The Rad6-Rad18 complex is a characteristic 
E2-E3 complex that is responsible for the monoubiquitination of PCNA which allows for 
TLS lesion bypass. In eukaryotes DNA lesions that stall replication are bypassed by TLS 
polymerases, specifically the Y family of DNA polymerases and DNA polymerase 
Pola member of the B family of polymerases). The TLS pathway was first 
identified by a genetic screen for mutants incapable of reverting the arg4-17 and lys1-1 
alleles following exposure to UV irradiation (Lemontt, 1971a, b). It has since become 
accepted that TLS is comprised of REV1, REV3, and REV7 (Figure 1.3). The TLS 
polymerases are known to have a relaxed fidelity for nucleotide incorporation, a function 
that is required to promote DNA synthesis in the presence of DNA damage, and as such 
results in a bypass mechanism that is highly mutagenic. REV1 is known to have 
deoxycytidyl transferase activity (Nelson et al., 1996a), and is known to have separate 
PCNA- and Ub-interacting domains. Rev1 is thought to function as a scaffolding protein 
for TLS independent of its terminal transferase activity. Rev3 and Rev7 form the non-
essential DNA polymerase Polwhich interacts with Rev1; all three REV genes are 
required for the characteristic mutagenesis induced by UV irradiation lesions or other  
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Figure 1.3 – Model Depicting the Budding Yeast DNA Damage Tolerance Pathways 
Mediated by Covalent Modifications of PCNA. Covalent modification of PCNA at 
K164 allows for the monoubiquitination of PCNA and in combination with Rev1, Rev3 
and Rev7 allows for TLS, or error-prone lesion bypass. The sequential polyubiquitination 
of PCNA by Rad5–Ubc13–Mms2 results in an error-free mechanism of lesion bypass. 
Although some form of a homologous chromatid template is thought to be required for 
error-free lesion bypass the exact mechanisms involved remain unknown. It is therefore 
the hypothesis of this body of work that additional genes and proteins are involved in 
error-free PRR, and thus we intend to identify them.  
 33 
 
chemical carcinogens (Johnson et al., 1998). PCNA provides the main scaffold to which 
TLS polymerases bind to in order to execute their role. Rev3, which is the catalytic 
subunit of Pol, is not essential for cell growth or viability in yeast cells; however, 
deletion of Rev3l in mice results in embryonic lethality (Bemark et al., 2000; Esposito et 
al., 2000; Wittschieben et al., 2000). Evidence also suggests that abasic lesions on DNA 
induce PCNA ubiquitination because TLS DNA polymerases are required for proficient 
replication through abasic sites in yeast and mammalian cells (Pages et al., 2008b). 
Underscoring the significance of TLS process is the finding that mutations of the 
XPV/POLH gene, which encodes Pol in humans, results in a modified form of XP, 
xeroderma pigmentosum variant (XPV). Patients with XPV are hypersensitive to UV 
damage and are predisposed to cancer. However, while TLS is well characterized, 
relatively little is known about error-free PRR.  
 
1.3.3.3 – Error-free PRR 
 The existence of the error-free PRR branch under the RAD6 pathway is suspected 
because the rad6 or rad18 mutant is extremely sensitive to killing by DNA-damaging 
agents while the rev mutants are not (Lawrence, 1994; Prakash et al., 1993). Perhaps the 
first firm demonstration of the existence of error-free PRR was through genetic 
characterization of the mms2 mutant (Broomfield et al., 1998; Xiao et al., 1999). The 
mms2 mutant displays moderate sensitivity to killing by a variety of DNA-damaging 
agents and the gene is thus assigned to the RAD6 pathway. The characteristic features of 
mms2 include its strong synergistic interaction with rev3 and its REV3-dependent 
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increase in spontaneous mutagenesis. Since then Mms2, Ubc13, and Rad5 have all be 
allocated to the RAD6 error-free PRR pathway through genetic and epistatic analysis. 
MMS2 encodes a Ubc-like protein but does not contain an active-site Cys residue. It turns 
out that Mms2 forms a stable complex with Ubc13, and this complex specifically 
promotes the non-canonical Lys63-linked Ub chain formation (Figure 1.3) (Hofmann and 
Pickart, 1999). Indeed ubc13 is epistatic to mms2 and the two mutants share all 
characteristic features as described above (Brusky et al., 2000). Furthermore, Rad5, a 
member of the SWI/SNF family of ATPases with a C3HC4 RING finger motif, is capable 
of interacting with Pol30 (PCNA), Ubc13 and Rad18 and may serve as an E3 for Ubc13–
Mms2 (Ulrich and Jentsch, 2000). Thus, it is thought that Rad5 functions to recruit the 
Mms2–Ubc13 complex in close proximity to PCNA and facilitate the Lys63-linked 
polyubiquitination of PCNA. However, this is thought to be merely a signalling 
mechanism, and does not directly facilitate error-free lesion bypass. Additional genes are 
therefore required for error-free lesion bypass. 
During normal DNA synthesis DDT is thought to occur at sites of DNA damage, 
which has stalled the replication fork machinery. While replication may restart 
downstream of the DNA lesion, if synthesis continues on the undamaged strand there 
becomes two plausible mechanisms for error-free lesion bypass (Figure 1.4). One 
possible model is that stalled replication forks can be processed by fork reversal (or a 
chicken-foot model) a possible Rad51-independent template switching mechanism which 
allows for synthesis to continue after the unfolding of the template switch resulting in an 
error-free lesion bypass mechanism. Alternatively, template switching by HR in a Rad51-
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dependent manner may allow for strand invasion to occur thereby using an intact sister 
chromatid strand as template for DNA synthesis, resulting in error-free lesion bypass 
(Figure 1.4) following resolution of the intermediate structures. Although, these two 
mechanisms may not be mutually exclusive, either model allows for lesion bypass 
however leaving behind the original replication blocking lesion to be repaired later. 
Alternative to the error-free mechanisms, TLS and the associated low-fidelity 
polymerases may synthesize DNA across from the DNA lesion allowing for lesion 
bypass to occur, although it does so in a largely error-prone manner.  
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Figure 1.4 – Mechanisms of Lesion Bypass at Stalled Replication Forks. Possible 
means of lesion bypass include replication restart, translesion DNA synthesis and two 
alternate error-free lesion bypass mechanisms. While fork reversal is one error-free 
model for lesion bypass template switching in a Rad51-dependent manner is a 
possibility too, however, the two might not be mutually exclusive. (Modified with 
permission from Parker Andersen, (Andersen, 2009)). 
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1.4 – Rationale for This Study 
 Although the mechanisms of TLS have been well characterized and the existence 
of error-free pathway has been definitively demonstrated, relatively little was known 
about the detailed molecular mechanism of error-free PRR. Previous reports have 
proposed that some form of a homologous chromatid template was required (Broomfield 
et al., 2001; Li et al., 2002; Zhang and Lawrence, 2005); however, the exact mechanism 
of error-free lesion bypass remained uncertain. It is henceforth the ambition of this body 
of work to find novel genes and proteins involved in PRR, specifically error-free PRR, in 
hopes of expounding the current understanding of error-free PRR mechanisms and 
subsequently lesion bypass.  
 By taking advantage of the synergism between the TLS and error-free PRR 
pathways it is possible to search for novel genes involved in both PRR pathways. 
Synthetic lethal screening is a powerful genetic technique available to search for mutants 
in related pathways. The theory being that when either individual gene is deleted the cell 
is viable, as the alternative pathway can functionally compensate for the deletion; 
however, if both genes are deleted, thus eliminating both pathways, the cells become sick 
or inviable. To begin this study, a screen of the non-essential genes in the S. cerevisiae 
genome was initiated utilising synthetic genetic array (SGA) analysis with the help of Dr. 
Charles Boone at the University of Toronto. In addition, because we are searching for 
novel genes involved in a DNA damage tolerance mechanism, by conducting a 
conditional synthetic lethal screen (by adding a DNA-damaging agent to the SGA screen) 
we may broaden our search to identify genetic interactions that occur only in the presence 
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of DNA damage and may therefore give us a better understanding of the genetic 
interactions occurring in the PRR or DNA damage tolerance pathways. Initial screening 
results are presented here, and novel findings are explored to gain further insight into 
PRR.  
It is technically difficult and laborious to study DNA repair pathways in humans; 
therefore, this study utilizes a model eukaryotic organism, namely haploid S. cerevisiae 
yeast strains, which have a fast doubling time (approximately 1.5 hour) and an easily 
manipulated genome which are vital to studying DNA repair mechanisms. As many of 
these genes have known human homologues, it is hopeful that by gaining further insight 
into the yeast PRR, this study will provide insight into how these similar functions are 
conserved in higher eukaryotes to prevent the hallmark of genomic instability, namely 
cancer.  
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1 – Molecular Biology Techniques 
2.1.1 – Bacterial Culture and Storage 
 The E. coli strains DH10B and DH5 (Gibco BRL, Grand Island, NY USA) were used 
for bacterial transformations, while BL21 (DE3)-RIL (Strategene, # 230245) cells were utilized 
for protein overexpression of pGEX-Pol30. Unless otherwise noted bacterial strains were 
incubated at 37 ºC in Luria Broth (LB) (US Biological L1505) (10 g Tryptone, 5 g yeast extract, 
5 g NaCl in a total of 1 L ddH2O (double-distilled sterile or reverse osmosized H2O)). LB agar 
plates were made by resuspending the desired amount of LB agar powder (US Biological L1500) 
in ddH2O, autoclaving, and pouring approximately 25 mL into each Petri dish. Plasmid selection 
was maintained by the addition of Ampicillin (Amp) to a final concentration of 50 g/mL. For 
long term storage transformed cells were grown overnight in 900 L of LB + Amp at 37 ºC to 
which 100 L of dimethyl sulfoxide (DMSO. EMD Chemicals, MX1485-6) was added, and cells 
were subsequently frozen at -70 ºC. 
  
2.1.2 – Preparation of Competent Cells 
2.1.2.1 – Competent Cells for Chemical Transformation 
 Competent cells for chemical transformation were grown in the LB medium to an OD600 
of 0.3-0.4, diluted 1:1 in transformation solution storage (TSS) solution (LB with 10 % 
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polyethylene glycol8000 (PEG)8000, 5 % DMSO, 50 mM Mg
2+
 (MgSO4 or MgCl2), and pH 6.5), 
aliquoted 50 L/tube and stored at -70 ºC. This protocol was previously described (Chung et al., 
1989). 
 
2.1.2.2 – Competent Cells for Electroporation 
 Competent cells were prepared as outlined in the Bio-Rad E. coli Pulser manual. E. coli 
cells were grown to an OD600 of 0.6 in 1 L of LB media. Cells were collected by centrifugation at 
3500 rpm and the pellet was resuspended in 10 % sterile, cold glycerol. Centrifugation was 
repeated 4x, each time reducing the resuspension volume, with a final volume of 4 mL. Cells 
were then aliquoted, 25 L/tube and quickly frozen at -70 ºC for long term storage. 
 
2.1.3 – Bacterial Transformation 
2.1.3.1 – Transformation by Electroporation 
 Transformation of electroporation competent cells was achieved by thawing cells on ice, 
to which 1-2 L of 0.1-0.2 g/L DNA sample was added, and transferred to a GenePulser 
Cuvette (Bio-Rad, # 165-2089). The cuvette was then loaded into a Bio-Rad E. coli Pulser and 
treated with a 1.8 V electric pulse. 200 L of super optimal broth with catabolite repression 
(SOC) media (SOC Broth. American Biorganics, Inc., Niagra Falls N.Y., Catalog No. A19-8445. 
Containing 20 g peptone C, 5 g yeast extract, 0.585 g NaCl, 0.9523 g MgCl2, 1.204 g MgSO4, 
0.1864 g KCl and 3.603 g glucose per litre) was added to the cuvette to remove the cells and 
placed in a 37 ºC water bath for 45 minutes. 50 – 200 L (volume was dependent on the 
predicted efficiency of the transformation) of cell suspension was then plated on LB + drug 
selection agar plates, and incubated at 37 ºC overnight. 
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 2.1.3.2 – Chemical Transformation 
 Chemical transformations were achieved by thawing chemical competent cells on ice, 
adding DNA (no more than 10 % the final volume) and incubated on ice for 30 minutes. Cells 
were then heat shocked for 1 minute at 42 ºC, resuspended in 450 L SOC media and incubated 
at 37 ºC before being plated on LB + drug selective media and incubated at 37 ºC. 
 
2.1.4 – Plasmid DNA Isolation 
2.1.4.1 – Plasmid DNA Isolation by Quantum Prep® Kit 
 The majority of plasmid DNA isolation was achieved by using the Quantum Prep® 
Plasmid Miniprep kit purchased from Bio-Rad (Catalogue #732-6100) and utilising the protocol 
provided with the kit, with one slight modification: the last step was repeated twice, resulting in a 
total volume of 200 L of plasmid DNA obtained instead of the suggested 100 L. 
 
 2.1.4.2 – The Boiling Method 
 Plasmid isolation via the boiling method was performed as previously described 
(Maniatis et al., 1982). Bacterial cells were grown in 1.5 mL LB + drug selection media 
overnight at 37 ºC, collected by centrifugation and resuspended in 350 L of STET (0.1 M NaCl, 
10 mM Tris-HCl pH 8.0, 1 mM (Ethylenedinitrilo)tetraacetic Acid (EDTA. EMD Chemicals, 
EX0539-1) pH 8.0, 5 % Triton X-100). 25 L of lysozyme (10 mg/mL, Sigma, L-6876) was 
added to the eppendorf tube, which was briefly vortexed and placed in boiling water for 45 
seconds. Cells were then centrifuged for 10 minutes and the pellet was removed by a toothpick. 8 
L 5 M NaCl and 2 volumes of cold 95 % ethanol were added to the supernatant followed by 
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incubation at -20 ºC for 30 minutes. Samples were then centrifuged for 15 minutes at top speed 
(13,200 rpm) before the dried pellet was resuspended in sterile ddH2O, and stored at -20 ºC. 
 
2.1.4.3 – Alkaline-Lysis Method 
 Alkaline-lysis was achieved as previously described (Maniatis et al., 1982). In short, a 
single bacterial colony was used to inoculate 2 mL LB + drug selection media and incubated 
overnight. Next morning 1.5 mL of cells were collected by centrifugation and resuspended in 
100 L of ice-cold solution I (50 mM glucose, 25 mM Tris-HCl pH 8.0, 10 mM EDTA pH 8.0) 
vigorously vortexed, followed by the addition of 200 L freshly prepared solution II (0.2 N 
NaOH, 1 % sodium dodecyl sulfate (SDS. J.T. Baker, Phillipsburg, N.J. 4095-02). The tube was 
inverted several time and 150 L of ice-cold solution III (5 M potassium acetate, 11 % glacial 
acetic acid in ddH2O) was added. Again, the tube was inverted several times and incubated on 
ice for 3-5 minutes and centrifuged at 12,000 rpm for 5 minutes. The supernatant was then 
transferred to a new tube and the DNA was precipitated with 8 L 5 M NaCl, and 2 volumes of 
cold 95 % ethanol. Samples were then centrifuged for 15 minutes at top speed before being 
resuspended in sterile ddH2O, and stored at -20 ºC. 
 
2.1.5 – Polymerase Chain Reaction (PCR) 
 PCR was completed based on the instructions from the protocol for Platinum® Taq DNA 
polymerase purchased from Invitrogen (Carlsbad CA., USA. Cat. No. 10966-034). In short a 
typical PCR reaction mixture was composed of the following; 5 L of 10x PCR buffer (provided 
with purchase of Platinum® Taq), 1.0 L of 50 mM MgCl2, 1.8 L of 2.5 mM dNTPs (made 
from the 100 mM dNTP set, Invitrogen, Cat. No. 10297-018), 0.5 L Patinum® Taq DNA 
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polymerase, 0.5 L of each primer (primers were ordered from Integrated DNA Technologies 
and were specific to each PCR run) (See Table 2.1 for a full list of oligonucleotides used in this 
study), 0.5 L of template DNA, and sterile ddH2O to a total volume of 50 L. A standard PCR 
amplification was cycled as follows; initial denature at 94 ºC for 2 minutes, denature 94 ºC for 30 
seconds, annealing 55 ºC for 30 seconds, extension at 72 ºC for 1 minute/kb of the expected 
amplified fragment, a final extension of 72 ºC for 10 minutes followed by holding temperature at 
4 ºC until the samples were removed. Denaturation, annealing and extension steps were cycled 
30 times. Samples were stored at -20 ºC until they were analysed by an agarose gel 
electrophoresis.  
 44 
 
  Table 2.1 Oligonucleotides used in this study.
Oligonucleotide Sequence (5'-3')
EXO1-1 CTT ACG CGT CTT TAG CAA AGG C
EXO1-2 GTG AAT TGC ACA TGC CCA GCG
MMS2-2 CGT AGA AGA AAG CAG CG
MMS2-9 GGG TCG ACA AAG GTT TCT CCT TCC TTC
MRE11-7 GAG TTC ACA AGC AAG CCT G
MRE11-8 GAA TGC AAA TTT GCT CCT CTC
POL30-1 CCG GAT CCA AAT GTT AGA AGC AAA ATT TGA AG
POL30-2 GGC TCG AGT TAT TCT TCG TCA TTA AAT TTG A
PSY3-1 CCT AAC TTA AAG AAT TCC
PSY3-2 GGT AAG GGA GGA TCC GTT TC
PSY3-3 CCC GGA TCC ATG GAA GTT TTA
RAD51-1 GGT GGG ACC ATA AAGG GGG AAT AG
RAD51-2 GCA GTA GGG TTG CGA GGT ATA TG
REV3-2 CTT AGA GGA TAC GAA GAT TCC TC
REV3-3 AAT ACC CGT CAA ATT TGG GG
SAE2-1 GGG CTG CAG TGT ACT TAG CCG TTC
SAE2-2 GCG AAA ATA ACG TCG CAG TTC
SGS1-1 CAA GAA ACT CGA GCC TG
SGS1-2 GAT TTC ACC ACT GCA GG
SIZ1-3 CAG AAA GAA TGA ACC TTT GCC
SIZ1-4 GTG GAA GGA AAG GAC ATA TCC
Table 2.1 – Oligonucleotid s Used in This Study. 
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2.1.6 – Agarose Gel Electrophoresis and DNA Fragment Isolation 
Analysis of DNA samples (plasmid or genomic origin) was achieved by agarose gel 
electrophoresis. 0.7 % agarose (UltraPure™ Agarose. Invitrogen, Cat No. 15510-027) gels were 
made in 1xTAE (Tris-acetate EDTA) (50x TAE stock was made with 2.42 g Tris base, 57.1 mL 
glacial acetic acid, 150 mL EDTA pH 8.0 to a total volume of 1L) and run at 88 V before being 
stained with ethidium bromide to visualize DNA bands. To purify DNA from an agarose gel, the 
DNA band was cut out and places into a small 0.5 L microcentrifuge tube that contained a 
small amount of cheese cloth and a small hole in the bottom, which was then placed inside a 1.5 
mL tube. The sample was frozen at -70 ºC for a minimum of 20 minutes before being centrifuges 
at top speed for 10 minutes. The flow through was treated with phenol and chloroform, and the 
DNA was precipitated by ethanol before being resuspended in sterile water. 
 
2.2 – Recombinant Protein Overexpression and Purification 
 The pGEX-POL30 construct was created by amplifying the POL30 ORF (utilizing the 
POL30-1 and POL30-2 primers) with the addition of BamH1 and Xho1 restriction sites at 5’ and 
3’, respectively. This fragment was then cloned into the BamH1-Sal1 sites of pGEX6p to form 
pGEX-POL30. The plasmid DNA was then transformed into E. coli BL21(DE3)-RIL cells and 
selected for on LB + Amp plates. To overexpress pGEX-POL30 10 mL liquid medium was 
inoculated from a single colony. In the morning the 10 mL culture was used to inoculate 300 mL 
of fresh LB + Amp media and allowed to grow to an OD600 nm of 0.6 - 0.8 (approximately 3 
hours). Cells were then induced with 0.1 mM UltraPure™ IPTG (Isopropylthio-b-D-galactoside. 
Invitrogen, Cat. No. 15529-019) for 1 hour at 30 ºC. Following inductions cells were pelleted 
and resuspended in 90 mL phosphate buffered saline (PBS) before being French pressed twice at 
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10,000 psi. The supernatant was then collected by centrifugation at 15,000 rpm for 10 minutes 
and passed through a 0.45 m filter (Acrodisc® 25mm Syringe Filter w/ 0.45 m Supor® 
Membrane. Pall Corporation, Ann Arbor, MI. PN:4614). A 5 mL sample was then loaded onto a 
pre-packed 5 mL GSTrap column (GE Healthcare, #17-5131-01), and repeated several times 
before the sample was washed with 5 column volumes of PBS, and eluted with fresh reduced 
glutathione elution buffer (10 mM reduced glutathione (L-Glutathione reduced. Sigma, G4251) 
in 50 mM Tris-HCl, and pH 8.0). Eluted samples containing purified GST-Pol30 protein) were 
then collected and subjected to a buffer exchange into PreScission™ Protease Cleavage Buffer 
(PPCB) (50 mM Tris, 100 mM NaCl, 1 mM EDTA, and pH 8.0 adjusted with HCl) using an 
Amicon® Ultra-15 Centrifugal Filter Device (Millipore, Cat. No. UFC901024). This was 
accomplished first by concentrating the protein sample, adding 10 mL of PPCB, concentrating 
again, and repeating a minimum of four times. The final result was a concentrated sample in 
PPCB (Figure 2.2 (A), Lane 1) that was run on a 12% resolving and 5% stacking SDS-PAGE 
(SDS-polyacrylamide gel electrophoresis) gel for visualization as described on page 18.52 of 
(Maniatis et al., 1989). The protein concentration was determined using a BCA™ Protein Assay 
Kit (Pierce, Prod# 23227), and the GST-Pol30 fusion protein was then cleaved with 
PreScission™ Protease (Amersham Pharmacia Biotech Inc., 27-0843-01) at 1 L/100 g protein 
(Figure 2.2A, Lane 2). Following cleavage samples were then once again subjected to buffer 
exchange, this time into PBS (Figure 2.2B, Lane 1), and re-run through the GST column to 
eliminate GST from the sample. This time the initial flow-through was collected, concentrated, 
and the protein concentration was determined (Figure 2.2B, Lane 3). These protein sample was 
given to Dr. Barry Ziola whose laboratory raised polyclonal antibodies against Pol30, and 
subsequently screened for monoclonal antibodies against Pol30.  
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Figure 2.1 – Purification of Pol30 Protein. E. coli BL21(DE3)-RIL cells 
transformed with pGEX-POL30 were subjected to IPTG induction, lysis, and GST 
purification. Samples taken during the experiment were run on SDS-PAGE gels for 
visualization and verification. (A) Lane 1 is purified GST-Pol30 protein that resulted 
from the first round of GST purification. Lane 2 shows the result of PreScission™ 
Protease cleavage of the GST-Pol30 protein shown in lane 1. (B) Lane 1 is the same 
as lane 2 in (A) following buffer exchange into PBS. Lanes 2 and 3 are samples taken 
during the second round of GST purification which was carried out to separate the 
GST and Pol30 proteins. The sample in Lane 2 were taken while washing the GST 
column just before GST elution (Note; this lane is sequentially out of order and should 
follow Lane 3). Lane 3 contained the sample collected from the flow through during 
the loading step of the second round of GST purification. The predominant protein 
present in lane 3 is Pol30, and is the sample that was used to raise and screen 
antibodies against Pol30. 
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2.3 – Yeast Genetics 
2.3.1 – Yeast Cell Culture 
Yeast cells were cultured at 30 °C in either rich yeast-extract peptone dextrose (YPD) 
broth medium containing 1 % Bacto-yeast extract, 2 % Bacto-peptone, and 2 % glucose (YPD 
broth traditional formulation with peptone purchased from US Biological, C7062642) or YPD 
agar media (YPD agar traditional formulation with peptone (powder) purchased from US 
Biological, C9031173). Synthetic dextrose (SD) medium (0.67 % Bacto-yeast nitrogen base 
without amino acids (aa), carbohydrate and with ammonium sulphate, US Biological, 
C7082704), 2 % glucose, with or without 2 % bacto-agar (Becton, Dickinson and Company. 
REF # 214010)) was used for selection and supplemented with various amino acids as required 
(Sherman et al., 1983). In certain cases 5-Fluoroorotic acid (FOA, US Biological, F5050; 0.67 % 
yeast nitrogen base, 0.1 % FOA, 2 % glucose, plus required amino acids and 2x uracil) was used 
for the selection of appropriate genomic pop-outs. For long term storage, yeast cells were grown 
on agar plates (YPD or SD) at 30 ºC for 2-3 days. Cells were then removed from the plate using 
a sterile toothpick, and resuspended in 1.0 mL of sterile 15 % (v/v) glycerol. Cells were 
subsequently stored at -70 ºC. 
 
2.3.2 – Yeast Strains 
The yeast strains used in this study are listed in Table 2.2. All of the strains used are 
isogenic derivatives of DBY747, HK578 or BY4741. HK578 is a derivative of W303 corrected 
for the RAD5 gene by Dr. H. Klein (New York University), while the ORF deletion strains of 
BY4741 were created by the Saccharomyces Genome Deletion Project Consortium and 
purchased from Research Genetics (Invitrogen). DBY747 is from D. Botstein (Stanford 
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University). Additional strains used in this study are isogenic derivatives of the above strains and 
were created by gene disruption, or were the result of synthetic genetic array (SGA) crosses. See 
Table 2.2 for genotypes and modifications to the strain background. Newly created strains were 
confirmed by phenotypic changes when possible, and by PCR of genomic DNA. 
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Table 2.2 – Haploid Saccharomyces cerevisiae Strains Used in This study able 2.2 Haploid Saccharomyces cerevisiae  strains used in this study.
Strain Genotype Source
Y5565 MAT can1 ::MFA1pr -HIS3mfa1 ::MF1pr -LEU2  C. Boone
lyp1  his3 1 leu2 0 ura3 0 met15 0
Y8389 Y5565 with rev1 ::nat R  lys2 + C. Boone
Y8388 Y5565 with rad6 ::nat R  lys2 + C. Boone
Y8426 Y5565 with ubc13 ::nat R  lys2 + C. Boone
Y8621 Y5565 with rev3 ::nat R  lys2 + C. Boone
Y8622 Y5565 with rad30 ::nat R  lys2 + C. Boone
Y9897 Y5565 with mms2 ::nat R  lys2 + C. Boone
Deletion mutant array BY4741 MAT a can1 ::MFA1pr-HIS3 lrp1  C. Boone
WXY2491 DMA with rev3 ::nat R  mre11 ::kan R This Study
WXY2493 DMA with mms2 ::nat R  mre11 ::kan R This Study
WXY2460 DMA with rev3 ::nat R  rad50 ::kan R This Study
WXY2462 DMA with mms2 ::nat R  rad50 ::kan R This Study
WXY2219 DMA with rev3 ::nat R  rad51 ::kan R This Study
WXY2416 DMA with mms2 ::nat R  rad52 ::kan R This Study
WXY2032 DMA with rev3 ::nat R  rad52 ::kan R This Study
WXY2417 DMA with mms2 ::nat R  rad54 ::kan R This Study
WXY2555 DMA with rev3 ::nat R  rad54 ::kan R This Study
WXY2419 DMA with mms2 ::nat R  rad55 ::kan R This Study
WXY2020 DMA with rev3 ::nat R  rad55 ::kan R This Study
WXY2420 DMA with mms2 ::nat R  rad57 ::kan R This Study
WXY2421 DMA with rev3 ::nat R  rad57 ::kan R This Study
WXY2477 DMA with rev3 ::nat R  xrs2 ::kan R This Study
WXY2479 DMA with mms2 ::nat R  xrs2 ::kan R This Study
BY4741 MAT a his3 1 leu2 0 met15 0 ura3 0 Invitrogen
BY4741 trp1  BY4741 with trp1 ::kan R SGD Consortium
BY4741 psy3  BY4741 with psy3 ::kan R SGD Consortium
BY4741 shu1  BY4741 with shu1 ::kan R SGD Consortium
BY4741 shu2  BY4741 with shu2 ::kan R SGD Consortium
BY4741 csm2  BY4741 with csm2 ::kan R SGD Consortium
BY4741 sgs1  BY4741 with sgs1 ::kan R SGD Consortium
BY4741 rad51  BY4741 with rad51 ::kan R SGD Consortium
BY4741 rad9  BY4741 with rad9 ::kan R SGD Consortium
BY4741 rev3  BY4741 with rev3 ::kan R SGD Consortium
BY4741 xrs2  BY4741 with xrs2 ::kan R SGD Consortium
BY4741 mre11  BY4741 with mre11 ::kan R SGD Consortium
BY4741 mms2  BY4741 with mms2 ::kan R SGD Consortium
BY4741 rad50  BY4741 with rad50 ::kan R SGD Consortium
BY4741 rad52  BY4741 with rad52 ::kan R SGD Consortium
BY4741 rad54  BY4741 with rad54 ::kan R SGD Consortium
BY4741 rad55  BY4741 with rad55 ::kan R SGD Consortium
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Table 2.2 – Continued. 
Strain Genotype Source
BY4741 rad57  BY4741 with rad57 ::kan R SGD Consortium
BY4741 exo1  BY4741 with exo1 ::kan R SGD Consortium
BY4741 sae2  BY4741 with sae2 ::kan R SGD Consortium
WXY1353 BY4741 with sgs1 ::kan R  psy3 ::LEU2 This Study
WXY2469 BY4741 with mms2 ::kan R  rad51 ::LEU2 This Study
WXY2531 BY4741 psy3 ::kan R  rad54 ::HIS3 This Study
WXY2533 BY4741 with rad54 ::HIS3 This Study
WXY2534 BY4741 psy3 ::kan R  rad51 ::LEU2 This Study
WXY2546 BY4741 with sae2 ::kan R  rev3 ::LEU2 This Study
WXY2547 BY4741 with sae2 ::kan R  mms2 ::LEU2 This Study
WXY2550 BY4741 with sae2 ::kan R  rev3 ::LEU2  mre11 ::HIS3 This Study
WXY2551 BY4741 with rev3 ::kan R  exo1 ::LEU2 This Study
WXY2904 BY4741 rad9 ::kan R  psy3 ::LEU2 This Study
WXY2949 BY4741 with mms2 ::kan R  exo1 ::LEU2 This Study
WXY2950 BY4741 with sae2 ::kan R  exo1 ::LEU2 This Study
PJ69-4a MAT a trp1-901 leu2-3,112 ura3-52 his3-200 gal4  gal80  P. James
Met2::GAL7-lacZ LYS2::GAL1-HIS3 GAL2-ADE2
DBY747 MAT a his3 -1 leu2-3,112 trp1-289 ura3-52 D. Botstein
WXY664 DBY747 with mms2 ::URA3 Lab Stock
WXY667 DBY747 with rev3 ::hisG-URA3-hisG Lab Stock
WXY731 DBY747 rad5 ::HUH Lab Stock
WXY1164 DBY747 with rad51 ::HIS3 This Study
WXY1323 DBY747 with psy3 ::kan R This Study
WXY1324 DBY747 with rev3 ::hisG-URA3-hisG  psy3 ::kan R This Study
WXY1325 DBY747 with mms2 ::URA3  psy3 ::kan R This Study
WXY2379 DBY747 with mre11 ::HIS3 This Study
WXY2384 DBY747 with pol30-K164R This Study
WXY2389 DBY747 with mre11 ::HIS3 pol30-K164R This Study
WXY2390 DBY747 with mre11 ::HIS3 rev3 ::LEU2 This Study
WXY2392 DBY747 with sgs1 ::HIS3 This Study
WXY2393 DBY747 with rev3 ::HUH sgs1 ::HIS3 This Study
WXY2394 DBY747 with sae2 ::LEU2 This Study
WXY2917 DBY747 with exo1 ::LEU2 This Study
WXY2918 DBY747 with mms2 ::URA3 exo1 ::LEU2 This Study
WXY2974 DBY747 rad5- I916A This Study
WXY2991 DBY747 with exo1 ::LEU2 rev3 ::hisG-URA3-hisG This Study
WXY2990 DBY747 rad -IAA This Study
WXY2900 DBY747 rad5 -AA This Study
HK578-10A MAT a ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 H. Klein
HK578-10D MAT ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 H. Klein
HK590-10A HK578-10A with srs2 ::HIS3 H. Klein
Table 2.2 Continued
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Strain Genotype Source
HK578-2C 10A rad5 ::URA3 H. Klein
HK579-10A 10A mms2 ::HIS3 H. Klein
HK810 HK578-10A with rev3 ::LEU2 H. Klein
LSY396 HK578-10A with rad50 ::hisG-URA3-hisG L. Symington
LSY402 HK578-10A with rad51 ::LEU2 L. Symington
LSY386 HK578-10A with rad52 ::TRP1 L. Symington
LSY403 HK578-10A with rad54 ::LEU2 L. Symington
WXY902 HK578-10D mms2 ::HIS3 Lab Stock
WXY920 HK578-10A mms2 ::HIS3 rev3 ::HUH Lab Stock
WXY930 HK578-10D with rad18 ::LEU2 Lab Stock
WXY919 HK578-10A with ade2-1 ade3 ::hisG mrell ::HIS3 Lab Stock
WXY956 HK578-10D rev3 ::LEU2 Lab Stock
WXY963 HK578-10A with psy3 ::HIS3  rad52 ::LEU2 This Study
WXY964 HK578-10A with psy3 ::HIS3  rad51 ::LEU2 This Study
WXY965 HK578-10A with psy3 ::HIS3  rad50 ::hisG-URA3-hisG This Study
WXY966 HK578-10D with psy3 ::HIS3  rad54 ::LEU2 This Study
WXY970 HK578-10A with sgs1 ::LEU2 This Study
WXY989 HK578-10D with pol30 ::HIS 3  / YCpL-Pol30/ pGBTRAD18 Lab Stock
/YEpRAD6
WXY990 HK578-10D with pol30 ::HIS 3  / YCpL-pol30-K164R Lab Stock
/pGBTRAD18 /YEpRAD6
WXY994 HK578-10A with pol30-K164R Lab Stock
WXY1328 HK578-10D with psy3 ::LEU2 This Study
WXY1329 HK578-10D with mms2 ::HIS3 psy3 ::LEU2 This Study
WXY1330 HK578-10A with rev3 ::LEU2  psy3 ::HIS3 This Study
WXY1334 HK578-10A with rev3 ::LEU2  psy3 ::HIS3  srs2 ::TRP1 This Study
WXY1342 HK578-10A with psy3 ::HIS3  srs2 ::LEU2 This Study
WXY1358 HK578-10A with psy3 ::HIS3  sgs1 ::LEU2 This Study
WXY2959 HK578-10A with siz1 ::HIS3 This Study
WXY2960 HK578-10A with mms2 ::URA3 siz1 ::HIS3 This Study
WXY2962 HK578-10A with siz1 ::HIS3 sae2 ::LEU2 This Study
WXY2963 HK578-10A with siz1 ::HIS3 exo1 ::URA3 This Study
WXY2964 HK578-10A rad5 ::URA3 siz1 ::LEU2 This Study
WXY2965 HK578-10A rad5- AA  siz1 ::LEU2 This Study
WXY2966 HK578-10A rad5- IAA  siz1 ::LEU2 This Study
WXY2969 HK578-10A with sgs1 ::LEU2 siz1 ::URA3 This Study
WXY2975 HK578-10A with sae2∆::LEU2 This Study
WXY2981 HK578-10A rad5 -AA This Study
WXY2982 HK578-10A rad5 -IAA This Study
WXY2983 HK578-10A rad5- I916A  rev3 ::LEU2 This Study
WXY2985 HK578-10A rad5 ::URA3 rev3 ::LEU2 This Study
Table 2.2 Continued
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Strain Genotype Source
WXY2994 HK578-10A with siz1 ::HIS3 rad51 ::LEU2 This Study
WXY2995 HK578-10A with mre11 ::HIS3 siz1 ::LEU2 This Study
WXY2996 HK578-10A rad5 -AA  rev3 ::LEU2 This Study
WXY2997 HK578-10A rad5 -IAA  rev3 ::LEU2 This Study
WXY2998 HK578-10A rad5 -AA  mms2 ::URA3 This Study
WXY2999 HK578-10A rad5 -IAA  mms2 ::URA3 This Study
WXY3001 HK578-10A rad5- I916A This Study
WXY3002 HK578-10A rad5- I916A  mms2 ::LEU2 This Study
WXY3007 HK578-10A with pol30-K164R sae2∆::LEU2 This Study
WXY3008 HK578-10D with rad18 ::TRP1  sae2 ::LEU2 This Study
Table 2.2 Continued
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2.3.3 – Yeast Transformation  
     Yeast cells were transformed using a modified lithium acetate method (Ito et al., 1983). 
Overnight, 2 mL of yeast cultures were incubated at 30 ºC in appropriate liquid media (either 
YPD or SD minimal medium with required aa). The next morning cells were sub-cultured into 5 
mL of fresh media and allowed to grow until a mid-logarithmic growth phase was achieved. 1 
mL of yeast culture was then pelleted by centrifugation for each transformation being prepared, 
and subsequently washed in 500 l LiOAc solution (0.1 M lithium acetate (LiOAc), 10 mM Tris-
HCl; pH 8.0, 1 mM EDTA. Finally the pellet was resuspended in 100 L LiOAc. 4 L of carrier 
DNA (single-stranded salmon sperm) and 5 L of transforming DNA (See Table 2.3 for a full 
list of plasmids used in this study) were added to the resuspended yeast cells and allowed to sit at 
room temperature for 5 minutes. 280 L of 50 % PEG4000 was added and the contents of the tube 
were mixed by inverting the tube 8-10 times, and incubated at 30 ºC for 45 minutes. Following 
incubation 39 L of DMSO was added to each transformation, mixed by inverting the tube 8-10 
times and heat shocked at 42 ºC for 5 minutes. Yeast cells were then pelleted by centrifugation at 
top speed for 30 seconds, washed in 500 L of sterile ddH2O before finally being resuspended in 
100 L sterile ddH2O and plated on appropriate minimal media and allowed to grow for 3-5 days 
at 30 ºC.  
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 Table 2.3 Plasmids used in this study.
Plasmid Source Reference
YCp50-MAT a F. Fabre Heude and Fabre, 1993
YCp50-MAT F. Fabre Heude and Fabre, 1993
YCpL-Pol30 Lab stock
YCpL-pol30-K164R Lab stock
pGBT RAD18 Lab stock
YEpRAD6 D. Gietz
pexo1 ::LEU2 This study This study
pexo1 ::URA3 This study This study
pmms2 ::HIS3 Lab Stock Barbour et al ., 2006
pmms2 ::LEU2 Lab Stock Broomfield et al., 1998
pmms2 ::URA3 Lab Stock Broomfield et al ., 1998
pmre11 ::HIS3 W. Xiao Barbour et al ., 2000
ppsy3 ::HIS3 W. Xiao Ball et al ., 2009
ppsy3 ::Kan R W. Xiao Ball et al ., 2009
ppsy3 ::LEU2 W. Xiao Ball et al ., 2009
prad51 ::LEU2 W. Xiao Ball et al ., 2009
prad52 ::LEU2 Lab Stock Xiao et al ., 1996
prad54 ::HIS3 W. Xiao Ball et al ., 2009
pDG347 (prev3 ::hisG-URA3-hisG ) D. Gietz Roche et al ., 1994
prev3 ::LEU2 Lab Stock Xiao et al ., 1996
psae2 ::LEU2 This study This study
psiz1 ::HIS3 This study This study
psiz1 ::URA3 This study This study
pPWSGS1 I. Hickson Watt et al ., 1995
psgs1 ::HIS3 This study This study
pFP56 (psrs2 ::TRP1 ) H. Klein
pGAD424 SHU1 T. Ito Ito et al ., 2001
pGAD424 SHU2 T. Ito Ito et al ., 2001
pGAD424 CSM2 T. Ito Ito et al ., 2001
pGBKT7 SHU1 T. Ito Ito et al ., 2001
pGBKT7 SHU2 T. Ito Ito et al ., 2001
pGBKT7 CSM2 T. Ito Ito et al ., 2001
pGAD424 PSY3 W. Xiao Ball et al ., 2009
pGBT9 PSY3 W. Xiao Ball et al ., 2009
pGAD424 D. Gietz
pGBT9 D. Gietz
pGBKT7 Clontech
pGEX6-POL30 W. Xiao This study
Table 2.3 – Plasmids Used in This Study.  
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2.3.4 – Targeted Gene Disruption 
 Yeast strains created by one-step targeted gene deletion using a disruption cassette were 
introduced to the cells via yeast transformation following appropriate restriction digestion of the 
disruption cassette. Disruption cassettes used in this study are explained below.  
 
2.3.4.1 – Disruption Cassettes Created for this Study 
2.3.4.1.1 – EXO1 Disruption Cassettes 
 The 2.1 kb EXO1 open reading frame (ORF) was cloned into pBluescript and the 1.3 kb 
NdeI-BsaBI fragment within the EXO1 ORF was deleted and replaced by a BamHI linker, which 
was then used to clone either a 1.6 kb BamHI fragment containing LEU2 from YDp-L or a 1.1 kb 
BamHI fragment containing URA3 from YDp-U (Berben et al., 1991). The exo1∆::LEU2 
disruption cassette was released by BglII-PstI digestion and the exo1∆::URA3 disruption cassette 
was released by BglII-SnaBI digestion prior to yeast transformation. Following gradient plate 
analysis, putative mutants were further screened by PCR using primers EXO1-1 and EXO1-2 
(See Table 2.1).  
 
2.3.4.1.2 – PSY3 Disruption Cassettes 
 DBY747 strains containing the psy3::kanR allele were created by transforming cells 
with a DNA fragment obtained from PCR amplification of the BY4741 psy3::kanR allele by 
primers PSY3-1 and PSY3-2 (See Table 2.1). To construct plasmids containing the psy3 
disruption cassettes, a 1.8 kb genomic DNA fragment containing the PSY3 ORF and its flanking 
sequences were PCR amplified using PSY3-1 and PSY3-2, from which a 1.7 kb BamHI fragment 
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was cloned into pTZ19R. A 0.6 kb Eco47–SpeI fragment containing the vast majority of the 
PSY3 ORF was deleted and replaced with a BglII linker. A BamHI fragment containing either a 
1.6 kb LEU2 fragment from YDp-L or a 1.16 kb HIS3 fragment from YDp-H (Berben et al., 
1991) was cloned into the BglII site to form ppsy3::LEU2 or ppsy3::HIS3, respectively. These 
disruption cassettes were released by BamHI digestion prior to transformation. Following 
gradient plate analysis, putative mutants were further screened by PCR using primers PSY3-2 
and PSY3-3 (See Table 2.1).  
 
2.3.4.1.3 – RAD5 Point Mutations 
To create RAD5 site-specific mutants, a 3.5 kb PmlI-SalI yeast genomic fragment 
containing RAD5 ORF but missing the N-terminal 100 aa coding region was cloned into plasmid 
YIplac211 (URA3) (Gietz and Sugino, 1988) to form YIpU-Rad5∆N, which was used to create 
rad5-I916A and rad5-AA (D681A+E682A) mutations. Site-specific mutagenesis was performed 
by a mega-primer approach (Ke and Madison, 1997) using mutagenic primers that also create 
diagnostic restriction sites. The cloned site-specific mutations were screened by restriction 
analysis and further confirmed by sequencing. The resulting YIp plasmids were linearized by 
NruI cleavage prior to yeast transformation and the confirmed transformants were subject to 5-
FOA selection for the appropriate genomic pop-outs that only contain the desired point 
mutation(s) at the RAD5 locus. 
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2.3.4.1.4 – RAD51 Disruption Cassette 
To construct a plasmid containing the rad51 disruption cassette, a 3.7 kb BamHI 
fragment containing RAD51 and its flanking sequences was cloned and a 1.25 kb SpeI–BstEII 
fragment containing essentially the entire RAD51 ORF was deleted and replaced with a BglII 
linker, which allowed us to clone the 1.6 kb BamHI fragment from YDp-L containing LEU2. The 
resulting plasmid was cleaved by BamHI to release the rad51::LEU2 cassette. 
  
2.3.4.1.5 – RAD54 Disruption Cassette 
To construct a plasmid containing the rad54 disruption cassette, the 2.7 kb RAD54 ORF 
was amplified as an EcoRI–SalI fragment and cloned into pTZ19R. The 1.9 kb BamHI fragment 
within the RAD54 ORF was then deleted and replaced with the 1.16 kb HIS3 fragment from 
YDp-H. The rad54::HIS3 disruption cassette was released by StuI–EcoRV digestion. 
 
2.3.4.1.6 – SAE2 Disruption Cassette 
 A 1.7 kb yeast genomic DNA fragment containing the SAE2 ORF and flanking regions 
was amplified by primers SAE2-1 and SAE2-2 (See Table 2.1) and cloned into pGEM-T. A 1.0 
kb HindIII-BsiWI fragment containing essentially the entire SAE2 ORF was deleted and replaced 
by a BamHI linker, which was used to clone the 1.6 kb BamHI fragment containing LEU2 from 
YDp-L (Berben et al., 1991) to form psae2∆::LEU2. The sae2∆::LEU2 disruption cassette was 
released by PstI-SalI digestion prior to yeast transformation. 
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2.3.4.1.7 – SIZ1 Disruption Cassette 
 A 2.0 kb yeast genomic DNA fragment within the SIZ1 ORF was amplified by primers 
SIZ1-3 and SIZ1-4 (See Table 2.1) and cloned into pGEM-T. A 1.4 kb BamHI fragment was 
deleted and replaced by either a 1.16 kb BamHI fragment containing HIS3 from YDp-H or a 1.1 
kb BamHI fragment containing URA3 from YDp-U (Berben et al., 1991). The siz1∆::HIS3 
disruption cassette was released by ApaLI-EcoRV digestion and the siz1∆::URA3 disruption 
cassette was released by BglII-ClaI digestion prior to yeast transformation. Following gradient 
plate analysis, putative mutants were further screened by PCR using primers SIZ1-3 and SIZ1-4 
(See Table 2.1).  
   
2.3.4.1.8 – SGS1 Disruption Cassette 
 The 4.4 kb SGS1 ORF was PCR amplified and cloned into pGEM-T. A 1.3 kb ClaI-
HindIII fragment within SGS1 ORF was deleted and replaced with a BamHI linker, which was 
used to clone a 1.16 kb BamHI fragment containing HIS3 from YDp-H (Berben et al., 1991) to 
form psgs1∆::HIS3. The sgs1∆::HIS3 cassette was released by AflII-BsrGI digestion prior to 
yeast transformation. Following gradient plate analysis, putative mutants were further screened 
by PCR using primers SGS1-1 and SGS1-2 (See Table 2.1).  
 
2.3.4.2 – Other Disruption Cassettes Used in this Study 
 Sources and use of rad52::LEU2 (Xiao et al., 1996), rev3::hisG-URA3-hisG (Roche et 
al., 1994), rev3::LEU2 (Xiao et al., 1996) mms2::HIS3 (Barbour et al., 2006), mms2::LEU2 
(Broomfield et al., 1998), mms2::URA3 (Broomfield et al., 1998) and mre11::HIS3 (Barbour 
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et al., 2000) disruption cassettes have been previously described. Plasmid pPW∆SGS1 containing 
the sgs1∆::LEU2 disruption cassette was received from Dr. I. Hickson (University of Oxford, 
UK), and the sgs1::LEU2 cassette was released by NcoI–PstI. Plasmid pFP56 (which contains 
srs2::TRP1) was received from Dr. H. Klein and the srs2::TRP1 cassette was released by 
SacI–ClaI digestion.  
 
2.3.5 – Isolation of genomic DNA 
A 2 mL overnight culture of yeast cells was grown in appropriate media before being 
pelleted by centrifugation in a 2 mL screw cap tube. The pellet was resuspended in 230 L of 
yeast DNA extraction buffer to each tube. Alternatively yeast colonies can be scraped directly 
from a plate and resuspended in the yeast DNA extraction solution (however, this should not be 
done with a toothpick). Once the cells are resuspended, 100 L of phenol, 100 L of chloroform, 
and one scoop (approximately 0.3 g) of acid washed beads were added to each tube. Samples 
were then vigorously vortexed at top speed for 3 minutes, and centrifuged for 5-6 minutes at top 
speed. The supernatant was carefully removed and transferred to a new tube, to which 4 L of 5 
M NaCl and 600 L of cold 95 % ethanol was added, the tube was inverted several times and 
then placed in the -20 ºC freezer for a minimum of 20 minutes. Samples were then removed from 
the freezer and centrifuged at top speed for 15 minutes. The remaining pellet was dried, 
resuspended in 200 L of TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and incubated with 5 L 
of 10 mg/mL RNaseA at 37 ºC for 10 minutes. To each tube 8 L 5M NaCl and two volumes 
95% cold ethanol were added, followed by incubation at -20 ºC for a minimum of 20 minutes 
before being centrifuged at top speed for 15 minutes. The supernatant was removed, the samples 
were dried, and finally resuspended in 50 L sterile ddH2O (Hoffman and Winston, 1987). 
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2.3.6 – Testing for Sensitivity to DNA-Damaging Agents 
2.3.6.1 – Serial Dilution Plates 
 Serial dilution assays were used as a semi-quantitative means to determine MMS 
(Aldrich, 129925), hydroxyurea (HU, Sigma, H8627) and UV sensitivity as previously described 
(Barbour et al., 2006). 2 mL overnight yeast cell cultures were grown in YPD (or selective 
medium if necessary) at 30 ºC, subcultured the next morning into 3 mL of fresh media and 
allowed to grow to a mid-logarithmic phase. Cell density was determined by a hemocytometer 
and adjusted to 2 x 10
6
 cells/mL. 10-fold dilutions were then made in sterile ddH2O and 8 L 
aliquots of each dilution were spotted onto YPD and YPD + drug plates. MMS and HU were 
added to sterile, molten YPD agar once it had cooled to 55 ºC and just before the agar plates 
were poured. UV plates were spotted on YPD agar plates just like the control plates, but were 
subsequently exposed to 254-nm UV light in a UV crosslinker (Fisher Sci. model FB-UVXL at 
approximately 2400 mW/cm
2
) at specific doses. It should be noted that Petri dish lids must be 
removed during UV treatment, and any plates treated with UV require incubation in the dark to 
prevent photoreactivation. Once serial dilution plates were spotted they were incubated for 2 
days at 30 ºC, photographed, and the results were analysed. 
 
2.3.6.2 – Gradient plate analysis of MMS sensitivity 
The gradient plate assay was used as a semi-quantitative measurement of relative MMS 
sensitivity as previously described (Barbour et al., 2006). 30 mL of sterile molten YPD agar 
cooled to 55 ºC was mixed with an appropriate amount of MMS and poured into a square Petri 
dish to form the bottom layer of a gradient plate. The gradient was formed by allowing the 
bottom layer to solidify while the plate was tilted (Figure 2.2, Step 1). After the first layer had 
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solidified, the Petri dish was returned to a flat surface (Figure 2.2, Step 2) and an additional 30 
mL of sterile molten YPD agar without MMS was added to each plate to form the top layer 
(Figure 2.2, Step 3). The control plate, which contains no MMS, was made by simply pouring 60 
mL of sterile molten YPD agar into a square Petri dish and allowed to solidify while remaining 
level. To print the cultures on the gradient plates 400 L of sterile water was warmed to 55 ºC 
and combined with 500 L of sterile molten YPD agar and kept at 55 ºC until ready to use. Once 
ready, 100 L of a 2 mL overnight yeast culture was added to the pre-warmed water/molten 
YPD agar mixture and gently poured out over a sterile microscope slide. The long edge of a 
second sterile microscope slide was then dipped into the culture/water/molten YPD agar mixture 
and imprinted on one gradient plate (Figure 2.2, Step 4). The same microscope slide was 
repeatedly dipped into the same mixture and imprinted on the control plate and subsequently on 
the desired MMS plates. This process was then repeated for each strain required for analysis. 
Plates were then incubated at 30 ºC for two days before being photographed, and the results were 
then analysed.   
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Figure 2.2 – Making Gradient Plates for the Semi-Quantitative Analysis of MMS 
Sensitivity. Step 1 (side view): The bottom 30 mL of YPD sterile molten agar 
(containing the desired percentage of MMS) is poured into the bottom of a square 
Petri dish while the dish is slanted. Step 2 (side view): Once the bottom layer of agar 
has solidified the plate is returned to a flat surface. Step 3 (side view): The top 30 mL 
of YPD sterile molten agar is poured on top of the bottom layer to achieve an overall 
level surface, and allowed to solidify. Step 4 (top view): Plates were then imprinted 
with yeast cultures using the long edge of a microscope slide, and incubated at 30 ºC 
for two days before results are photographed and analysed. Arrows represent 
increasing MMS concentration gradient. 
Increasing MMS concentration 
Step 1 
  
  
  
  
Step 2 
  
  
  
Step 3 
 
 
 
 
 
 
 
 
 
Step 4 
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 2.3.6.3 – Quantitative Assessment of Sensitivity by a Liquid Killing Experiment 
 MMS-induced liquid killing was conducted as previously published (Xiao et al., 
1996). Briefly, overnight yeast cultures were used to inoculate fresh YPD and allowed to 
grow until a cell count of approximately 2 x 10
7
 cells/mL was reached. MMS was added 
to the liquid culture and samples were withdrawn at indicated times. Cells were then 
harvested by centrifugation, washed, diluted if necessary, and plated onto YPD agar 
plates. Colonies were counted after 3 days of incubation at 30 ºC and scored as a 
percentage of cell survival against untreated cells. 
 
2.3.7 – Spontaneous Mutagenesis Assay 
 The spontaneous mutation rate was measured by monitoring the Trp
+
 reversions 
of the trp1-289 allele in the DBY747 strain via a modified Luria and Delbruck 
fluctuation test, as previously described (Broomfield et al., 1998). An overnight yeast 
culture was subcultured into five (therefore each experiment contained five independent 
cultures for each strain) 10 mL YPD test tubes to a final cell count of 20 cells/mL and 
allowed to grow at 30 ºC for 3 days. Cells were then collected, washed, resuspended, 
diluted if required, and plated. Each strain was plated onto YPD (to score total survivors), 
and onto SD-Trp to score the Trp
+
 revertants. Spontaneous mutation rates were calculated 
as previously described (Williamson et al., 1985) , and calculated by the following 
formulas: 
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                    * Where 0.4343 is approximately log10e. 
  
 2.3.8 – Mating-Type Heterozygosity  
 The mating-type heterozygosity assay was performed as previously described 
(Barbour and Xiao, 2006). Essentially the mating-type heterozygosity assay was 
accomplished by transforming a control YCp-MATa or YCp-MAT plasmid (Heude and 
Fabre, 1993; Watt et al., 1995) into a yeast strain containing a null mutation in the gene 
of interest. Yeast strains were then compared for their sensitivity to MMS via gradient 
plate analysis. 
 
2.3.9 – Yeast Two-Hybrid (Y2H) Analysis 
 pGBKT7 and pGAD424 plasmids containing CSM2, SHU1 or SHU2 ORFs were 
received from Dr T. Ito (Kanazawa University, Japan). The original PSY3 genes from the 
above collection contained sequence errors. The PSY3 ORF was PCR amplified as a 
BamHI–SalI fragment, cloned into pGBT9 and pGAD424, and the cloned insert 
sequences were confirmed. Y2H was first described in 1989 by Fields and Song (Fields 
and Song, 1989), and performed by transforming the yeast strain PJ69-4a (James et al., 
1996) with various combinations of the GalBD and GalAD plasmids. The transformants 
were selected on SD-Trp-Leu agar, and subsequently restreaked. Liquid cultures were 
grown overnight before being scored for growth on selective media. Alternatively, cells 
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were taken directly from selective agar plates, resuspended in sterile ddH2O and spotted 
on Y2H selective plates. SD-Trp-Leu-His and SD-Trp-Leu-His + various concentrations 
of 3-amino triazole (3-AT) were used to test for activation of the PGAL1-HIS3 reporter 
gene, and SD-Trp-Leu-Ade screened for activation of the PGAL1-ADE reporter. At least 
three independent transformation colonies were selected and compared for each Y2H 
interaction tested. Plates were photographed following minimum 3 day incubation at 30 
°C. 
 
2.3.10 – Synthetic Genetic Array (SGA) Analysis 
 The query genes chosen for SGA were RAD30, RAD6, UBC13, MMS2, REV1, 
and REV3. BY4741 yeast strains containing null mutation of these genes were used to 
create the query strains required for SGA. The query strains were created by a non-
essential gene switching method using the strain Y5565 from Dr. Charles Boone 
(University of Toronto). The query strains were then crossed with the deletion mutant 
array and analysed in triplicate by SGA as previously described (Tong and Boone, 2006; 
Tong et al., 2001). SGA screens were performed in Dr. Charles Boone’s laboratory. In 
addition to the standard SGA screen a conditionally synthetic lethal screen was run by 
adding 0.004 % MMS to the final MATa-kan
R
-nat
R
 double mutant selection plates and 
scored for fitness. Thus, we expanded our search to include putative genetic interactions 
occurring in the presence of a DNA-damaging agent. The result was 407 putative genetic 
interactions which were then subsequently screened by random spore analysis (RSA). 
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2.3.11 – Random Spore Analysis (RSA) 
 RSA was performed on putative interactions that appeared at least twice in the 
three rounds of SGA screening. During the initial steps in SGA diploid cells are plated 
onto sporulation medium to allow for subsequent selection of MATa meiotic progeny. 
These sporulation plates were sent to us from Dr. Boone’s lab, and used to perform RSA 
analysis on putative genetic interactions found during SGA screening. In short, spores 
were resuspended in 500 L of sterile water and an aliquot was plated onto selective 
media with or without 0.004 % MMS as follows: 20 L onto SD-His/Arg/Lys + 
canavanine/thialysine, 40 L onto SD-His/Arg/Lys + canavanine/thialysine/G418, 40 L 
onto SD-His/Arg/Lys + canavanine/thialysine/clonNAT and 80 L onto SD-His/Arg/Lys 
+ canavanine/thialysine/G418/clonNAT (Tong and Boone, 2006). The plates were 
incubated at 30 °C for 3 days before they were photographed and scored for synergistic 
interactions. 
 
2.3.12 – Flow Cytometry Analysis 
 A 50 mL culture was grown overnight at 30 °C in YPAD (YPD supplemented 
with 20 mg/L Ade from Sigma, A9126), diluted into 50 mL of warm YPAD to a cell 
count of 5 x 10
6
 cells/mL, and allowed to grow to 1 x 10
7
 cells/mL (approximately 2 
hours). Cells were then collected by centrifugation, washed twice with sterile water and 
resuspended in 50 mL of warm YPAD at pH 5. -Factor was added at a dose at which 
>90 % of cells were arrested, which took approximately 2 hours. Cells were then 
centrifuged and vigorously washed three times in sterile water before being resuspended 
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in 20 mL of YPAD and divided into two 10 mL cultures. MMS (0.02 %) was added to 
one of the cultures and incubation continued at 30 °C. Culture (600 L) was taken at each 
time point, added to 1.4 mL of 100 % ethanol and stored at 4 °C until all samples were 
ready to be analysed. Samples were then spun down and resuspended in 500 L of 50 
mM sodium citrate (pH 7). 2.5 L of 10 mg/mL RNaseA was added and the samples 
were incubated at 50 °C for 1 hour. 20 L of 10 mg/mL Proteinase K was added, and 
each sample was vortexed and returned to 50 °C for another hour. Cells were collected by 
centrifugation and resuspended in 500 L of 50 mM sodium citrate (pH 7) containing 
propidium iodide (Fluka) by vortex. Samples were then briefly sonicated and subjected to 
analysis at the Flow Cytometry Core Facility at the University of Calgary. 
 
2.3.13 – Detection of PCNA Ubiquitination  
2.3.13.1 – Yeast Cell Preparation 
 Detection of ubiquitinated PCNA was adapted from a previous report (Knop et 
al., 1999). Two 10 mL overnight cultures were grown at 30 °C in YPAD for each strain 
being tested. The two cultures were then combined; cells were counted with a 
haemocytometer and diluted to 0.3x10
-7
 in a total volume of 100 mL (in a 250 mL flask) 
of pre-warmed YPAD and allowed to grow for an additional 2 hours. Cultures were then 
split in two; one was treated with 0.05 % MMS while the other remained untreated and 
both cultures were then returned to 30 °C for 90 minutes. 20 mL of culture was pelleted 
(2 minutes at 4300 rpm at 4 °C), the supernatant was immediately discarded, and the 
pellet was quickly frozen in liquid nitrogen for 10 minutes. The pellet was then 
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resuspended in cold sterile ddH2O containing 25 mM N-ethylmaleimide (NEM) (Sigma, 
E1271) (made fresh in 95 % cold ethanol) and 1 mM phenylmethylsulfonyl fluoride 
(PMSF) (Sigma, P-7626) (made fresh in 95 % cold ethanol) and transferred to a 1.5 mL 
screw cap tube that had been pre-chilled on ice. 150 L of a 1.85 M NaOH solution with 
7.5 % -mercaptoethanol was then added to each tube, mixed by inverting the tube 
several times, and incubated on ice at 4 °C for 15 minutes. Next, 150 L of 55 % w/v 
TCA (trichloracetic acid), made fresh in cold ddH2O, was added, mixed by inverting the 
tube. Samples were then incubated on ice at 4 °C for 10 minutes before samples were 
centrifuged at 13,200 rpm at 4 °C for 10 minutes. The supernatant was discarded and the 
pellet was resuspended in a modified, freshly made HU buffer; 8 M urea, 5 % SDS, 200 
mM Tris-HCl pH 6.8, 1 mM EDTA, 0.025 % bromophenol blue (Sigma, B5525), 1.5 % 
dithiothreitol (DTT) (EMD Chemicals, 3860), 25 mM NEM, 1 mM PMSF, and 0.5 % 
Triton-X-100 (Sigma). 12 L of a 2 M Tris-base solution was added to each sample, and 
the protein was denatured for 10 minutes at 65 °C while shaking at 1400 rpm (initial 
pellet should be completely dissolved at this point and purple in colour). Samples were 
then centrifuged at room temperature for 30 seconds at 13,200 rpm, and 50 L of the 
supernatant was removed and added to 50 L of Bio-Rad laemmli sample buffer 
(catalogue #161-0737), and frozen overnight at -20 °C. Samples should not be boiled at 
any subsequent step as urea can induce carbamylation which can interfere with antibody 
binding (Kaiser and Tagwerker, 2005). Samples were then analysed by SDS-PAGE 
(Laemmli, 1970), followed by immunoblotting. 
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2.3.13.2 – SDS-PAGE Gel 
 40 Ls of each sample was run on a 1.5 mm 13 % SDS-PAGE gel; 4.5 mL sterile 
ddH2O, 6.45 mL 30 % acrylamide (acrylamide/bis-acrylamide 37:1 ratio. Sigma, A6050), 
3.75 mL 1.5 M Tris pH 8.8 (Tris Amino ultra pure. Angus Buffers & Biochemicals, 
Niagra, NY, Cat # 15-40500), 150 L of 10 % ammonium persulfate (APS, Sigma, A-
9164), 150 L of 10 % SDS, and finally 6 L of N,N,N’,N’–Tetramethylethylenediamine 
(TEMED, Sigma, T-9281) resulting in a final volume of 15 mL which is sufficient for 
two gels. SDS-PAGE gels were made with a 4 % stacking layer; 5.375 mL sterile ddH2O, 
1.0015 mL 30 % acrylamide, 0.975 mL 1.5 M Tris pH 6.8, 75 L of 10 % SDS, 75 L of 
10 % APS, and 7.5 L TEMED. Gels were run at 128V until the 25 kDa marker 
(Precision plus protein standards from Bio-Rad cat. # 161-0374) had run to the bottom of 
the gel. The gels were then soaked in transfer buffer (6.07 g Tris-base, 28.5 g glycine, 
150 mg SDS, 150 mL methanol, and ddH2O up to 1L) for 10 minutes before being 
transferred to a polyvinlyidene fluoride (PVDF) transfer membrane.  
 
2.3.13.3 – Western Blot 
Proteins from SDS-PAGE gels were transferred to the Polyscreen (R) PVDF 
transfer membrane (Perkin Elmer NEF1002001PK) by wet transfer. TCA-treated samples 
reportedly require a longer blotting transfer time (Wright et al., 1989); therefore a wet 
transfer system (Bio-Rad) was used for 4 hours at 100 V at 4 °C on ice. The transfer 
buffer (as previously described) and ice packs were changed every hour. Membranes 
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were then blocked overnight in 10 % skim milk (Carnation instant skim milk powder) in 
PBST (phosphate buffered saline (PBS, 8 g NaCl, 0.2 g KCL, 1.44 g Na2HP04, 0.24 g 
KH2P04 add ddH2O up to 1L and pH 7.4 with hydrochloric acid) plus 0.05 % Tween 20 
(Tween®20 Polyoxyethylene 20 Sorbitan Monolaurate. EMD Chemicals, 9480)), before 
the primary antibody was added at a 1:2000 dilution in 1 % skim milk (in PBST) for 2 
hours. We raised monoclonal antibodies in mice against yeast PCNA from bacterial 
overexpressed pGST-POL30 with the help of Dr. Barry Ziola (University of 
Saskatchewan). Membranes were vigorously washed for 10 minutes in PBST three times 
before incubating with the secondary antibody (Bio-Rad goat  mouse HRP, catalogue # 
172-1011) at a 1:8000 dilution. The membrane was incubated for an hour with the 
secondary antibody before being washed for 10 minutes with PBS, and repeated three 
times. Results were visualized by Western Lightning Plus-ECL (Perkin and Elmer Life 
Sciences, NEL #104) and developed on HyBlot CL autoradiograph film from Denville 
Scientific, Inc. (Cat. No. E3018) with appropriate exposure times. 
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CHAPTER THREE 
THE YEAST Shu COMPLEX COUPLES ERROR-FREE 
POSTREPLICATION REPAIR TO HOMOLOGOUS 
RECOMBINATION 
 
 
This chapter is essentially as published in Ball et al. 2009. 
 
 
3.1 – Abstract 
DNA postreplication repair functions to bypass replication-blocking lesions and 
prevent damage-induced cell death. PRR employs two different mechanisms to bypass 
damaged DNA. While translesion synthesis has been well characterized, little is known 
about the molecular events involved in error-free bypass, although it has been assumed 
that homologous recombination is required for such a mode of lesion bypass. We 
undertook a genome-wide synthetic genetic array screen for novel genes involved in 
error-free PRR and observed evidence of genetic interactions between error-free PRR and 
HR. Furthermore, this screen identified and assigned four genes, CSM2, PSY3, SHU1 and 
SHU2, whose products form a stable Shu complex, to the error-free PRR pathway. 
Previous studies have indicated that the Shu complex is required for efficient HR and that 
inactivation of any of these genes is able to suppress the severe phenotypes of top3 and 
sgs1. We confirmed and further extended some of the reported observations and 
demonstrated that error-free PRR mutations are also epistatic to sgs1. Based on the above 
analyses, we propose a model in which error-free PRR utilizes the Shu complex to recruit 
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HR to facilitate template switching, followed by double-Holliday junction resolution by 
Sgs1-Top3. This mechanism appears to be conserved throughout eukaryotes. 
 
3.2 – Introduction 
Cellular DNA is dynamic and subject to constant assault as it readily reacts with a 
variety of agents that can lead to genomic instability. Genomic instability may also occur 
during replication, recombination and repair itself. Most lethal replication-blocking 
lesions are repaired by two radiation repair epistasis groups in S. cerevisiae, namely NER 
and HR. In addition, lesions induced by oxidative and alkylating agents are often dealt 
with by BER (Friedberg et al., 2006). If these pathways are unable to function or the 
damage exceeds repair capacity, cell death may occur. In order to avoid such severe 
consequences, replication may be reinitiated at blocks without removing the lesion itself 
(Ganesan, 1974; Sarasin and Hanawalt, 1980; Walker, 1995). The third radiation repair 
epistasis group in S. cerevisiae, represented by RAD6, is presumed to mediate this 
process and has been termed PRR (Broomfield et al., 2001; Prakash et al., 1993). PRR is 
defined as a cellular process that converts low-molecular-weight genomic fragments into 
high-molecular-weight DNA in the presence of DNA damage, which can be detected by 
an alkaline sucrose gradient assay (di Caprio and Cox, 1981; Prakash, 1981).  
PRR is centrally controlled by a stable complex formed between Rad6 and Rad18 
(Bailly et al., 1994), which possesses ATPase, ssDNA-binding and ubiquitination 
activities (Bailly et al., 1997a). Rad6, which has diverse functions beyond PRR 
(Broomfield et al., 2001), encodes a Ub-conjugating enzyme (Ubc or E2) (Jentsch et al., 
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1987) that is essential for all of its known biological functions (Sung et al., 1990). Rad18 
is a ssDNA-binding protein (Bailly et al., 1994) that appears to function exclusively in 
PRR and contains a Rad6-binding domain (Bailly et al., 1997b), a really interesting new 
gene (RING) finger domain characteristic of a Ub-ligase (E3), and a putative Zn-finger 
DNA-binding domain (Jones et al., 1988).  
The PRR pathway is subdivided into two parallel pathways: error-prone (TLS or 
mutagenesis) represented by REV1, REV3 and REV7, and error-free PRR represented by 
MMS2, UBC13 and RAD5 (Barbour and Xiao, 2003; Broomfield et al., 2001). It is now 
clear that the entire RAD6 pathway is dependent on the sequential ubiquitination of 
PCNA, a DNA polymerase sliding clamp encoded by the POL30 gene in budding yeast 
(Hoege et al., 2002). Monoubiquitination of PCNA at the K164 residue by the Rad6–
Rad18 complex (Hoege et al., 2002) allows for lesion bypass, which requires Rev1, a 
member of the Y-family of DNA polymerases, and the non-essential B-family DNA 
polymerase Pol, comprised of Rev3 and Rev7 (Nelson et al., 1996a, b; Stelter and 
Ulrich, 2003). Inactivation of the REV genes causes only a moderate level of sensitivity 
to killing by a variety of DNA-damaging agents, but confers major defects in UV-
induced mutagenesis (Lawrence, 2004). Rev1 contains a PCNA interacting domain (Guo 
et al., 2006) and Ub-binding motifs (UBM) (Bienko et al., 2005), as well as a Pol-
interacting domain (Acharya et al., 2005; Acharya et al., 2006; Guo et al., 2003), 
suggesting Rev1 functions as a scaffold for TLS.  
While TLS is well characterized, relatively little is known about error-free PRR. 
The existence of this branch under the RAD6 pathway was initially surmised because the 
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rad6 or rad18 mutant is extremely sensitive to killing by DNA-damaging agents while 
the rev mutants are not (Lawrence, 1994; Prakash et al., 1993). Perhaps the first firm 
demonstration of the existence of error-free PRR was through genetic characterization of 
the mms2 mutant (Broomfield et al., 1998; Xiao et al., 1999). The mms2 mutant displays 
moderate sensitivity to killing by a variety of DNA-damaging agents and the gene is 
assigned to the RAD6 pathway. The characteristic features of mms2 include its strong 
synergistic interaction with rev3 and its REV3-dependent increase in spontaneous 
mutagenesis. MMS2 encodes a Ubc-like protein but does not contain an active-site Cys-
residue. It turns out that Mms2 forms a stable complex with Ubc13, and this complex 
specifically promotes the non-canonical Lys63-linked Ub chain formation (Hofmann and 
Pickart, 1999). Indeed ubc13 is epistatic to mms2 and the two mutants share all 
characteristic features as described above (Brusky et al., 2000). Furthermore, Rad5, a 
member of the SWI/SNF family of ATPases with a C3HC4 RING finger motif, is capable 
of interacting with Pol30, Ubc13 and Rad18 and may serve as an E3 for Ubc13–Mms2 
(Ulrich and Jentsch, 2000). Thus, it is thought that Rad5 functions to recruit the Mms2–
Ubc13 complex in close proximity to PCNA and facilitate the Lys63-linked 
polyubiquitination of PCNA. 
The above sequential PCNA ubiquitination model satisfactorily explains the 
current genetic observations with regard to how the RAD6 pathway operates to tolerate 
DNA damage. However, while it becomes apparent that the error-free mode of lesion 
bypass requires the completion of sister chromatid synthesis past the replication blocking 
lesion and that it most likely employs some form of homologous chromatid as a template 
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(Broomfield et al., 2001; Li et al., 2002; Zhang and Lawrence, 2005), exactly how this is 
achieved is currently unclear. Furthermore, we argue that, analogous to the role of PCNA 
monoubiquitination in TLS, PCNA polyubiquitination following DNA damage only 
serves as a signal for error-free PRR and hence additional members of this pathway may 
be present to couple PCNA polyubiquitination to the error-free bypass. In order to 
understand how this pathway operates, we undertook a large-scale genomic screen to 
search for additional components of error-free PRR and report here the identification and 
genetic characterization of four genes that form a complex to function in coupling error-
free PRR to HR. This study also allows us to demonstrate that error-free PRR utilizes HR 
proteins to form a recombinant intermediate that requires helicase-topoisomerase 
activities to complete the error-free bypass process. 
 
3.3 – Results 
3.3.1 – Identification of Novel Error-Free PRR Genes 
One method to identify novel genes and their putative function is synthetic lethal 
screening. Synthetic lethality occurs when the combination of two mutations leads to a 
inviable organism, but either single mutant is viable (Guarente, 1993). Synthetic lethal 
interactions most likely occur if the two genes are in distinct pathways and one is capable 
of functionally compensating for defects in the other (Hartman et al., 2001). In the past, 
we have adapted the synthetic lethal screening protocol to isolate novel genes whose 
inactivation demonstrated synergistic interaction with yeast error-free PRR mutations 
(Barbour et al., 2006; Barbour and Xiao, 2006). With the completion of the yeast genome 
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sequence and the establishment of genome-wide SGA (Tong et al., 2001), we attempted 
to search for novel non-essential genes involved in both error-free PRR and TLS 
pathways. 
 A typical SGA screen involves a query mutation being crossed to an ordered array 
of approximately 5000 nonessential gene deletions (Tong et al., 2001) allowing meiotic 
progeny containing both mutations to be scored for fitness. Our design for this genetic 
screen was based on the initial discovery of dramatic synergism between error-free PRR 
(MMS2 and UBC13) and TLS (REV1, REV3 and REV7) pathway mutations (Broomfield 
et al., 1998; Xiao et al., 1999). For example, on a plate containing 0.005% MMS, the 
growth of wild-type and each of the above single mutants is not inhibited, while 
simultaneous inactivation of both error-free PRR and TLS pathways results in complete 
inhibition of growth (Barbour et al., 2006). Quantitative analysis indicates that the 
synergism is greater than 103-fold (Broomfield et al., 1998). Hence, we reasoned that if 
an SGA screen was performed in the presence of a very low-dose of MMS using a TLS 
mutant as the query strain, we would be able to preferentially identify candidate genes 
involved in error-free PRR, and vice versa. 
 Two query mutants from each pathway (mms2, ubc13, rev1 and rev3), as well as 
rad30 and rad6 were utilized as query strains for SGA. The initial screens resulted in 407 
potential genetic interactions, and subsequent random spore analysis (RSA) confirmed 
108 putative genetic interactions (Table 3.1). While rad6 resulted in identifying many 
synthetic lethal genetic interactions, there are likely due to the functions Rad6 has outside 
of its function in PRR. In addition the RAD30 query mutant only identified RAD5, an  
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Table 3.1 – Putative Genetic Interactions Confirmed by SGA and RSA 
ubc13Δ mms2Δ mms2Δ cont. rev1Δ rev3Δ rad30Δ rad6Δ
YML012C-A RIM8 RAD24 SIC1 YPL144W RAD5 KEM1
YPR101W MGA2 RAD17 FMP35 THP1 SWC5
MNN10 MNN10 BIM1 ASF1 RAD54 SWR1
VID21 YKL069W RLF2 MPH1 MMS2 SWC3
MAG1 YML096W POL32 CTF4 SHU1 MRE11
RAD9 PSY2 HSL1 PSY3 PSY3 CTG4
REV3 VID21 ELM1 SIC1 CSM2 MMS22
REV1 BRE1 CKB1 DDC1 RAD55 XRS2
REV7 MRC1 RTS1 RAD55 RAD17 RAD50
MSI1 PAT1 RIM13 RAD17 RAD24 CSF1
REV1 CHL1 VPS9 RAD24 UBC13 SWI4
HUR1 MAG1 HSP26 DCC1 RAD57 MSC1
RVS167 RAD1 TPS1 UBC13 RAD51 BUB3
SCS7 CAC2 HSP26 RAD51 RAD52 NUP133
VPS8 RAD9 DEG1 RAD57 AAT2
CIK1 MSI1 LSM1 MMS2 STO1
DDC1 REV3 PMR1 BUB1
RAD24 REV1 RIM9 CLA4
NUP133 REV7 RIM21 RPL27A
POL32 HUR1 SRB2 VPS72
CKB1 VPS21 UMP1 ARP6
ELM1 RVS167 YNL171C VPS71
VPS9 HIR3 YLR358C DEP1
VPS9 CLB2 YGL046W DEG11
KCS1 SGF29 YML102C-A UME6
DEG1 RIM20 YML012C-A CYS3
RIM9 VPS8 CIK1 PGD1
YML012C-A RIM8 KAP122 FUR4
YLR358C
YNL171C
* This table shows the SGA query strains across the top, and all of the synthetic
   lethal relationships (in bold type) and conditionally synthetic lethal 
   interactions that were confirmed by RSA analysis. 
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already known PRR gene. Additional results included the identification of REV1, REV3 
and REV7 via the mms2 and ubc13 query strains, while MMS2 and UBC13 were 
identified using rev1 and rev3 query strains. As expected, all four screens identified 
damage checkpoint genes, further supporting the notion that DNA damage checkpoints 
form a third alternative pathway for damage tolerance (Barbour et al., 2006) and 
validating this screen. Here we report the genetic characterization of four genes, CSM2, 
PSY3, SHU1 and SHU2, three of which were identified in this study using rev1 and rev3 
query strains, and the involvement of HR and Sgs1-Top3 in error-free PRR. Other 
putative genes will be further investigated and reported elsewhere. 
 
3.3.2 – HR is Involved in Error-Free PRR 
Of the RSA-confirmed genetic interactions, we noticed that both rev1 and rev3 
identified HR genes, including RAD51, RAD52, RAD54, RAD55 and RAD57. In contrast, 
neither mms2 nor ubc13 identified any of the above genes. A serial dilution assay 
demonstrates that all HR mutations are indeed synergistic to rev1 (data not shown) or 
rev3 (Figure 3.1) with respect to killing by MMS or UV irradiation, whereas when these 
mutations were combined with mms2 (Figure 3.1) or ubc13 (data not shown), the double 
mutants only displayed slightly more sensitivity than either of corresponding single 
mutants.  
 It has been previously argued that the error-free and error-prone pathways within 
PRR deal with similar lesions, namely a stalled replication fork facing a replication block 
on the template strand (Broomfield et al., 2001; Xiao et al., 1999). If one assumes that  
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Figure 3.1 – Differential Genetic Interactions Between REV3 or MMS2 and 
Homologous Recombination Genes with Respect to MMS and UV Sensitivity. All 
the strains were in the BY4741 background and created by crossing Y8621 
(rev3::natR) or Y9897 (mms2::natR) with the yeast deletion mutant array. (A) 
rad51; (B) rad52; (C) rad54; (D) rad55; and (E) rad57. Cells grown overnight 
were spotted on YPD or YPD plus 0.002 % MMS. For UV treatment, spotted plates 
were exposed to the UV does as indicated. The plates were then incubated at 30 ºC for 
2 days before being photographed. Results were observed a minimum of three times. 
Results contributed by Ke Zhang.  
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TLS and HR pathways function independently, an obvious conclusion would be that 
error-free PRR and HR functions overlap so that the double mutant is not as sensitive as 
that of the TLS–HR double mutant. As a matter of fact, it has been proposed for decades 
that the presumed error-free PRR pathway must utilize some means of homologous 
search for newly synthesized sister chromatid as a template to complete error-free bypass 
(Prakash et al., 1993), and it has been reported recently that error-free PRR does employ 
homologous sister chromatid exchange (Zhang and Lawrence, 2005). Our observations 
provide direct evidence for the involvement of HR proteins and indicate that even the 
accessory HR proteins like Rad55 and Rad57 play pivotal roles in this process. 
 
3.3.3 – CSM2, PSY3, SHU1 and SHU2 Act in the Same Pathway and Their Products 
Form a Stable Complex  
 In this study, we argued that there must be a cellular component that links error-
free PRR to HR and further proposed that inactivation of this component would result in 
epistatic interactions with both error-free PRR and HR. In the subsequent sections, we 
describe the characterization of a Shu complex consisting of Csm2, Psy3, Shu1 and Shu2 
(Shor et al., 2005) in support of our claim that the Shu complex fulfills the role of 
coupling error-free PRR to HR. PSY3 was identified in the SGA and RSA screens via 
both rev1 and rev3 query strains. Figure 3.2 shows genetic interaction between psy3 and 
rev3 in a typical RSA experiment. In this case, all wild-type, single and double mutants 
grew well on minimal media; however, in the presence of 0.004% MMS, growth of the 
psy3 rev3 double mutant is inhibited, indicating that the interaction between psy3 and   
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Figure 3.2 – Genetic Interaction Between REV3 and PSY3 as Demonstrated via 
RSA. The Y8621 strain (rev3::natR) was crossed with the deletion mutant array and 
the relevant diploids carrying a psy3::kanR allele were analysed using RSA. Meiotic 
progeny derived from the sporulation of heterozygous diploids were selected on media 
for either the single or double mutants, with or without 0.004 % MMS, as indicated. 
The plates were incubated at 30 ºC for 3 days and photographed.  
 83 
 
rev3 is synergistic with respect to MMS sensitivity. In addition, CSM2 and SHU1 were 
also identified through this screen. PSY3 (platinum sensitivity) was initially identified as 
part of a genome-wide screen for mutants sensitive to platinum (Wu et al., 2004). CSM2 
(chromosome segregation in meiosis) was initially discovered as part of a genome-wide 
screen for mutations affecting chromosome segregation in meiosis (Rabitsch et al., 
2001), while SHU1 and SHU2 (suppressor of sgs1HU sensitivity) were identified by a 
screen for non-sgs1 suppressors of the top3 slow-growth phenotype and thought to be 
part of HR (Shor et al., 2005). Indeed, deletion of any of the four genes results in a 
similar level of MMS sensitivity and the double mutants did not further enhance 
sensitivity phenotypes (Figure 3.3A) (Shor et al., 2005). Furthermore, a genome-wide 
Y2H experiment indicated physical interaction among these four proteins (Ito et al., 
2001). Therefore, we obtained these Y2H clones, made sequence corrections wherever 
necessary as the initial Y2H clones contained point mutations, and cloned the correct 
ORF in both Y2H vectors. Our Y2H analysis (Figure 3.3B) confirmed the previously 
reported interactions (Ito et al., 2001; Shor et al., 2005) and allowed us to create an 
interaction map, in which Psy3 not only interacts with Csm2, Shu1 and Shu2, but Shu1 
and Shu2 also bind to each other (Figure 3.3C). All the interactions are deemed to be 
strong since they survived the most stringent test on SD-Ade plate (James et al., 1996). In 
this study psy3 was primarily used to study the Shu complex because it was identified by 
both rev1 and rev3 query mutants, and it is the only component of the Shu to interact 
with all other three members (Figure 3.3C).  
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Figure 3.3 – Functional and Physical Interactions Amongst Members of the S. 
cerevisiae Shu Complex. (A) All four null mutants, csm2, psy3, shu1 and 
shu2 display a similar level of sensitivity to MMS. Overnight cell cultures were 
imprinted on YPD or YPD + 0.025 % MMS gradient plates. Plates were incubated at 
30 ºC for 2 days and then photographed. The arrow indicates the increasing gradient 
of MMS. Strains used were isogenic to BY4741 (Table 2.2). Results were observed a 
minimum of three times. (B) Yeast two-hybrid analysis demonstrates the physical 
interaction between Psy3, Shu1, Shu2 and Csm2. The yeast strain PJ69-4a was co-
transformed with various combinations of the GalBD and GalAD plasmids before being 
scored for growth on selective media. Plates were photographed following 3 days of 
incubation at 30 ºC. Results were observed from a minimum of three independently 
transformed cells. These results are consistent with previous reports (Ito et al., 2001; 
Shor et al., 2005). (C) A schematic diagram of the Shu complex illustrating the 
involved physical interactions.  
Shu1 
Shu2 
Csm2 
Psy3 
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3.3.4 – HR Repair Mutations are Epistatic to shu Mutations 
It has been reported that rad52 is epistatic to shu mutations (Shor et al., 2005). 
However, rad52 is extremely sensitive to MMS and, under the above experimental 
conditions, the shu single mutants do not display apparent sensitivity. We combined psy3 
with rad51, rad52 and rad54, among which rad51 and rad54 are relatively less sensitive 
to MMS than rad52 and are primarily involved in HR (Paques and Haber, 1999). Both 
the gradient plate assay (Figure 3.4A–C) and the quantitative liquid killing experiment 
(Figure 3.5) showed that the hr mutations are epistatic to psy3 regardless of the level of 
hr mutant sensitivity. These observations are consistent with a recent report (Mankouri et 
al., 2007) employing rad51 and rad54. It was also reported that in the presence of a low-
dose of MMS, inactivation of RAD52 results in delayed S-phase progression (Oakley et 
al., 2002). We found that although psy3 is much less sensitive to MMS than rad51or 
rad54 (Figure 3.4), he progression through S-phase in the presence of 0.02% MMS is 
delayed to the same extent as rad51 and rad54 (Figure 3.6). More importantly, the psy3 
hr double mutants do not further delay the progression (Figure 3.6). Together, we 
confirm that the SHU genes belong to the HR pathway and may have a specific function 
during S-phase. 
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Figure 3.4 – Gradient Plate Assays Explore Genetic Interactions Between psy3 
and Selected hr Mutations. (A-C) Gradient plate assays. Overnight cell cultures were 
imprinted on YPD or YPD + MMS gradient plates at the indicated concentrations and 
incubated at 30°C for two days before being photographed. Arrows indicate the 
increasing concentration of MMS. Results were observed a minimum of three times. 
- 
- 
- 
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Figure 3.5 – Quantitative Assessment of the Genetic Interactions Between psy3 
and rad51 by a 0.2 % MMS-Induced Liquid Killing Experiment. All strains used 
were isogenic derivatives of HK578; (�) HK578-10A (wild-type), (○) WXY402 
(rad51), (●) WXY1328 (psy3) and (■) WXY964 (psy3rad51). Results are the 
average of three independent experiments.  
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Figure 3.6 – psy3 is Epistatic to rad51 and rad54 with Respect to MMS-Induced 
Cell Cycle Delay. -factor arrested G1 cells were released into either (A) rich YPAD 
or (B) YPAD + 0.02% MMS. Samples were taken at the indicated time points and 
analysed by flow cytometry. Vertical lines in each graph indicate (from left to right) 
G1, mid-S and G2 phases. All strains used were isogenic to BY4741. Results were 
observed by three independent experiments.  
Wild-type Wild-type 
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3.3.5 – shu Mutations Suppress sgs1 Phenotypes 
All four SHU genes were isolated by their mutational phenotype to suppress the 
HU sensitivity of top3 and sgs1 (Shor et al., 2005). However, the authors reported that 
shu mutations are additive to sgs1 with respect to killing by MMS. We examined the 
genetic interactions between psy3 and sgs1 in three different strain backgrounds (W303, 
BY4741 and DBY747) and in each case, deletion of PSY3 was able to suppress the 
severe sgs1 sensitivity to HU and MMS (e.g. Figure 3.7). In contrast, neither single nor 
the double mutant displayed enhanced sensitivity to UV. This observation differs from 
that of Shor et al. (2005) but agrees with a recent report by Mankouri et al. (2007), who 
also found that deletion of SHU genes can reduce MMS-induced X-molecules 
accumulated in the absence of SGS1.  
To further address whether deletion of SHU suppresses the sgs1 mutant 
phenotypes, especially during S-phase, we took advantage of the knowledge that SGS1 
confers an S-phase checkpoint function (Frei and Gasser, 2000). In our experimental 
setting and as reported (Frei and Gasser, 2000), wild-type cells complete S-phase within 
1 h in the absence of MMS, and psy3, sgs1 single and the psy3 sgs1 double mutants do 
not display apparent differences (Figure 3.8). In the presence of low-dose MMS, cell 
cycle progression through S-phase is delayed in wild-type cells, which do not complete 
S-phase in 3 h, whereas deletion of SGS1 results in an accelerated progression through S-
phase, which is completed by 3 h (Figure 3.8). In contrast, in the presence of MMS, psy3 
cells further delay S-phase progression compared to wild-type cells as shown 3 h after 
release from -factor, the majority of psy3 cells remain in 
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Figure 3.7 – Deletion of PSY3 Suppresses the sgs1 Mutant Phenotype. Relative 
sensitivity of psy3 and sgs1 mutants to MMS, HU and UV by 10-fold serial dilution 
assays. Cells grown overnight were spotted on YPD or YPD plus DNA-damaging 
agents at indicated concentrations. For UV treatment, spotted plates were exposed to 
the UV dose as indicated. The plates were then incubated at 30 ºC for 2 days before 
being photographed. All strains used were isogenic to BY4741. Results were observed 
a minimum of three times. 
- 
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Figure 3.8 – Deletion of PSY3 Suppresses the sgs1 S-phase Checkpoint Defect. -
factor arrested G1 cells were released into rich YPAD or YPAD + 0.02 % MMS. 
Samples were taken at the indicated time points and analysed by flow cytometry. 
Vertical lines in each graph indicate (from left to right) G1 and G2 phases. R stands 
for random, or an asynchronous sample of cells. All strains used were isogenic to 
BY4741. Results were observed in three independent experiments.  
Wild-type 
Wild-type 
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mid-S-phase. Interestingly, deletion of PSY3 completely suppresses the sgs1 cell cycle 
checkpoint so that in the presence of 0.02% MMS, the sgs1 psy3 double mutant 
progresses through S-phase at a rate nearly indistinguishable from that of the psy3 single 
mutant (Figure 3.8). Taken together, we are able to confirm previous reports that shu 
mutations are indeed epistatic to sgs1, indicating that the Shu complex functions 
upstream of the Sgs1-Top3-Rim1 pathway as shu mutations are able to reduce the severe 
sensitivity of an SGS1 mutant.  
 
3.3.6 – SHU Belongs to the Error-Free PRR Pathway 
The synergistic interaction between shu and rev mutations does not necessarily 
place SHU genes in the error-free PRR pathway. A good example is that mutations in the 
DNA damage checkpoint genes display synergistic interactions with both error-free and 
TLS PRR mutations (Barbour et al., 2006). However, none of the SHU genes were 
identified by the mms2 or ubc13 query strains. To further determine genetic interactions 
between shu and mms2/ubc13, isogenic single and double mutants were created and their 
various phenotypes examined with respect to their involvement in the error-free PRR 
pathway. First of all, both plate-based (Figure 3.9A) and quantitative liquid killing 
(Figure 3.9B) experiments demonstrate that psy3 is epistatic to mms2 while synergistic to 
rev3, and that the synergism is over 103-fold, which is reminiscent of the genetic 
interaction between mms2 and rev3 (Broomfield et al., 1998). Second, error-free PRR is 
characterized by its enhanced spontaneous mutagenesis in a REV3-dependent manner 
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Figure 3.9 – Sensitivity of mms2, psy3 and rev3 Mutants to MMS. (A) A 10-fold 
serial dilution assay on rich media with or without MMS at concentrations as 
indicated. The plates were incubated at 30 °C for 2 days before being photographed. 
Strains used were HK578-10A and its isogenic derivatives. Results were observed a 
minimum of three times. (B) Cell survival in the presence of 0.3 % MMS by a liquid-
killing assay. The results are the average of four independent experiments. Strains 
used were isogenic to DBY747. (□) DBY747 (wild-type), (●) WXY1323 (psy3), (∆) 
WXY667 (rev3), (○) WXY644 (mms2), (■) WXY1324 (rev3psy3) and (▲) 
WXY1325 (mms2 psy3).  
A 
B 
           YPD                 YPD + 0.002% MMS    YPD + 0.005% MMS 
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(Broomfield et al., 1998). We found that deletion of PSY3 resulted in a 10-fold increase 
in the spontaneous trp1-289 reversion rate over wild-type cells, which is REV3 dependent 
(Table 3.2). As previously reported (Broomfield et al., 1998), deletion of MMS2 results 
in a nearly 20-fold increase in spontaneous mutation rate. Importantly, we found in this 
study that deletion of PSY3 in the mms2 strain only enhances spontaneous mutagenesis 
slightly (Table 3.2), indicating that PSY3 and MMS2 function in the same pathway. Third, 
the psy3 mutant displayed MMS-induced mutagenesis in a REV3- dependent manner and 
at the level comparable to that of mms2, which was higher than wild-type cells (data not 
shown). Finally, we also found that rad5 and rad18 are epistatic to psy3 with respect to 
MMS-induced killing (data not shown), further confirming that PSY3, and hence the SHU 
complex, belongs to the error-free branch of the RAD6 epistasis group. 
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Table 3.2 – S. cerevisiae Spontaneous Mutation Rates to Examine psy3 
Strain
a Key alleles Rate (x 10
-8
)
b
Fold
c
DBY747 Wild-type 1.12 ± 0.3 1
WXY667 rev3 0.31 ± 0.14 0.3
WXY644 mms2  19.8 ± 1.4 17.6
WXY1323 psy3  11.8 ± 3.9 10.5
WXY1324 psy3 rev3 0.98 ± 0.34 0.9
WXY1325 psy3 mms2  25.3 ± 0.8 22.6
a. All strains are isogenic derivatives of DBY747.
b. The spontaneous mutation rates are the average of at least 
    three independent experiments with standard deviation.
c. Relative to the wild-type mutation rate. 
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3.3.7 – Additional Evidence that the SHU Genes are Novel Members of the RAD6 
Epistasis Group 
Currently, there are no direct assays to determine whether a gene is involved in 
error-free PRR. In addition to the above standard genetic analyses initially employed to 
define error-free PRR, there are three other phenotypes that appear to be unique to the 
RAD6 group of genes. First, only mutations in the RAD6 epistasis group are suppressed 
by inactivation of SRS2 (Broomfield and Xiao, 2002; Ulrich, 2001). SRS2 encodes a 3′-5′ 
DNA helicase that inhibits Rad51-ssDNA filament formation and was initially isolated 
by its ability to suppress the severe DNA damage sensitivity of rad6. Indeed, we found 
that srs2 is epistatic to psy3 (Figure 3.10A). Furthermore, deletion of SRS2 is able to 
completely suppress the severe sensitivity of the psy3 rev3 double mutant to killing by 
MMS (Figure 3.10A). We noticed that the psy3 rev3 srs2 triple mutant is even more 
resistant to MMS than the srs2 single mutant. This phenotype has been repeatedly 
observed in several independent strains and the mechanism remains to be investigated. 
Second, we previously reported that mating-type heterozygosity enhances tolerance to a 
wide range of DNA-damaging agents, an effect that is unique to mutations in the RAD6 
pathway (Barbour and Xiao, 2006). Here we demonstrate that the MMS sensitivity of a 
psy3 single mutant is partially rescued in a pseudodiploid with opposite mating types, an 
effect that is not observed when cells carry two copies of the same mating-type gene 
(Figure 3.10B). Third, we recently reported that the damage checkpoint pathway 
mutations are synergistic to mutations in both PRR branches (Barbour et al., 2006). 
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Figure 3.10 – Additional Phenotypes of psy3 are Indicative of a Member of the 
Error-Free PRR Pathway. (A) Suppression of the psy3 sensitivity to MMS by the 
srs2 mutation. (B) Effects of mating-type heterozygosity on psy3 sensitivity to MMS. 
(C) The genetic interaction between psy3 and rad9. Overnight cell cultures were 
imprinted on YPD or YPD + MMS and incubated at 30 °C for 2 days before being 
photographed. Arrows indicate the increasing concentration of MMS. Strains used in 
(A) and (B) were isogenic to HK578-10A and strains used in (C) were isogenic to 
BY4741. Cells carrying the YCp50 vector, YCp50-MATa (pMATa) or YCp50-MAT 
(pMAT) are indicated in (B). Figure 3.10B contributed by Ke Zhang. Results were 
observed a minimum of three times. 
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Indeed, the rad9psy3 double mutant appears to be much more sensitive to killing by 
MMS than either of the corresponding single mutants (Figure 3.10C). In summary, all of 
the above results are consistent with the notion that SHU genes are novel members of the 
error-free PRR pathway.  
 
3.3.8 – mms2 is Epistatic to sgs1 with Respect to MMS Sensitivity 
If Sgs1-Top3 indeed acts downstream of the error-free PRR-Shu-HR pathway to 
resolve stalled replication forks, one would predict that mms2/ubc13 mutations will be 
epistatic to sgs1. Indeed we found that in a strain in which mms2 is slightly less sensitive 
to MMS than sgs1, the mms2 sgs1 double mutant is indistinguishable from mms2 (Figure 
3.11A), indicating that mms2 suppresses the sgs1 sensitivity. We also examined the effect 
of mms2 and mms2 sgs1 mutations on the cell cycle progression in the presence of MMS. 
Like wild-type, mms2 cells accumulate at S-phase in the presence of 0.02% MMS even 
after 3 h of incubation. In contrast, most sgs1 cells pass through S-phase rapidly within 2 
h after release from G1.The sgs1 mms2 double mutant cells progress through S-phase 
much slower than sgs1 cells and do not complete the progress even 3 h after release 
(Figure 3.11B). Hence, we are able to conclude that error-free PRR mutations are 
epistatic to sgs1 for MMS-induced DNA damage.  
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Figure 3.11 – Deletion of MMS2 Suppresses sgs1 Mutant Phenotypes. (A) mms2 
suppresses sgs1 for MMS sensitivity. A gradient plate assay was performed as 
described and the plates were incubated at 30 °C for 2 days before being 
photographed. Arrows indicate the increasing concentration of MMS. Results were 
observed a minimum of three times. (B) mms2 suppresses the sgs1 S-phase checkpoint 
defect. Experimental conditions were as described in Figure 3.8 legend. All strains 
used were isogenic to BY4741. Results were observed in three independent 
experiments.  
Wild-type 
Wild-type 
Wild-type 
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3.4 – Discussion 
By employing a modified SGA screen protocol, we identified three out of four 
genes known to form the Shu complex. Our screening protocol was set strictly to aim at 
identifying genes within the RAD6 pathway and subsequent genetic analyses demonstrate 
that SHU genes indeed belong to the error-free branch of PRR. First of all we show, as 
previously reported, that the single mutants of the SHU genes have indistinguishable 
phenotypes and that the four gene products form a stable complex. Second, shu is 
epistatic to mms2/ubc13 with respect to killing by MMS, a genetic definition that the 
corresponding genes belong to the same pathway. Third, shu is synergistic to rev3 with 
respect to MMS-induced killing, and the level of synergism is characteristic of two 
branched pathways handling the same substrate. Fourth, shu mutants display a mutator 
phenotype characteristic of error-free PRR defects, and this increase in spontaneous 
mutagenesis is dependent on functional REV3. Finally, shu mutations also confer 
phenotypes only observed with defects in typical error-free PRR genes, such as 
suppression by the srs2 mutation (Broomfield and Xiao, 2002) or mating-type 
heterozygosity (Barbour and Xiao, 2006), as well as the synergistic interaction with 
damage checkpoint (Barbour et al., 2006). These phenotypes collectively place SHU 
genes as members of error-free PRR in a most stringent manner.  
Members of SHU genes have also been identified through several previous 
genetic screens, including increase in gross chromosomal rearrangement (GCR) (Huang 
et al., 2003; Smith et al., 2004), suppression of slow growth and HU sensitivity of top3 
(Shor et al., 2005) and alleviation of synergistic phenotypes of sgs1 mms4/mus81 or 
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mph1 mms4/mus81 (St Onge et al., 2007). These phenotypes can be attributed to the role 
of Shu complex in promoting certain aspect(s) of HR mediated by Rad51 and Rad54 
(Mankouri et al., 2007). Based on previous reports and results presented in this study, we 
argue that the Shu complex plays a unique role in S-phase and is probably responsible for 
converting stalled replication forks into HR intermediates, which are subsequently 
resolved by Sgs1-Top3. First, rad52 in general and rad51, rad54 more specifically are 
epistatic to shu in response to killing by MMS, suggesting that the Shu complex functions 
only in the presence of HR. Second, inactivation of SHU effectively suppresses HU and 
MMS sensitivity seen in the sgs1 mutant, as well as other phenotypes associated with 
top3 (Mankouri et al., 2007; Shor et al., 2005), suggesting that it functions upstream of 
Sgs1-Top3-Rim1. This is reminiscent of hr mutations that also suppress sgs1 and top3 
phenotypes (Shor et al., 2002). Third, although shu mutants are much less sensitive to 
MMS than hr mutants, they have a similar effect in delaying S-phase progression in the 
presence of MMS, and the shu hr double mutation has the same effect as corresponding 
single mutations, suggesting that the Shu complex plays an important role in this 
particular aspect of HR. Fourth, shu mutations have an opposite effect to sgs1 on S-phase 
progression in the presence of MMS, while shu is epistatic to sgs1. This observation 
supports more direct evidence that inactivation of HR (Liberi et al., 2005) or SHU genes 
(Mankouri et al., 2007) inhibits MMS-induced X-molecules, which represent abnormal 
DNA replication intermediates, from accumulating in the sgs1 mutant. Since X-
molecules have been implied to be a recombinant intermediate derived from sister 
chromatid invasion at the stalled replication fork, a model is conceivable (Figure 3.12) in  
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Figure 3.12 – A Proposed Model Depicting the Budding Yeast DNA Damage 
Tolerance Pathways Mediated by Covalent Modifications of PCNA, Paying Special 
Attention to the Error-Free PRR Pathway. It is proposed that after PCNA 
polyubiquitination by Rad5–Ubc13–Mms2, the Shu complex helps to recruit homologous 
recombination proteins to the site of a stalled replication fork, resulting in the invasion and 
utilization of the newly synthesized sister chromatid for translesion synthesis. Continual 
template switching and replication creates a double-Holliday junction, which requires the 
Sgs1 helicase for branch migration and the Top3 topoisomerase to resolve the resulting 
hemicatenane structure without crossing over. Essentially as published in Ball et al. 2009. 
 103 
 
which the Shu complex channels blocked replication forks to undergo HR-mediated 
DNA synthesis, or template switching, resulting in the formation of a double-Holliday 
junction (dHJ) that requires the Sgs1 helicase for strand migration and the Top3 
topoisomerase to resolve the Sgs1 product to avoid crossing over (Wu and Hickson, 
2003). Finally, to confirm that the Shu complex indeed couples error-free PRR to HR-
Sgs1, we observed phenotypes indicative of functional overlap between the two pathways 
and more strikingly the phenotypic suppression of sgs1 phenotypes by mms2.  While 
this study demonstrates firmly that error-free PRR employs HR and Sgs1-Top3 resolution 
to bypass replication blocks arising during S-phase, a recent report also demonstrated an 
in vitro assay where Rad5, through its intrinsic helicase activity, promotes replication 
fork regression (Blastyak et al., 2007). Although fork regression and template switching 
are two proposed models of error-free bypass (Broomfield et al., 2001), they are not 
necessarily mutually exclusive. One possibility is the fork regression followed by sister 
chromatid invasion and resolution. Alternatively, it remains possible that error-free PRR 
employs both modes of bypass. Consistent with the latter possibility is the fact that Rad5 
is a multifunctional protein (Ahne et al., 1997; Chen et al., 2005; Johnson et al., 1992) 
and that the rad5 mutant is much more sensitive to DNA-damaging agents than a typical 
error-free PRR pathway mutant such as mms2 or ubc13 (Xiao et al., 2000). Nevertheless, 
the template switch model is supported by an observation using a carefully designed 
damage substrate that mimics UV-induced lesions on both DNA strands (Zhang and 
Lawrence, 2005). 
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 Although SHU genes are assigned to the error-free PRR pathway through this 
study, we notice some differences between mms2/ubc13 mutants and shu mutants. First, 
while hr mutations are epistatic to shu, they are additive to mms2/ubc13. Second, while 
mms2/ubc13 are synergistic with rev3 to essentially any DNA-damaging agents 
examined (Broomfield et al., 1998; Xiao et al., 1999), the strong synergism between shu 
and rev3 appears to be limited to MMS (L.G. Ball and W. Xiao, data not shown). Third, 
mms2 or ubc13 mutant is slightly more sensitive to MMS than shu mutants (e.g. Figure 
3.9A). Finally, the mms2 mutant consistently displays a higher spontaneous mutation rate 
than psy3 in the trp1-289 reversion assay. Interestingly, SHU genes have been identified 
in the screen for GCR suppressors, whereas neither mms2 nor ubc13 came out of these 
screens (Huang et al., 2003; Smith et al., 2004). Collectively, we interpret these 
differences as an indication that the Shu complex may inherit a subset of error-free PRR 
activities, most likely during S-phase, and respond to lesions induced by agents like 
MMS.  
 PSY3 and SHU2 appear to have homologues in Schizosaccharomyces pombe (rld1 
and swi1 respectively) and human cells (RAD51D and SWI1 respectively), and their 
functions are reminiscent of SHU with respect to promoting HR and suppressing RecQ 
family mutant phenotypes (Martin et al., 2006). Given that Mms2–Ubc13-mediated DNA 
damage tolerance pathway is also conserved in eukaryotes (Andersen et al., 2005; Brown 
et al., 2002; Li et al., 2002), it would be of great interest to examine whether these 
homologues also function in a similar manner.  
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CHAPTER FOUR 
DNA ENDO/EXONUCLEASES AND THE Sgs1 HELICASE ARE 
REQUIRED FOR YEAST DNA POSTREPLICATION REPAIR 
 
4.1 – Abstract 
Yeast DNA PRR functions to bypass replication-blocking lesions in order to 
prevent damage-induced cell death. PRR employs two different mechanisms to bypass 
damaged DNA, namely TLS and error-free PRR. We recently demonstrated that error-
free PRR utilizes homologous recombination and the Sgs1 helicase to facilitate template 
switching. To our surprise, sgs1 and null mutations of genes encoding the Mre11-Rad50-
Xrs2 (MRX) complex, which are also required for HR, are epistatic to TLS mutations. 
Further genetic analyses indicated that two other nucleases involved in double-strand end 
resection, Sae2 and Exo1, are also variably required for efficient lesion bypass. The 
modes of their involvement in different branches of PRR were further confirmed by 
mutagenesis assay and their effects on the inhibition of PCNA ubiquitination. In light of 
the distinct and overlapping activities of the above nucleases in the resection of double-
strand breaks, we propose that the interplay among Sgs1 and distinct single-strand 
nuclease activities of MRX, Sae2 and Exo1 dictate the preference between TLS and 
error-free PRR for lesion bypass. 
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4.2 – Introduction 
 In order to maintain genomic integrity, living organisms have developed a set of 
highly conserved mechanisms to deal with spontaneous and induced DNA damage. DNA 
lesions that result in stalled replication apparatus are among the most dangerous and 
result in genomic instability, a well-known hallmark of cancer. DNA repair and 
replication checkpoints act to prevent the collapse of blocked replication apparatus, while 
HR acts to rescue DSBs induced by collapsed replication forks (Friedberg et al., 2006). 
To prevent detrimental outcomes, the budding yeast Saccharomyces cerevisiae RAD6 
DNA PRR epistasis group functions to bypass replication blocks (Barbour and Xiao, 
2003). Within this pathway, Rad6 is known to have diverse functions outside of PRR, 
while Rad18 functions exclusively in a stable complex with Rad6 to monoubiquitinate 
PCNA. PCNA is encoded by the essential gene POL30 in budding yeast and is a DNA 
polymerase sliding clamp. It is generally believed that upon exposure to DNA damage, 
PCNA is monoubiquitinated at the K164 residue (Hoege et al., 2002) and that this 
monoubiquitination promotes TLS. The TLS pathway is represented by REV3 and REV7, 
which encode the catalytic and regulatory subunits of DNA Pol, and REV1; inactivation 
of any one of the above genes results in severely compromised induction of mutagenesis 
after DNA damage treatment and a reduction in spontaneous mutagenesis (Lawrence, 
2004). 
 Monoubiquitinated PCNA can be further polyubiquitinated by Mms2-Ubc13-
Rad5 to form non-canonical K63-linked Ub chains, which leads to an error-free mode of 
PRR (Hoege et al., 2002). An mms2 null mutation causes moderate sensitivity to killing 
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by numerous DNA-damaging agents, strong synergistic interaction with rev3, and a 
REV3-dependent increase in spontaneous mutagenesis (Broomfield et al., 1998; Xiao et 
al., 1999). Similar phenotypes have been observed for the ubc13 null mutant as well 
(Brusky et al., 2000; Hofmann and Pickart, 1999). It has long been proposed that error-
free PRR utilizes some form of HR to bypass replication-blocking lesions (Prakash et al., 
1993); however, direct evidence only emerged recently for the involvement of HR in 
error-free PRR (Chapter 3) (Ball et al., 2009). In this report, genes required for HR, 
including RAD51, RAD52, RAD54, RAD55 and RAD57, were placed downstream of 
MMS2 and UBC13 within the error-free branch of PRR. However, other genes involved 
in HR, including MRE11, RAD50 and XRS2, whose products form a stable complex 
known as the MRX complex (Krogh and Symington, 2004), have not been characterized 
with respect to PRR. 
The MRX complex binds DNA and is known to be involved in numerous 
activities such as telomere length, damage recognition and processing following DSBs, 
non-homologous end joining, cell cycle checkpoint activation, meiosis and most recently 
BER (D'Amours and Jackson, 2002; Daley et al., 2005; Grenon et al., 2001; Ivanov et al., 
1994; Lisby et al., 2004; Steininger et al.; Steininger et al., 2008; Tsukuda et al., 2005). 
Mre11 is also known to function as both a ssDNA endonuclease and a 3’-5’ exonuclease 
(Paull and Gellert, 1998, 1999). Phenotypically, the null mutant of any one of the MRX 
components exhibits extreme sensitivity to ionizing radiation and other DNA-damaging 
agents (Krogh and Symington, 2004). Rad50 belongs to the structural maintenance of 
chromosomes (SMC) family of proteins and contains two heptad repeats in its center that 
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fold into a coiled-coil (de Jager et al., 2001). Mre11 binds to the base of the coiled-coil 
(Mre11-Rad50), while at the very tip a conserved Cys-X-X-Cys motif is found to form a 
hook-shaped domain allowing dimerization with another Mre11-Rad50 dimer resulting in 
an Mre112Rad502 heterotetramer (Anderson et al., 2001; Hopfner et al., 2002). Xrs2, the 
third component of MRX, binds to Mre11 via its conserved C-terminal domain; the 
interaction between Mre11 and Xrs2 is essential for all known Mre11 functions 
(Tsukamoto et al., 2005). 
Here we report our investigation of novel functions of the MRX complex in both 
TLS and error-free PRR. Two relevant nucleases Exo1 and Sae2 were also characterized 
in this study. In addition we examined the role of the Sgs1 helicase in the early steps of 
lesion bypass. These studies unexpectedly revealed the involvement of the MRX 
complex and Sgs1 in regulating PRR pathways. 
 
4.3 – Results 
4.3.1 – The MRX Complex Functions in Both TLS and Error-free PRR 
 Previous work in our laboratory (Chapter 3) utilized an SGA screen (Tong et al., 
2001) of all non-essential genes in S. cerevisiae to identify novel genes involved in TLS 
and error-free PRR (Ball et al., 2009). Both rev1 and rev3 query strains identified HR 
genes including RAD51, RAD52, RAD54, RAD55, and RAD57 (Ball et al., 2009). 
Mutations of all the above genes conferred characteristic synergistic interactions with tls 
mutations (Figure 4.1 and data not shown), while neither the mms2 nor ubc13 mutation 
displayed  
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Figure 4.1 – Differential Genetic Interactions between REV3 or MMS2 and 
Homologous Recombination Genes with Respect to MMS Sensitivity by a 
Gradient Plate Assay. Overnight cell cultures were imprinted on YPD or YPD + 
MMS at the concentration indicated and incubated at 30 °C for 2 days before being 
photographed. The arrows indicate the increasing MMS concentration. All strains 
used were isogenic to BY4741. (A) rad51∆ vs. rev3∆ or mms2∆. (B) rad52∆ vs. 
rev3∆ or mms2∆. (C) rad54∆ vs. rev3∆ or mms2∆. (D) rad55∆ vs. rev3∆ or mms2∆. 
(E) rad57∆ vs. rev3∆ or mms2∆. Results were observed a minimum of three 
times.Results contributed by Ke Zhang.  
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synergistic interaction with the above HR mutations (Figure 4.1 and data not shown). To 
our surprise, none of the MRX genes were pulled out in the above SGA screens, 
suggesting that mrx mutations may have unexpected genetic interactions with tls 
mutations. Upon further screening and characterization of the MRX complex, we found 
that null mutations of mre11 (Figure 4.2A), rad50 (Figure 4.2B), and xrs2 (Figure 4.2C) 
are essentially epistatic to rev3 with respect to killing by the alkylating agent MMS that 
specifically causes replication-blocking lesions, which was in sharp contrast to the 
synergistic interactions between hr rev3 double mutants (Figure 4.1). On the other hand, 
genetic interactions between mrx and mms2 are essentially identical to that of hr and 
mms2 (Figure 4.2A, B, C, and Figure 4.1). To further illustrate differences between mrx 
and hr with respect to their genetic interactions with TLS mutations, we performed 
quantitative liquid killing experiments to compare rad51 and mre11. While rad51 is 
indeed synergistic with rev3 (Figure 4.3A), the mre11 rev3 double mutant is barely more 
sensitive to 0.1% MMS than the mre11 single mutant (Figure 4.3B). In addition, while 
the mms2 rad51 double mutant is more sensitive to MMS-induced killing than either of 
the corresponding single mutants (Figure 4.3A), the mms2 mre11 double mutant is again 
barely more sensitive to 0.1% MMS than the mre11 single mutant (Figure 4.3B). Similar 
results were also obtained after UV irradiation (Figure 4.4). Together these observations 
suggest that the MRX complex does not function exclusively in error-free PRR like other 
known HR genes, and instead functions in both the TLS and error-free PRR pathways. 
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Figure 4.2 – Genetic Interactions Between REV3 or MMS2 and the MRX 
Complex Genes with Respect to MMS Sensitivity. (A-C) Cell survival in a gradient 
plate assay. Overnight cell cultures were imprinted on YPD or YPD + 0.005 % MMS 
and incubated at 30 °C for 2 days before being photographed. The arrow indicates the 
increasing MMS concentration. All strains used were isogenic to BY4741. (A) 
mre11∆ vs. rev3∆ or mms2∆; (B) rad50∆ vs. rev3∆ or mms2∆; (C) xrs2∆ vs. rev3∆ or 
mms2∆. Results were observed a minimum of three times. Results contributed by Ke 
Zhang.  
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Figure 4.3 – Cell Survival in a Liquid Killing Assay to Explore the Genetic 
Interactions Between REV3 or MMS2 and the MRX Complex. These results are 
the average of three independent experiments with standard deviations indicated by 
error bars. All strains used were isogenic to BY4741. (A) rad51∆ vs. rev3∆ or mms2∆; 
(B) mre11∆ vs. rev3∆ or mms2∆. Results contributed by Ke Zhang. 
A B 
Wild-type Wild-type 
mms2 
rev3 
rad51 
rad51mms2 
rad51rev3 
rev3 
mms2 
mre11 
mre11rev3 
mre11mms2 
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Figure 4.4 – Genetic Interactions Between REV3 or MMS2 and the MRX 
Complex Genes with Respect to UV Sensitivity. Overnight cell cultures were used 
to make a series of 10-fold dilutions, spotted and the plates were then exposed to the 
UV dose as indicated and incubated at 30 °C for 2 days before being photographed. 
All strains used were isogenic to BY4741. Results were observed a minimum of three 
times. Results contributed by Ke Zhang.  
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4.3.2 – Genetic Interactions Between MRX and PCNA Modifications 
It is the sequential ubiquitination of PCNA that satisfactorily explains the current 
genetic observations with regard to how the RAD6 pathway operates to tolerate and 
bypass replication-blocking lesions. To critically determine whether MRX genes are 
involved in the PRR pathways, we combined the mre11 null mutation with a pol30-
K164R point mutation that abolishes ubiquitination of PCNA (Hoege et al., 2002). Our 
prediction was that if the increased sensitivity conferred by mre11 were due to its 
involvement in PRR, the mre11 pol30-K164R double mutant would be as sensitive as one 
of the single mutants. Indeed, while mre11 appears slightly more sensitive to MMS than 
the pol30-K164R single point mutation, the mre11 pol30-K164R double mutant is less 
sensitive than the mre11 single mutant and more like the pol30-K164 single mutant 
(Figure 4.5). This result further supports the notion that Mre11 functions in the same 
pathway as PCNA posttranslational modifications at the K164 residue. 
The epistatic genetic relationship between mre11 and pol30-K164R does not 
necessarily indicate whether the MRX complex acts upstream or downstream of PCNA 
ubiquitination. To answer this question, we set out to determine if deletion of MRX genes 
could alter the relative level of ubiquitinated PCNA. To achieve this objective, we raised 
polyclonal antibodies against purified Pol30 expressed from bacterial cells. When it was 
realized that cross reactions to other yeast proteins became a concern, we screened a large 
number of monoclonal antibodies and obtained functional monoclonal antibodies (mAbs) 
for this study. We were able to verify monoubiquitinated PCNA in the wild-type yeast 
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Figure 4.5 – MRE11 and Belongs to the Yeast PRR Pathway. Overnight cell 
cultures were imprinted on YPD or YPD + MMS gradient plates at the given 
concentrations, and incubated at 30 °C for 2 days before being photographed. The 
arrow indicates the increasing MMS concentration. pol30-K164R is epistatic to mre11. 
Strains used were DBY747 (Wild-type) and its isogenic derivatives WXY2379 
(mre11∆), WXY2384 (pol30-K164R) and WXY2389 (mre11∆ pol30-K164R). Results 
were observed a minimum of three times. Results contributed by Ke Zhang.   
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whole cell extracts without the need for Hisn-affinity purification, and notably this 
modification was absent in a strain containing a genomic integration of the pol30-K164R 
point mutation (Figure 4.6A, lanes 3 and 4), and was not detected in the absence of MMS 
treatment (cf. lanes 1, 2 vs. 5, 6). The fact that this band was slightly shifted up in the 
strain containing the POL30-His7 allele compared to the native Pol30 allele (cf. lanes 5 
and 6) further confirms that this band is PCNA modification. It was previously reported 
that overexpression of RAD18 alone can enhance PCNA ubiquitination (Davies et al., 
2008). Our laboratory also found that simultaneous overexpression of both RAD6 and 
RAD18 could enhance Rad17 monoubiquitination (Fu et al., 2008). In this study, we 
found that overexpressing RAD18 alone or RAD6+RAD18 was able to enhance the 
visualization of monoubiquitinated PCNA, although it is not required (Figure 4.6B). In 
addition, as expected, a null mutation of rad18 abolishes monoubiquitinated PCNA 
(Figure 4.7, lane 5). In addition, we found that deletion of mre11 visually reduced the 
level of monoubiquitinated PCNA (Figure 4.14). Together our results clearly demonstrate 
that the MRX complex is a novel member of the PRR pathway functioning upstream of 
PCNA modification.
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Figure 4.6 – Characterization of Monoubiquitinated PCNA. (A) Detection of 
monoubiquitinated PCNA. (B) Overexpression of RAD6 +RAD18 or RAD18 alone 
improves the detection of PCNA in whole cell extracts. Overnight cultures were 
subcultured and allowed to grow to a cell count of approximately 1x10
7
 cells/mL 
before being treated with 0.05 % MMS for 90 minutes or remained untreated. Total 
cell extracts were subject to SDS-PAGE and western blot analyses with an in-house 
anti-Pol30 monoclonal antibody. Strains used were HK578-10A (wild-type), 
WXY994 (pol30-K164R), WXY989 (Pol30-His7), and WXY990 (pol30-K164R-His7).  
Molecular size markers are labeled on left (in kD). Unmodified Pol30 protein is 
indicated by PCNA, and monoubiquitinated PCNA is indicated by Ub1. *** An 
unknown band that appears only in a pol30-K164R point mutation after MMS 
treatment, and may represent a different modification of PCNA. The lower box in 
Figure B resulted from a shorter exposure time of the same western depicted above it. 
Results were observed a minimum of three times. 
PCNA PCNA 
*** 
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Figure 4.7 – PCNA Monoubiquitination is Dependent on RAD18. Overnight 
cultures were subcultured and allowed to grow to a cell count of approximately 1x10
7
 
cells/mL before being treated with 0.05 % MMS for 90 minutes. Total cell extracts 
were subject to SDS-PAGE and western blot analyses with an in-house anti-Pol30 
monoclonal antibody. Strains used were HK578-10A (wild-type), WXY994 (pol30-
K164R), WXY989 (POL30-His7), WXY990 (pol30-K164R-His7) and WXY930 
(rad18∆). Molecular size markers are labeled on left (in kD). Unmodified Pol30 
protein is indicated by PCNA, and monoubiquitinated PCNA is indicated by Ub1. The 
lower box resulted from a shorter exposure time of the same western shown above. 
Results were observed a minimum of three times. 
PCNA 
PCNA 
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4.3.3 – Involvement of Two Nucleases, Sae2 and Exo1, in PRR 
 The MRX complex is rapidly recruited to DSBs, signals checkpoint activation 
and regulates 5’-3’ resection of the DNA ends (Lee et al., 1998; Lisby et al., 2004; 
Nelms et al., 1998). MRX is also known to interact with Sae2/CtIP/Ctp1 (Clerici et al., 
2005; Limbo et al., 2007; Sartori et al., 2007). Sae2 was initially discovered in two 
genetic screens designed to isolate mutants defective in the steps following the initiation 
of Spo11-induced DSBs but functioning before resolution of the recombination 
intermediates (McKee and Kleckner, 1997; Prinz et al., 1997). Since then Sae2 has been 
deemed the “unofficial fourth member” of the MRX complex (Mimitou and Symington, 
2009). However, the function of the MRX complex in cooperation with Sae2 in 
processing DSBs is partly redundant with the 5’-3’ exonuclease Exo1 (Tran et al., 2004). 
Exo1 has been implicated in mismatch repair, telomere integrity (Liberti and Rasmussen, 
2004; Tran et al., 2004), error-free PRR (Tran et al., 2007) and most recently long-range 
resection of DSBs together with MRX and Sae2 (Bonetti et al., 2009; Mimitou and 
Symington, 2008; Zhu et al., 2008). Therefore, it is necessary to investigate the roles of 
Sae2 and Exo1 in relation to PRR. 
The genetic interaction between sae2 and both mms2 and rev3 resulted in double 
mutations that were only slightly more sensitive than their respective single mutants 
(Figure 4.8A), making it difficult to specifically place SAE2 in one of the two PRR 
pathway. This result is also reminiscent of the genetic interaction between mrx and both 
PRR pathways (Figure 4.2 and 4.3). To determine whether SAE2 plays a role in PRR, we  
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Figure 4.8 – Genetic Interactions Between SAE2, EXO1, and REV3 or MMS2. 
Overnight cell cultures were imprinted on YPD or YPD + MMS gradient plates at the 
given concentrations, and incubated at 30°C for 2 days before being photographed. 
Arrows indicate the increasing MMS concentration. All strains used were isogenic to 
BY4741. (A) sae2∆ vs. mms2∆ or rev3∆. (B) sae2∆ vs. mms2∆ rev3∆. (C) exo1∆ vs. 
mms2∆ or rev3∆. (D) exo1∆ vs. sae2∆. Results were observed a minimum of three 
times. 
 121 
 
deleted SAE2 in the mms2 rev3 double mutant and found that the resulting triple mutant 
was as sensitive to MMS as the mms2 rev3 double mutant (Figure 4.8B), suggesting that 
SAE2 plays partial roles in both TLS and error-free PRR. To further address whether the 
increased MMS sensitivity of the sae2 mutant is due to its role within the PRR pathway, 
we combined sae2 with either rad18 or the pol30-K164R mutation and in both cases the 
double mutants were as sensitive to MMS as the corresponding single mutants (Figure 
4.9A and B). These observations clearly place SAE2 within the yeast PRR pathway with 
respect to MMS sensitivity. 
The exo1 single mutant does not display noticeable sensitivity to MMS-induced 
killing (Figure 4.8C), making it difficult to determine its epistatic relationship with other 
gene mutations. However, the exo1 rev3 double mutant displays a much greater 
sensitivity to MMS than either corresponding single mutant (Figure 4.8C), suggesting 
that EXO1 functions in a pathway distinct from TLS. In sharp contrast, the exo1 mms2 
double mutant is as sensitive to MMS as the mms2 single mutant (Figure 4.8C), 
indicating that EXO1 functions in the error-free PRR pathway. This observation agrees 
with a recent report (Tran et al., 2007). We also examined the genetic interaction between 
SAE2 and EXO1 and found that the exo1 sae2 double mutant is as sensitive to MMS as 
the sae2 single mutant (Figure 4.8D). Given the fact that the exo1 mutation could 
enhance rev3 sensitivity, this observation indicates that sae2 is epistatic to exo1, or that, 
like EXO1, SAE2 also functions in the error-free PRR pathway. 
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Figure 4.9 – SAE2 Belongs to the Yeast PRR Pathway. (A-B) Overnight cell 
cultures were imprinted on YPD or YPD + MMS gradient plates at the given 
concentrations, and incubated at 30 °C for 2 days before being photographed. The 
arrow indicates the increasing MMS concentration. (A) pol30-K164R is epistatic to 
sae2∆. Strains used were HK578-10A (Wild-type) and its isogenic derivatives 
WXY2975 (sae2∆), WXY994 (pol30-K164R) and WXY3007 (sae2∆ pol30-K164R. 
(B) rad18 is epistatic to sae2. Strains used were HK578-10A (wild-type), WXY930 
(rad18), WXY2975 (sae2), and WXY3008 (rad18sae2). Results were observed 
a minimum of three times.  
pol30K164R 
 
sae2pol30-K164R 
 
sae2 
 123 
 
Error-free PRR is characterized by its enhanced spontaneous mutagenesis (Broomfield et 
al., 1998). If EXO1 is a member of error-free PRR, its inactivation would be expected to 
cause an increased spontaneous mutagenesis. Indeed, deletion of EXO1 resulted in a 16-
fold increase in spontaneous mutagenesis (Table 4.1). Two observations ruled out the 
possibility that this increase was due to the loss of the mismatch repair activity of EXO1. 
Firstly, the increased mutagenesis as seen in the exo1 mutant was completely dependent 
on REV3, since the exo1 rev3 double mutant has a spontaneous mutation rate comparable 
to that of wild-type cells. Secondly, the spontaneous mutation rate in the exo1 mms2 
double mutant is comparable to that of the mms2 single mutant, which is consistent with 
a predicted outcome if the enhanced mutagenesis by exo1 and mms2 were due to the 
same mechanisms. Unlike exo1, deletion of MRE11 or SAE2 did not alter the 
spontaneous mutation rate over wild-types cells (Table 4.1), suggesting that if MRX and 
Sae2 function within PRR, they must play pivotal roles in the TLS pathway. This is in 
sharp contrast to rad51, which inactivates HR downstream of error-free PRR (Ball et al., 
2009) and results in a 30-fold increase in spontaneous mutagenesis over wild-type cells 
(Table 4.1). 
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Table 4.1 – S. cerevisiae Spontaneous Mutation Rates to Examine the mrx 
Complex, exo1, sae2 and sgs1 
Table 4.1 S. cerevisiae  spontaneous mutation rates
Strain
a Key alleles Rate (x 10
-8
)
b
Fold
c
DBY747 Wild-type 0.14 ± 0.12 1
WXY667 rev3  0.031 ± 0.014 0.2
WXY2917 exo1  2.27 ± 0.63 16.2
WXY644 mms2  2.72 ± 0.64 19.4
WXY2394 sae2  0.18 ± 0.08 1.3
WXY2397 mre11  0.16 ± 0.07 1.1
WXY1164 rad51  4.2 ± 0.6 30.0
WXY2392 sgs1  0.044 ± 0.012 0.3
WXY2918 exo1 mms2  3.33 ± 0.3 23.8
WXY2991 exo1 rev3  0.12 ± 0.07 0.9
a. All strains are isogenic derivatives of DBY747.
b. The spontaneous mutation rates are the average of at least 
    three independent experiments with standar deviation.
c. Relative to the wild-type mutation rate. 
Results courtesy of Michelle Hanna 
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4.3.4 – Sgs1 Is Required for TLS 
Based on the observations that the human Sgs1 homolog, BLM, dissociates D-
loop and double-Holliday junction intermediates (Gangloff et al., 2000; Karmakar et al., 
2006; van Brabant et al., 2000; Wu and Hickson, 2003), Sgs1 has been thought to 
function downstream of HR and upstream of Top3. Consistently, previous work from our 
laboratory demonstrated that mms2 is epistatic to sgs1 with respect to MMS sensitivity, 
placing SGS1 downstream of MMS2 for error-free lesion bypass via HR (Ball et al., 
2009). This model predicts that, like other HR mutations, sgs1 is synergistic with TLS 
mutations. However, genetic analysis of the sgs1 rev3 double mutant consistently shows 
that sgs1 is completely epistatic to rev3 (Figure 4.10) indicating that Sgs1 has a more 
complex function with respect to PRR than previously thought. This result suggests that 
Sgs1 functions in both branches of the PRR pathway, and is reminiscent of recent reports 
that Exo1 and Sgs1 function in different mechanisms for 5’-3’ DSB processing (Bonetti 
et al., 2009; Mimitou and Symington, 2008; Zhu et al., 2008). To further confirm the 
involvement of Sgs1 in TLS, we examined the spontaneous mutation rate in an sgs1 
mutant and found that deletion of SGS1 resulted in a spontaneous mutation rate 
comparable to that of rev3 (Table 4.1), hence placing SGS1 within the TLS pathway. 
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Figure 4.10 – Genetic Interactions Between SGS1 and REV3 or MMS2. Overnight 
cell cultures were imprinted on YPD or YPD + MMS gradient plates at the given 
concentrations, and incubated at 30°C for 2 days before being photographed. Arrows 
indicate the increasing MMS concentration. All strains used were isogenic to BY4741. 
sgs1∆ vs. mms2∆ or rev3∆. Results were observed a minimum of three times, and in 
two different strain backgrounds. 
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4.3.5 – The Nuclease Activities of Mre11 and Sae2 Are Required for Their Functions 
in PRR 
 The MRX complex is well known for its structural function in maintaining sister 
chromatid cohesion during DNA metabolic events (Williams et al., 2007). However 
Mre11 also maintains a nuclease activity responsible for processing DSB ends and 
hairpins (Connelly et al., 1999; Furuse et al., 1998; Lobachev et al., 2002; Paull and 
Gellert, 1998; Trujillo and Sung, 2001). The nuclease activity of Mre11 is not essential 
for some of its known functions including DNA damage sensitivity (Furuse et al., 1998) 
and the stabilization of the replisome (Tittel-Elmer et al., 2009). In order to determine 
whether the nuclease activity of Mre11 is required for its function in PRR, we compared 
the relative sensitivity of a nuclease deficient mre11-3 (125-126
HD->LV
) mutant with the 
mre11-3 rev3 double mutant. It should be noted that this nuclease dead mutant is still 
proficient in allowing the MRX complex to assemble (Bressan et al., 1998) and is much 
less sensitive to MMS than the mre11 null mutant (Figure 4.11A). We argue that if the 
nuclease activity of Mre11 was not required for its function in PRR one would expect to 
see a synergistic interaction between mre11-3 and rev3. In contrast, the mre11-3 rev3 
double mutant is nearly as sensitive to MMS as the mre11-3 single mutant (Figure 
4.11A), confirming that the nuclease activity of Mre11 is indeed required for its function 
in TLS. 
Sae2 controls the initiation of DNA-end resection in meiotic and mitotic cells and 
was recently shown to be a DNA endonuclease (Lengsfeld et al., 2007), a function that is  
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Figure 4.11 – Involvement of Nuclease Activities of Mre11 and Sae2 in TLS. 
Single and double mutants were transformed with plasmids carrying wild-type, the 
nuclease/helicase-dead mutations or the vector alone. Overnight cell cultures were 
imprinted on YPD or YPD + MMS at desired concentrations and incubated at 30 °C 
for 2 days before being photographed. (A) mre11∆ vs. rev3∆, strains are isogenic to 
DBY747. (B) sae2∆ vs. rev3∆, strains are isogenic to BY4741. Results were observed 
a minimum of three times. Results contributed by Ke Zhang.  
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abolished by a sae2-G270D mutation. Furthermore, it has been reported that a sae2-
S267A point mutation, which prohibits the Cdc28-dependent phosphorylation of Sae2, 
displays a phenotype indistinguishable from the sae2 null mutant (Huertas et al., 2008). 
We found that sae2-G270D and sae2-S267A mutants displayed intermediate sensitivity to 
MMS; when combined with rev3, the double mutants were slightly more sensitive to 
MMS than the rev3 single mutant (Figure 4.11B), suggesting that these activities are also 
required for the PRR function. 
  To determine whether the helicase activity of Sgs1 is important for DSB 
processing in PRR, we compared wild-type or the helicase-dead (sgs1-hd) mutant with 
rev3 or the rev3 sgs1-hd mutant. As seen in Figure 4.12, the sgs1-hd mutant is as 
sensitive to MMS as the null mutant, and the rev3 sgs1-hd double mutant is no more 
resistant to MMS than the rev3 sgs1 double mutant, which is consistent with a notion that 
the Sgs1 helicase activity is required for its function within PRR. The slightly increased 
sensitivity of rev3 sgs1-hd to MMS over the rev3 sgs1 null mutant is probably due to a 
dominant-negative effect of Sgs1-hd protein on other pathway(s). 
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Figure 4.12 – Involvement of the Helicase Activity of Sgs1 in TLS. Single and 
double mutants were transformed with plasmids carrying wild-type, the 
nuclease/helicase-dead mutations or the vector alone. Overnight cell cultures were 
imprinted on YPD or YPD + MMS at desired concentrations and incubated at 30 °C 
for 2 days before being photographed. sgs1∆ vs. rev3∆, strains are isogenic to 
DBY747. Results were observed a minimum of three times. 
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4.3.6 – Effects of mre11, sae2, exo1, and sgs1 on PCNA Ubiquitination 
TLS and error-free PRR are achieved by sequential ubiquitination of PCNA in 
response to DNA damage (Hoege et al., 2002). To investigate how Mre11, Sae2, Exo1 
and Sgs1 are involved in PRR, we endeavoured to detect both mono- and 
polyubiquitinated PCNA. As SUMOylation (SUMO - small ub-like modifier) of PCNA 
and diubiquitination of PCNA migrate similarly under our experimental conditions we 
introduced a siz1 null mutation to our query strains to eliminate SUMOylation of PCNA. 
Siz1 is a SUMO ligase of the SIZ/PIAS family (Johnson and Gupta, 2001) and a null 
mutation of siz1 abolishes SUMOylation of PCNA without affecting PCNA 
ubiquitination (Stelter and Ulrich, 2003). As seen in Figure 4.13A, SUMOylated PCNA 
is observed in the absence of MMS treatment (lanes 1 and 3), but it is dependent on the 
Pol30-K164 residue (lanes 2 and 4), as well as SIZ1 (lane 5). Upon MMS treatment, the 
two prominent bands marked as Ub1 and Ub2 are deemed to be PCNA mono- and 
diubiquitinations, respectively, as they were shifted in the lane containing the Pol30-His7 
cell extract (Figure 4.13B, lane cf. lanes 1 and 3), and were abolished in the pol30-K164R 
mutations (lanes 2 and 4). As expected, they were not affected by deletion of SIZ1 (lane 
5) and only the diubiquitinated PCNA was abolished by the mms2 null mutation (lane 6). 
We repeatedly observed a drastic decrease in monoubiquitinated PCNA in an mre11 siz1 
mutant compared to the siz1 and rad51 null mutants (Figure 4.14, cf. lanes 4, 5 and 8). 
rad51 is not expected to alter the ubiquitination state of PCNA as it has only been 
suggested to function downstream of error-free PRR (Ball et al., 2009). In addition 
mre11 appears to reduce the level of detectable diubiquitinated 
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Figure 4.13 – Characterization of Diubiquitinated PCNA. (A) Western blot 
analysis with extracts from cells without DNA damage treatment. (B) Western blot 
analysis with extracts from cells treated with 0.05 % MMS for 90 minutes. A siz1∆ 
mutation was used to eliminate SUMOylation of PCNA in order to better detect 
diubiquitinated PCNA. Cell extracts were prepared as previously described and 
subject to western blot analyses with an in-house anti-Pol30 monoclonal antibody. 
Strains used were HK578-10A (wild-type), and its isogenic derivatives WXY994 
(pol30-K164R), WXY989 (POL30-HIS7), WXY990 (pol30-K164R-His7), WXY2959 
(siz1) and WXY2960 (mms2siz1). Molecular size markers are labeled on left (in 
kD). Unmodified Pol30 protein is indicated by PCNA, and monoubiquitinated PCNA 
is indicated by Ub1 and diubiquitinated PCNA is indicated by Ub2. *** An unknown 
band that appears only in a pol30-K164R point mutation after MMS treatment, and 
may represent a different modification of PCNA. The lower box in both Figure A and 
B resulted from a shorter exposure time of the same western directly above. Results 
were observed a minimum of three times. 
PCNA 
PCNA 
*** 
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Figure 4.14 – Effects of mre11, sae2, exo1, rad51 and sgs1 on MMS-induced 
Mono- and Diubiquitination of PCNA. Overnight cultures were subcultured and 
allowed to grow to a cell count of approximately 1x10
7 
cells/mL before being treated 
with 0.05 % MMS (as indicated) for 90 minutes. Total cell extracts were obtained 
under denaturing conditions and analysed by SDS-PAGE and western blot. Cell 
extracts were prepared as previously described and subject to western blot analyses 
with an in-house anti-Pol30 monoclonal antibody. Strains used were HK578-10A 
(wild-type) and its isogenic derivatives WXY994 (pol30-K164R), WXY2959 (siz1∆), 
WXY2995 (mre11∆ siz1∆), WXY2962 (sae2∆siz1∆), WXY2963 (exo1∆siz1∆), 
WXY2994 (rad51∆siz1∆) and WXY2969 (sgs1∆siz1∆). Molecular size markers are 
labeled on left (in kD). Unmodified Pol30 protein is indicated by PCNA, and 
monoubiquitinated PCNA is indicated by Ub1 and diubiquitinated PCNA is indicated 
by Ub2. The lower box resulted from a shorter exposure time of the same western 
directly above. Results were observed a minimum of three times. 
PCNA 
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PCNA (Figure 4.13, lane 5). Although genetic analysis does not clearly assign Sae2 to 
the error-free or TLS PRR pathway, deletion of SAE2 appears to decrease 
monoubiquitinated and possibly diubiquitinated PCNA (Figure 4.14, lane 6), further 
suggesting Sae2 functions in PRR, primarily in the TLS pathway. Deletion of exo1 does 
not affect monoubiquitinated PCNA; however, it does appear to decrease the level of 
diubiquitinated PCNA (lane 7), lending further support to the notion that Exo1 plays an 
accessory role in error-free PRR. Finally, deletion of SGS1 drastically decreases the level 
of monoubiquitinated PCNA without an apparent impact on diubiquitinated PCNA (lane 
9). Collectively, the above observations allow us to conclude that MRX, Sae2 and Exo1 
nucleases and the Sgs1 helicase involved in the processing of DSB ends are variably 
required for PCNA ubiquitination while some of them play multiple roles in PRR. 
 
4.4 – Discussion 
 Here we report unexpected observations that MRX, Sae2 and Exo1 
endo/exonucleases and the Sgs1 helicase are variably involved in the error-prone and 
error-free branches of PRR. This study gives a greater understanding of how TLS and 
error-free PRR are co-coordinately operated at the molecular level. 
 
4.4.1 – MRX and Sae2 
 MRX has been implicated in numerous DNA damage response pathways 
specifically the processing of DSBs during meiosis and mitosis. It would be highly 
expected for MRX to play a role downstream of error-free PRR along with other HR 
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proteins (Ball et al., 2009). However, in addition to its expected genetic interactions with 
members of error-free PRR, mrx mutations are surprisingly epistatic to mutations in the 
TLS pathway. The involvement of MRX was further confirmed by several observations. 
First of all, unlike other HR genes, none of the MRX genes were identified from a 
conditional synthetic lethal screen using either TLS or error-free PRR pathway mutants 
as queries, these absent synergistic interactions were later individually confirmed. 
Secondly, the pol30-K164R mutation is epistatic to mre11, indicating that the DNA 
damage tolerance to MMS conferred by the MRX complex is completely dependent on 
PCNA covalent modifications at the K164 residue. Thirdly, despite numerous roles 
played by MRX to maintain genomic stability, deletion of MRE11 does not result in an 
increased spontaneous mutagenesis in a trp1-289 reversion assay, which is tailored to 
base substitutions. This is in sharp contrast to the hr mutant rad51. Finally, deletion of 
MRE11 noticeably reduces levels of both mono- and diubiquitination of PCNA, 
providing direct physical evidence that the MRX complex is required for both branches 
of PRR. 
 Sae2 is considered an accessory factor of the MRX complex during DSB 
resection. Although sae2 does not display a clear epistatic relationship with either mms2 
or rev3, we argue that this observation is a result of Sae2 being partially required for both 
PRR pathways. This argument is further supported by several observations. Firstly, 
although sae2 is slightly additive to mms2 or rev3, when both MMS2 and REV3 are 
inactivated, further deletion of SAE2 does not cause increase sensitivity to MMS. 
Secondly, both rad18 and pol30-K164R are epistatic to sae2, indicating that once PCNA 
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cannot be ubiquitinated, SAE2 plays no role in the protection of host cells from MMS-
induced DNA damage. Thirdly, like mre11, the sae2 mutant does not display an 
increased spontaneous mutagenesis, consistent with a role in TLS. Fourthly, sae2 is 
epistatic to exo1, suggesting that Sae2 must play an overlapping role with Exo1 within 
error-free PRR. Finally, careful examination of PCNA ubiquitination indicates that 
deletion of SAE2 partially reduces both mono- and diubiquitinated PCNA, albeit to a 
lesser extent than mre11. These observations are consistent with Sae2 being an accessory 
protein for MRX within PRR pathways. 
 
4.4.2 – Exo1 
 The Exo1 exonuclease is also a multi-functional protein. Its involvement in error-
free PRR was recently reported by means of epistasis analyses (Tran et al., 2007). 
Supporting this conclusion was the observation that exo1 and rad9 were synergistic (Tran 
et al., 2007), a characteristic trait of an error-free PRR component (Barbour et al., 2006). 
We further extend this conclusion by providing additional experimental evidence. 
Deletion of EXO1 resulted in a dramatic increase in spontaneous mutations in a trp1-289 
based mutagenesis assay and this increase was largely dependent on the functional REV3 
and due to defective error-free PRR. Remarkably, deletion of EXO1 specifically 
compromises the relative level of diubiquitinated PCNA without affecting its 
monoubiquitination. Hence, Exo1 is exclusively involved in the error-free PRR branch. 
Given the fact that the exo1 single mutant barely displays an increased sensitivity to 
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MMS, we suspect that Exo1 only plays an accessory role in the promotion of error-free 
PRR. 
 
4.4.3 – Sgs1 
 It has previously been determined that Sgs1 plays a role downstream of the error-
free PRR pathway in resolving the recombination intermediate (Ball et al., 2009). Here 
we unequivocally demonstrate that Sgs1 also plays a role upstream of TLS. First of all, 
sgs1 is completely epistatic to rev3, which is unexpected if Sgs1 were only required for 
the downstream events of error-free PRR. Secondly, deletion of SGS1 resulted in a 
spontaneous mutation rate comparable to that of rev3, which is in sharp contrast to the 
fact that sgs1 causes increased spontaneous gross chromosomal rearrangements (Myung 
et al., 2001) and overall genomic instability (Chu and Hickson, 2009). Finally, deletion 
of SGS1 specifically reduces monoubiquitinated PCNA without apparent alteration of 
diubiquitinated PCNA. Hence, Sgs1 must play dual roles in both TLS and error-free PRR 
via two distinct mechanisms. 
 
4.4.4 – Comparison of ssDNA Gap Processing and DSB End Resection 
The involvement of MRX, Sae2, Exo1 and Sgs1 in the different modes of PRR is 
highly surprising and unexpected. When this research was in progress, several 
laboratories independently reported the differential involvement of the above proteins in 
the sequential processing of DSB ends (Bonetti et al., 2009; Mimitou and Symington, 
2008; Zhu et al., 2008), which shed light on the possible co-ordination of these proteins 
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in the PRR pathway. We argue that to apply the DSB processing model to PRR, one has 
to first ask whether the nuclease and helicase activities of the above proteins are required 
for PRR. Our experimental results, although preliminary, collectively suggest that these 
enzymatic activities are indeed required for PRR. Secondly, we envisage that the major 
difference between the DSB model and PRR is that the latter acts on ssDNA gaps. This 
may not impose a problem since based on the DSB processing model the above enzymes 
primarily act at the junction of single-double stranded DNA. Thirdly, the long-range DSB 
end processing model only deals with the 5’-3’ resection, whereas it is unclear whether 
this is the only orientation of processing for PRR. Nevertheless, it is noticed that the 
Mre11 subunit of MRX possesses a 3’-5’ exonuclease activity (Paull and Gellert, 1998), 
which has not been fully accounted for by the DSB processing model. By our genetic and 
physical analyses and inference to the DSB processing model, we propose that MRX and 
its accessory protein Sae2 participate in the initial processing of ssDNA gaps, which is 
required for efficient PCNA ubiquitination and lesion bypass. In contrast, Sgs1 and Exo1 
promote TLS and error-free PRR, respectively, primarily by signalling for, or balancing 
between, mono- vs. polyubiquitination. Of great interest is the division of labour for Sgs1 
and Exo1 to modulate the two alternative mechanisms of lesion bypass, whereas in the 
DSB processing model, the two proteins are known to play overlapping roles for long-
range 5’-3’ resection (Bonetti et al., 2009; Mimitou and Symington, 2008; Zhu et al., 
2008); however, their division of labour at the molecular level is unclear to date. A 
working model of PRR based on previous reports and the above analyses is presented in 
Figure 4.15. Based on this model, we hypothesize the MRX complex functions upstream  
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Figure 4.15 – Proposed Working Model for the Budding Yeast PRR Pathways. 
MRX in conjunction with Sae2 function upstream of PCNA monoubiquitination by 
ssDNA resection thus promoting Rad6-Rad18 to monoubiquitinate PCNA. Sgs1 is 
also required for Rad6-Rad18 mediated PCNA monoubiquitination, which allows for 
TLS in the presence of Pol (Rev3 + Rev7) and Rev1. Exo1 processes ssDNA gaps at 
the 5’-3’ direction, which facilitates PCNA polyubiquitination by Rad5-Ubc13-Mms2 
and subsequent error-free lesion bypass mediated by the Shu complex, HR and Sgs1-
Top3 resolution. 
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of PCNA to resect ssDNA at the stalled replication fork. Sae2 may facilitate MRX 
activity by removing DNA-binding proteins (Hartsuiker et al., 2009) or secondary 
structures (Lengsfeld et al., 2007). The resulting ssDNA may recruit RPA and lead to the 
recruitment of Rad6-Rad18 (Davies et al., 2008), which, in conjunction with Sgs1, 
monoubiquitinates PCNA for efficient lesion bypass via TLS. On the other hand, the 5’-
3’ exonuclease activity of Exo1 causes further strand resection that favours the 
recruitment of Rad5-Ubc13-Mms2 to polyubiquitinate PCNA and allows for error-free 
PRR lesion bypass via the Shu complex, HR and Sgs1-Top3. As all the genes described 
in this report are conserved in eukaryotes, from yeast to human, it would be of great 
interest to determine if the same regulatory mechanisms occur in higher eukaryotes. 
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CHAPTER FIVE 
THE HELICASE ACTIVITY OF Rad5 IS REQUIRED FOR ERROR-
FREE POSTREPLICATION REPAIR 
 
5.1 – Abstract 
 DNA postreplication repair (PRR) functions to bypass replication-blocking 
lesions and is subdivided into two parallel pathways: error-prone translesion synthesis 
(TLS) and error-free PRR. While both pathways are dependent on the ubiquitination of 
PCNA, error-free PRR utilizes non-canonical K63-linked polyubiquitinated PCNA to 
signal lesion bypass through template switching, a process thought to be dependent on 
Mms2-Ubc13 and a RING finger motif of the Rad5 Ub-ligase. Previous in vitro studies 
demonstrated the ability of Rad5 to promote replication fork regression, a function 
dependent on its helicase activity. To investigate the genetic and mechanistic relationship 
between fork regression and template switch, we created and characterized site-specific 
mutants defective in the Rad5 RING finger and/or helicase activity. Our results indicate 
that both the Rad5 Ub-ligase and the helicase activities are exclusively involved in error-
free PRR. To our surprise, lack of the Rad5 helicase activity abolishes the K63-linked 
PCNA polyubiquitin chain assembly. Thereby suggesting that the Rad5 helicase activity 
functions upstream of Mms2-Ubc13-Rad5 assembly and PCNA polyubiquitination. 
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5.2 – Introduction 
In addition to mechanisms that cells possess to remove DNA damage, they also 
possess the ability to bypass replication-blocking lesions. In S. cerevisiae this mechanism 
is termed PRR, which is mediated by the RAD6 epistasis group of genes. PRR can be 
divided into two parallel pathways; the error-prone TLS pathway and the error-free PRR 
pathway. The stable complex formed between Rad6-Rad18 (Bailly et al., 1994) is known 
to monoubiquitinate the RAD30 gene product PCNA (Hoege et al., 2002). The 
monoubiquitination of PCNA at K164 allows for TLS lesion bypass that requires a Y-
family of polymerases Rev1 and a B-family polymerase Pol, consisting of Rev3 and 
Rev7 (Nelson et al., 1996a, b). Inactivation of the TLS pathway abolishes DNA damage-
induced mutagenesis and a moderate increase in the sensitivity to DNA-damaging agents 
(Lawrence, 2004). 
 Genetic characterization of the mms2 null mutant demonstrated the existence of 
the error-free PRR branch (Broomfield et al., 1998; Xiao et al., 1999). mms2 displays 
strong synergistic interaction with rev3 and REV3-dependent increase in spontaneous 
mutagenesis. Although Mms2 encodes a Ubc-like protein it does not contain an active-
site Cys residue essential for a Ub-conjugating enzyme (Ubc or E2). It turned out that 
Mms2 forms a stable complex with Ubc13 to promote non-canonical Lys63-linked 
polyubiquitination (Hofmann and Pickart, 1999) and that error-free PRR is dependent on 
the K63-linked polyubiquitination of PCNA by Mms2-Ubc13 and an E3 Ub-ligase Rad5 
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(Hoege et al., 2002). Although ubc13 is epistatic to mms2 and they share all characteristic 
phenotypes (Brusky et al., 2000), Rad5 appears to have additional activities. 
Rad5 is a multifunctional protein known to prevent non-homologous end-joining 
(Ahne et al., 1997), promote instability of simple repetitive sequences (Johnson et al., 
1992) and repair DNA DSBs (Chen et al., 2005). Rad5 is also implicated in the repair of 
DNA minor groove adducts in association with NER (Kiakos et al., 2002) and a potential 
role in TLS (Pages et al., 2008a). Indeed, the rad5 mutant is much more sensitive to 
killing by DNA-damaging agents than the mms2/ubc13 mutants, particularly ionizing 
radiations (Friedl et al., 2001), and demonstrates elevated rates of spontaneous mitotic 
recombination as well as GCR (Liefshitz et al., 1998; Smith et al., 2004). The current 
working model suggests that Rad5 interacts with Ubc13 (Ulrich and Jentsch, 2000) 
through its RING finger motif (Ulrich, 2003) and recruits Mms2-Ubc13 in close 
proximity to monoubiquitinated PCNA through its association with and PCNA (Hoege et 
al., 2002) and Rad18 (Ulrich and Jentsch, 2000), which facilitates the sequential 
polyubiquitination of PCNA. In addition to E3 Ub-ligase activity, Rad5 also contains a 
conserved helicase-like domain of the SWI/SNF family of ATPases (Johnson et al., 1992; 
Johnson et al., 1994). Previous in vitro experiments demonstrated the ability of Rad5 to 
promote replication fork regression, a function dependent on its helicase activity 
(Blastyak et al., 2007). However, there are two possible competing modes for error-free 
lesion bypass, namely replication fork regression and template switching (Figure 1.4), 
both gained recent experimental support (Ball et al., 2009; Blastyak et al., 2007). 
However, it remains plausible that fork regression followed by sister chromatid invasion 
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and resolution may allow for error-free bypass. Alternatively, error-free PRR may 
employ two parallel modes of lesion bypass. Furthermore, it is unclear whether Rad5-
mediated fork regression promotes one or both error-prone and error-free pathways of 
lesion bypass. In order to address the above questions, yeast strains were created to 
characterize the rad5 mutants defective in either RING finger and/or the DNA helicase 
activity. Genetic analyses clearly demonstrate that both the Rad5 E3 and helicase 
activities are exclusively involved in error-free PRR and their mutations are epistatic, 
indicating that the two activities act sequentially. Furthermore, lack of either one of these 
Rad5 functions abolishes the PCNA polyubiquitination chain formation, suggesting that 
the Rad5 helicase activity is required upstream of PCNA polyubiquitination. 
 
5.3 – Results 
5.3.1 – Experimental Design and Rationale 
 While molecular mechanisms of translesion DNA synthesis have been well 
characterized in recent years, little is known about the detailed molecular events leading 
to the error-free PRR in eukaryotes, despite the fact that two models of error-free lesion 
bypass, namely the template switch and the replication fork regression, have been 
proposed for many years (Broomfield et al., 2001). Recently, we provided experimental 
evidence suggesting that the HR machinery acts downstream of PCNA 
polyubiquitination to mediate error-free PRR (Chapter 3) (Ball et al., 2009), which 
favours the template switch model. Meanwhile, it was reported that Rad5 possesses a 
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helicase activity required for the fork reversal in vitro (Blastyak et al., 2007), which 
supports the fork regression model of error-free PRR. 
 It has been well established that the E2 complex Ubc13-Mms2 and the E3 protein 
Rad5 are required for the non-canonical K63-linked polyubiquitination of PCNA, which 
leads to the error-free mode of PRR (Hoege et al., 2002). However, unlike Ubc13 and 
Mms2, which are exclusively involved in the above E2 activity and error-free PRR, Rad5 
has been implicated in several DNA repair/damage tolerance pathways. Indeed, although 
rad5 is epistatic to ubc13/mms2 (Ulrich and Jentsch, 2000), the rad5 mutant is much 
more sensitive to DNA-damaging agents than the ubc13 or mms2 mutant (Xiao et al., 
2000). Rad5 is a rather large protein and contains several putative functional domains 
(Figure 5.1). We reasoned that if the Rad5 RING finger E3 activity is required for PCNA 
polyubiquitination together with Ubc13-Mms2, this activity will be involved in signalling 
for the template switch. Meanwhile, if the Rad5 helicase activity acts in the same 
pathway as PCNA polyubiquitination, the helicase- and RING- (or mms2/ubc13) 
mutations will be epistatic. Alternative, if Rad5-mediated fork regression and PCNA 
polyubiquitination-mediated template switch constitute two means of lesion bypass, the 
above mutations will be additive or synergistic with respect to killing by DNA-damaging 
agents. Experiments were designed to critically test the above two hypotheses. 
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Figure 5.1 – A Schematic Representation of the Rad5 Domains in Budding Yeast 
S. cerevisiae and the Point Mutations Used in this Study. 
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5.3.2 – The Rad5 Helicase Mutation is Epistatic to the Rad5 RING Finger Mutation 
 To ask whether the Rad5 E3 activity is mediated by its RING finger motif, we 
initially created a rad5-C914S mutation known to inactivate its RING finger activity. 
Unfortunately, this mutant is much more sensitive to killing by MMS than mms2 or 
ubc13, although it is epistatic to mms2 (data not shown), suggesting that the rad5-C914S 
mutation affects other Rad5 functions, most likely its proper folding and/or stability. It 
was reported (Ulrich, 2003) that an adjacent rad5-I916A mutation abolished its 
interaction with Ubc13 and that cells carrying this mutation are epistatic to and 
indistinguishable from ubc13. Hence we created the same mutation and examined its 
genetic interaction with the rad5-AA mutation defective in the helicase activity (Blastyak 
et al., 2007). 
 A gradient plate assay (Figure 5.2A) shows the rad5-AA mutant is slightly more 
sensitive to MMS than the rad5-I916A mutant; nevertheless, the rad5-IAA double mutant 
is as sensitive to MMS as the rad5-AA single mutant, suggesting that the two Rad5 
activities function in the same pathway. This observation was further confirmed by a 
quantitative killing experiment (Figure 5.2B), in which the rad5-IAA double mutant is as 
sensitive to MMS as the rad5-AA single mutant, clearly demonstrating that the double 
mutant displays a similar phenotype to the single mutant of rad5-AA. Furthermore, the 
rad5-IAA double mutant is no more sensitive than the rad5-AA single mutant to killing 
induced by UV irradiation (Figure 5.2C), indicating that the two Rad5 activities function 
in the same pathway. 
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Figure 5.2 – The rad5-AA Mutation Displays a Similar Phenotype to the rad5-IAA 
Mutation. (A) A gradient plate assay demonstrating an epistatic relationship between 
rad5-AA and rad5-I916A. The gradient plate assay was performed as previously 
described and the plates were incubated for 2 days at 30ºC before being photographed. 
The arrow indicates the increasing concentration of MMS. Results were observed a 
minimum of three times. (B) A liquid killing experiment for the relative sensitivity to 
MMS. Results are the average of four independent experiments with standard 
deviations shown as error-bars. (C) A serial dilution assay to compare the relative 
sensitivity of wild-type (WT) and rad5 mutants to MMS and UV irradiation. All 
strains are isogenic to HK578-10A (WT); HK578-2C (rad5), WXY3001 (rad5-
I916A), WXY2981 (rad5-AA), and WXY2982 (rad5-AA). Results were observed a 
minimum of three times. Figure 5.2B and 5.2C were completed in collaboration with 
Amanda Lambrecht.  
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5.3.3 – The Rad5 Helicase Activity is Exclusively Involved in the Error-Free PRR 
Pathway 
 During the above studies, we noticed that the rad5-AA mutant is more sensitive to 
MMS and UV-induced killing than the rad5-I916A mutant (Figure 5.2A, B, C), which 
can be explained by one of two possibilities: either the rad5-I916A mutation does not 
completely abolish its RING finger activity or the Rad5 helicase has functions beyond 
that of error-free PRR. To address the first possibility, we examined genetic interactions 
between rad5-I916A and mms2. As seen in Figure 5.3A, the rad5-I916A mutant is 
noticeably less sensitive to killing by MMS than the mms2 mutant. Since Mms2 and 
Ubc13 are absolutely required for PCNA polyubiquitination and error-free PRR, and this 
function requires the Rad5 RING finger activity, we infer that the rad5-I916A point 
mutation may not completely abolish its RING finger E3 function. Nevertheless, the 
mms2 rad5-I916A double mutant is as sensitive to MMS as the mms2 single mutant, and 
the rev3 rad5-I916A double mutant displays an extreme sensitivity to MMS (Figure 
5.3A). These results reaffirm the exclusive role of Rad5 RING finger domain in error-
free PRR. 
 To ask whether the Rad5 helicase activity is exclusively involved in error-free 
PRR, we examined genetic interactions between the Rad5 helicase function and both 
branches of PRR. It has been previously reported that the rad5-AA mutant is as sensitive 
to killing by UV as the mms2 null mutant (Gangavarapu et al., 2006). As seen in Figure 
5.3B, the rad5-AA single mutant is as sensitive to MMS as the mms2 mutant, and more 
importantly the corresponding double mutant is still as sensitive to MMS as the rad5-AA  
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Figure 5.3 – Gradient Plate Assays to Assess Genetic Interactions Between rad 
Mutations and Error-Free PRR or Error-Prone TLS. (A) mms2∆ is epistatic to the 
rad5-I916A point mutation. (B) mms2∆ is epistatic to the rad5-AA point mutation. (C) 
Both rad5-AA and rad5-I196A point mutations are synergistic with rev3. The gradient 
plate assay was performed as previously described and the plates were incubated for 2 
days at 30ºC before being photographed. The arrow indicates the increasing 
concentration of MMS. All strains used were isogenic to HK578-10A (WT), HK578-
2C (rad5), WXY901 (mms2), WXY2998 (rad5-AA mms2), WXY2981 (rad5-
AA), WXY2996 (rad5-AA rev3), WXY956 (rev3), WXY3002 (rad5-I916A 
mms2), and WXY2983 (rad5-I916A rev3). Results were observed a minimum of 
three times. 
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or mms2 single mutant, indicating that the two mutations are epistatic to each other. In 
sharp contrast, the rad5-AA rev3 double mutant is extremely sensitive to MMS, and the 
genetic interaction is clearly synergistic, reminiscent of the rad5-I916A rev3 or mms2 
rev3 double mutant (Figure 5.2C). The above observations suggest that the Rad5 helicase 
activity functions exclusively in the error-free branch of PRR and in the same pathway as 
Mms2. 
 A hallmark of faulty error-free PRR is an elevated spontaneous mutagenesis 
(Broomfield et al., 1998). To ask whether the Rad5 helicase and RING finger activities 
inherit all error-free PRR functions within Rad5, we compared the spontaneous mutation 
rates of the above site-specific mutants with that of the rad5 null mutant. This trp1-289 
reversion assay is particularly sensitive to error-free PRR defect, which channels 
replication-blocking lesions to Pol-mediated translesion synthesis. As seen in Table 5.1, 
both rad5-AA and rad5-I916A mutants display strongly elevated spontaneous mutation 
rates, which are slightly higher than that of the rad5 null mutant. Interestingly, the rad5-
IAA double mutant has an elevated spontaneous mutation rate comparable to that of 
corresponding single mutant, once again confirming that the two activities represented by 
each mutation function in the same error-free PRR pathway. 
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Table 5.1 – S. cerevisiae Spontaneous Mutation Rates to Examine 
the rad5 point mutations 
Table 5.1 S. cerevisiae  spontaneous mutation rates
Strain
a Key alleles Rate (x 10
-8
)
b
Fold
c
DBY747 Wild-type 0.15 ± 0.07 1
WXY731 rad5  1.61 ± 0.51 10.7
WXY2900 rad5-AA 2.24 ± 0.38 14.9
WXY2990 rad5-IAA 2.09 ± 0.05 13.9
WXY2974 rad5-I916A 1.90 ± 0.15 12.7
a. All strains are isogenic derivatives of DBY747.
b. The spontaneous mutation rates are the average of at least 
    three independent experiments with standar deviation.
c. Relative to the wild-type mutation rate. 
Results are courtesy of Michelle Hanna. 
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5.3.4 – The Rad5 Helicase Domain is Required for the Polyubiquitination of PCNA 
After establishing that the rad5-AA mutation is specifically defective in the error-
free PRR, we wished to investigate the molecular mechanism(s) by which this helicase 
activity is involved in the error-free lesion bypass. It is well established that Ubc13, 
Mms2 and Rad5 are required for PCNA polyubiquitination and the subsequent error-free 
lesion bypass. The current model predicts that the Rad5 RING finger motif is required for 
the E3 activity and hence the rad5-I916A mutation will affect PCNA polyubiquitination. 
On the other hand, it is unclear if the Rad5 helicase activity acts upstream or downstream 
of PCNA polyubiquitination. To critically address the above issue, we raised polyclonal 
antibodies against purified Pol30 expressed from bacterial cells, and further screened for 
monoclonal antibodies. Subsequently we verified our antibody for its ability to detect 
both mono- and diubiquitinated PCNA (as demonstrated in Chapter 3)(Ball et al., 2009). 
Furthermore, we were able to verify monoubiquitinated PCNA following MMS treatment 
in wild-type yeast whole cell extracts without the need for Hisn-affinity purification 
(Figure 5.4 lanes 2 and 3). Notably this modification is absent in a strain containing the 
pol30-K164R point mutation (cf. lanes 1 and 2, 3 and 4). The predicted PCNA-Ub band 
is slightly shifted up in the strain containing the Pol30-His7 allele compared to the native 
Pol30 allele (cf. lanes 2 and 3), further confirming that this band contains modified 
PCNA. As PCNA sumoylation and diubiquitination at the K164 residue co-migrate under 
our experimental conditions we introduced a siz1 null mutation to our query strains to 
eliminate this PCNA sumoylation. Siz1 is a SUMO ligase of the SIZ/PIAS family 
(Johnson and Gupta, 2001) 
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Figure 5.4 – The Effects of rad5 Mutations on PCNA Ubiquitination. A PCNA 
ubiquitination assay showing mono- and diubiquitinations. Overnight cultures were 
subcultured and allowed to grow to a cell count of approximately 1x10
7
 cells/mL 
before being treated with 0.05% MMS for 90 minutes before harvesting proteins 
under denaturing conditions. Proteins were separated on an SDS-page gel and PCNA 
was identified by an anti-PCNA western blot. Molecular size markers are labeled on 
left (in kD) and monoubiquitinated and diubiquitinated PCNA are labeled on the right 
as Ub1 and Ub2, respectively. Unmodified Pol30 protein is indicated by PCNA. A 
short exposure of the same blot is shown in the lower panel. The blot containing cells 
extracts from untreated cells and other control blots to identify mono- and 
diubiquitinated PCNA bands are shown in Chapter 3. Strains used are isogenic to 
HK578-10A (WT), WXY994 (pol30-K164R), WXY989 (pol30-His7), WXY990 
(pol30-K164R-His7), WXY2959 (siz1, WXY2964 (rad5siz1, WXY2965 (rad5-
AA siz1, WXY2966 (rad5-I916A siz1 HK578-2C (rad5), WXY3001 (rad5-
I916A), WXY2981 (rad5-AA)Results were observed a minimum of three times. 
1 
PCNA 
PCNA 
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and thus a null mutation of siz1 abolishes sumoylation of PCNA without affecting its 
ubiquitination (lane 5) (Stelter and Ulrich, 2003). As expected, a prominent Pol30-K164 
dependent and SIZ1-independent band is noticed in the siz1∆ mutant (lane 5) but is 
absent in the rad5∆siz1∆ double mutant (lane 6), which was also shifted in the Pol30-
His7 allele (lane 2). This band was deemed to be diubiquitinated PCNA by this and other 
experimental observations (data not shown), which allowed us to examine the role of 
Rad5 RING finger and helicase motifs in DNA damage-induced PCNA 
polyubiquitination. As seen in Figure 5.4, while rad5-I916A (lane 7) and rad5-AA (lane 
8) point mutations do not affect PCNA monoubiquitination, they both reduced (or 
eliminated) PCNA diubiquitination to the level indistinguishable from that of rad5∆ (lane 
6). These observations indicate that both the RING finger and the helicase motifs are 
required for PCNA polyubiquitination. 
 
5.3.5 – Suppression of rad5 Mutations by siz1 
 It has been previously reported that the siz1 mutation suppresses the severe DNA 
damage sensitivity phenotypes of rad6 and rad18 (Stelter and Ulrich, 2003). During the 
process of validating rad5 and siz1 mutant strains, we noticed that deletion of SIZ1 also 
partially suppresses the rad5 null mutant sensitivity to MMS (Figure 5.5). More 
interestingly, deletion of SIZ1 brings rad5-AA and rad5-I916A point mutants to the same 
level of MMS sensitivity, although the two single mutants display different levels of 
MMS sensitivity (Figure 5.5). This observation further reinforces the notion that the  
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Figure 5.5 – Relative Sensitivity of the Strains Used in Figure 5.4 to Killing by 
MMS in a Gradient Plate Assay. Note that the siz1 null mutation partially 
suppresses rad5∆, rad5-AA and rad5-I916A sensitivity. The gradient plate assay was 
performed as previously described and the plates were incubated for 2 days at 30ºC 
before being photographed. The arrows indicate the increasing concentration of MMS.  
Strains used were isogenic to HK578-10A (wild-type), WXY2959 (siz1, WXY2964 
(rad5siz1, WXY2965 (rad5-AA siz1, WXY2966 (rad5-I916A siz1 HK578-
2C (rad5), WXY3001 (rad5-I916A), WXY2981 (rad5-AA)Results were observed a 
minimum of three times. 
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Rad5 RING finger E3 activity and helicase activity act in the same damage tolerance 
pathway. 
 
5.4 - Discussion 
Although it is well accepted that Rad5-Ubc13-Mms2 mediated PCNA 
polyubiquitination results in error-free PRR (Hoege et al., 2002) the exact mechanism for 
the error-free lesion bypass is unclear. Historically two possible models have been 
proposed for error-free lesion bypass, namely replication fork regression (the chicken-
foot model) and template switching (Broomfield et al., 2001). Template switching would 
involve homologous sister chromatid invasion, high-fidelity DNA synthesis and Holliday 
junction resolution. Initial support for this model came from visualization of Holliday 
junctions, which were enhanced in temperature-sensitive DNA Pol and  mutants held 
at the restrictive temperature (Zou and Rothstein, 1997). Recently, template switching 
was characterized as an X-shaped replication intermediate in a 2-D gel electrophoresis 
assay (Branzei et al., 2008; Minca and Kowalski, 2010). In addition, we recently 
demonstrated that error-free PRR does employ template switching via Ubc13-Mms2 and 
PCNA polyubiquitination, homologous recombination and Sgs1-Top3 resolution to 
bypass replication blocking lesions that arise during S-phase (Chapter 3) (Ball et al., 
2009). Meanwhile, a report by Blastyak et al. demonstrated in vitro that Rad5, through its 
intrinsic ATPase/helicase activity, promotes replication fork regression (Blastyak et al., 
2007). In this report, we examined the two competing models based on the rad5 point 
mutations that specifically inactivate either the helicase or the RING finger activity. If the 
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two modes of error-free PRR functions separately, the rad5 RING finger and helicase 
double mutant would display an additive or synergistic effect. Alternatively, if the two 
activities function in the same pathway, the rad5 double mutant would be as sensitive to 
DNA damage as one of the single mutants. We found that both rad5-I916A and rad5-AA 
mutations exclusively affect error-free PRR and are synergistic to the TLS mutation. 
Furthermore, they are epistatic to each other and to the mms2 mutation. Hence, our 
experimental results collectively support the latter prediction and confirm that the Rad5 
helicase activity and PCNA polyubiquitination act sequentially for the error-free lesion 
bypass. 
Based on the above observations and their enzymatic activities, the simplest 
model for error-free PRR would be; fork regression, PCNA polyubiquitination by Mms-
Ubc13-Rad5 followed by sister chromatid invasion, synthesis and resolution (Figure 5.6). 
However, this model predicts that the fork regression event promotes, but may not be 
absolutely required for the strand invasion, yet the rad5-AA mutant is as sensitive to UV 
(Gangavarapu et al., 2006) and MMS as the mms2 mutant. In addition, to our complete 
surprise, the rad5-AA mutation actually reduced PCNA polyubiquitination to the same 
extend as the rad5-I916A mutation, suggesting that the helicase activity acts upstream of 
PCNA polyubiquitination. Nevertheless, the above observations suggest that the Rad5 
“helicase motif” may play dual roles within error-free PRR, namely fork regression and 
the E2-E3 complex assembly. 
It was noticed that a previous report by Chen et al. (Chen et al., 2005) concluded 
that polyubiquitination of PCNA does not require the ATPase activity of Rad5. We also  
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Figure 5.6 – A Proposed Working Model Depicting the Budding Yeast Error-
Free PRR Pathway. Our results suggest that for error-free PRR the Rad5 helicase 
activity functions upstream of Mms2-Ubc13-Rad5 assembly and PCNA 
polyubiquitination. Following polyubiquitination of PCNA the Shu complex is 
thought to couple error-free PRR to HR for sister chromatid invasion, synthesis and 
resolution by Sgs1-Top3, thus completing error-free PRR and lesion bypass. 
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noticed that a recent report by Minca and Kowalski (Minca and Kowalski, 2010) found 
an additive effect between rad5 RING finger mutation and the ATPase mutation. In both 
cases, the authors characterized a rad5-KT538A,539AA (GAA) mutation within a 
presumed “GKT” ATP-binding motif. Although these point mutations have been 
previously described to abolish all ATP-binding and hydrolytic activities of Rad5 (Davies 
et al., 1998; Pause and Sonenberg, 1992; Richmond and Peterson, 1996), a subsequent 
report demonstrated that it is the rad5-DE681,682AA (AA) mutation that biochemically 
abolishes the ATPase activity of Rad5 in an in vitro assay (Gangavarapu et al., 2006). 
The same rad5-AA mutation was found to abolish the fork regression helicase activity in 
vitro (Blastyak et al., 2007) and was employed in this in vivo study. In addition, the rad5-
K538A mutation confers much less sensitivity to DNA-damaging agents than mms2 or 
rad5-AA, and does not have a clear synergistic effect with TLS mutations (data not 
shown), indicating that mutations at the Rad5 GKT motif are more complicated than we 
previously thought, and hence may not represent a true ATPase/helicase dead mutation. 
Alternatively, the ATPase activity conferred by the Rad5 GKT motif may not be required 
for its helicase activity as defined by Blastyak et al. (Blastyak et al., 2007). Nonetheless, 
our results clearly suggest that the Rad5 helicase activity functions upstream of Mms2-
Ubc13-Rad5 assembly and PCNA polyubiquitination to allow for lesion bypass. 
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CHAPTER 6 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1 – Conclusions   
 Overall, the purpose of this study was to identify novel genes and proteins 
involved in the PRR pathways. By initiating this study with a large-scale genomic SGA 
screen of all the non-essential genes in the S. cerevisiae genome, I believe that I was able 
to accomplish this task. The result is a new working model depicting the budding yeast 
DNA damage tolerance pathways (Figure 6.1). The new PRR model now begins with 
MRX. We propose that MRX and its accessory protein Sae2 participate in the initial 
processing of ssDNA gaps at stalled replication forks which may recruit RPA and lead to 
the recruitment of Rad6-Rad18 (Davies et al., 2008) which is required for efficient 
PCNA monoubiquitination by Rad6-Rad18. Sae2 may facilitate MRX activity by 
removing DNA-binding proteins (Hartsuiker et al., 2009) or secondary structures 
(Lengsfeld et al., 2007). Our observations are consistent with Sae2 being an accessory 
protein for MRX within PRR pathways. In addition, Sgs1 is required for Rad6-Rad18-
mediated PCNA monoubiquitination allowing for TLS DNA lesion bypass in the 
presence of Pol (Rev3 + Rev7) and Rev1. Rad5 also appears to have a role in TLS, 
perhaps in a structural or recruiting role by initially binding to PCNA (Pol30) and Rad18 
thus recruiting Rev1 and the TLS polymerases allowing for TLS lesion bypass. Epistasis  
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Figure 6.1 – A Proposed Working Model Depicting the Budding Yeast PRR 
Pathways. MRX and its accessory protein Sae2 participate in the initial processing of 
ssDNA gaps at stalled replication forks which may recruit RPA and lead to the 
recruitment of Rad6-Rad18. In addition, Sgs1 is required for Rad6-Rad18-mediated 
PCNA monoubiquitination allowing for TLS DNA lesion bypass. To continue, we 
suspect that Exo1 only plays an accessory role in the promotion of error-free PRR. We 
found that the helicase and RING finger function of Rad5 act sequentially in the same 
biochemical pathway, and that both functions are required with Mms2-Ubc13 for 
PCNA polyubiquitination. Subsequently we showed that the Shu complex couples 
error-free PRR to HR to allow for strand invasion and resolution by Sgs1-Top3.  
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analysis of the exo1 mutant is difficult as it barely displays an increased sensitivity to 
MMS, however, we suspect that Exo1 only plays an accessory role in the promotion of 
error-free PRR as the double exo1 rev3 mutant displays a much greater sensitivity to 
MMS than either corresponding single mutant, suggesting that EXO1 functions in a 
pathway distinct from TLS. Along with the observation that mms2 is epistatic to exo1 we 
are able to conclude that Exo1 is exclusively involved in and perhaps plays an accessory 
role in the promotion of error-free PRR. The 5’-3’ exonuclease activity of Exo1 causes 
further strand resection that favours the recruitment of Rad5-Ubc13-Mms2 to 
polyubiquitinate PCNA. Hence, Sgs1 and Exo1 promote TLS and error-free PRR, 
respectively, primarily by signalling for, or balancing between, mono- vs. 
polyubiquitination.  
 We also examined two competing models based on the rad5 point mutations that 
specifically inactivate either the helicase or the RING finger activity. If the two modes of 
error-free PRR function separately, the rad5 RING finger and helicase double mutant 
would display an additive or synergistic effect; however, we found that the double mutant 
is no more sensitive than the corresponding single point mutants indicating an epistatic 
interaction, suggesting that the helicase and RING finger functions of Rad5 act 
sequentially in the same biochemical pathway. The Rad5 helicase and RING finger 
domain together with Mms2-Ubc13 are all required for the polyubiquitination of PCNA. 
Following PCNA polyubiquitination, we demonstrated that it is the Shu complex that 
couples error-free PRR to HR to allow for strand invasion and resolution by Sgs1-Top3. 
Hence, Sgs1 plays dual roles in both TLS and error-free PRR at two distinct steps. This 
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study expands our understanding of how TLS and error-free PRR are coordinately 
operated at the molecular level. 
 As the majority of genes described in this report are conserved in eukaryotes, 
from yeast to humans, it would be of great interest to determine if the same regulatory 
mechanisms occur in higher eukaryotes to prevent genomic instability, a hallmark of 
cancer.  
 
6.2 – Future Directions 
6.2.1 - Roles of the Shu Complex in PCNA Polyubiquitination 
 Although this body of work identified and genetically characterized the Shu 
complex to function by coupling error-free PRR to HR, exactly how the Shu complex 
fulfills this role remains to be determined. Analysis of protein-protein interactions 
between members of the Shu complex and known error-free and HR proteins might give 
further insight into the function of the Shu complex. It may also help to pinpoint at which 
step(s) in error-free PRR the Shu complex functions. In addition, it is unclear whether the 
Shu complex functions upstream or downstream of polyubiquitinated PCNA, as 
mutations in the shu complex are not nearly as sensitive to MMS as rad5, mms2 or ubc13 
mutation, which can be explained by either model. Analyzing the shu complex in the 
PCNA polyubiquitination assay (in a siz1 background) is expected to give a definitive 
answer as to whether the Shu complex functions upstream or downstream of PCNA 
polyubiquitination. This critical experiment was not performed  or previously reported 
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(Ball et al., 2009) because it was not until after publication that detection of PCNA 
polyubiquitination was established in my hands in our laboratory.  
 
6.2.2 – Molecular Mechanisms of the S. cerevisiae Rad5 Helicase Domain in Error-
free PRR 
 By utilising specific point mutations, genetic characterization and the PCNA 
ubiquitination assay, this study clearly demonstrates that the Rad5 helicase and E3 RING 
finger activities act in a sequential manner for error-free lesion bypass. Based on the 
above observations of Rad5 and its enzymatic activities, the preferred model is that the 
Rad5 helicase and RING finger domain together with Mms2-Ubc13 are all required for 
the polyubiquitination of PCNA which then allows for signalling fork regression 
followed by sister chromatid invasion, synthesis and resolution.  However, it should be 
taken into account that Rad5 is known to bind to PCNA, Ubc13 and Rad18 (Ulrich and 
Jentsch, 2000). Therefore, it becomes essential to ensure that the rad5-AA point mutation 
is still able to bind to its targets. This will ensure that the loss of PCNA 
polyubiquitination demonstrated in the rad5-AA mutation is indeed completely dependent 
on the Rad5 helicase function and not due to a loss of interaction with PCNA, Ubc13 
and/or Rad18. In order to accomplish this task a PCR product of the Rad5 genomic 
integration containing the point mutation could be cloned into a Y2H expression vector. 
The functionality of the fusion constructs can be assessed by functional complementation 
analysis in the rad5 null mutant, and the ability of these Rad5 point mutations to interact 
with Rad5 binding partners can be determined by the Y2H assay through comparison 
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with wild-type Rad5. However, if a physical interaction is not seen in this Y2H 
experiment it does not mean the physical protein-protein interaction does not exist. The 
demonstration of a physical interaction in a Y2H experiment is a valid result; however, a 
negative result would be considered inconclusive. Nevertheless, the Y2H system itself 
may be altered, for example, by switching fusion partners or utilising different Y2H 
systems, to achieve enhanced detection sensitivity. In addition, it has been reported that 
some protein interactions are only identifiable in the presence of a DNA-damaging agent 
such as 4NQO (Zhang et al., 2001). Therefore, by adding MMS or 4NQO to the Y2H 
selection media detection of a protein-protein interaction could be strengthened as this 
interaction would only be required for lesion bypass following DNA damage.  
 An alternative approach to Y2H would be utilising DNA constructs that exist for 
the genomic tagging of proteins for fluorescence or affinity tagging (Deng et al., 2009). 
One possibility would be to tag Rad5, rad5-I916A, and rad5-AA and utilize affinity 
purification or co-immunoprecipitation to identify protein interactions. In theory Rad5, as 
an experimental control, and rad5-AA should still physically interact with PCNA, Ubc13 
and Rad18; however, rad5-I916A should only interact with PCNA and Rad18, but not 
Ubc13.  
 
6.2.3 – Roles of Rad5 in TLS 
 In addition to exploring Rad5 physical interactions for error-free PRR a recent 
report demonstrated the importance of Rad5 in TLS mediated by Pol (Pages et al., 
2008a). Pages et al. suggest that because Rad5 binds to the Rad6-Rad18 complex, the 
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function of Rad6-Rad18-Rad5 is to promote assembly of the TLS polymerases through 
the binding of Rad5 to Rev1, thus targeting Pol to the site of stalled replication. 
Although Rad5 has been shown to interact with Rev1 (Pages et al., 2008a), a result which 
we have duplicated (data not shown), the exact region of Rad5 and Rev1 which are 
required for protein-protein interaction has not yet been mapped and may allow for 
further insight into the function of Rad5 in lesion bypass.  
 
6.2.4 – How Does Rad5 Function When Error-free PRR Is Dissociated From 
Replication Forks? 
 A recent report adds a further level of complexity to our model presented in this 
study. Karras et al. found that limiting TLS or the error-free PRR pathway to the G2/M 
phase of the cell cycle allowed for efficient promotion of lesion bypass (Karras and 
Jentsch, 2010). One issue raised by this paper in association with our finding that the 
Rad5 RING finger and helicase activities act sequentially in error-free PRR is: how is the 
fork reversal structure able to form in the absence of a replication fork? Therefore, in the 
absence of a replication fork, are there other proteins able to promote replication-fork-
independent fork reversal structures to allow for lesion bypass in the G2/M phase of the 
cell cycle? These are questions to be pondered and further investigated in the future. 
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6.2.5 – Roles of MRX and Sae2 in the Formation of ssDNA Gaps Near Replication 
Forks and Their Implication in PRR 
 Further investigation to expand on the genetic and ubiquitination analysis of the 
MRX complex explored in this body of work, by a more mechanistic means, might give 
further insight into the function of the MRX complex in PRR. Niu et al. recently 
demonstrated a system that can serve as a model for delineating the mechanistic intricacy 
of the DNA break resection process in eukaryotes (Niu et al., 2010). Therefore, by 
utilising this system it would be possible to monitor DSBs and determine if they persisted 
in yeast strains containing mutations in known PRR genes, which would give us an 
additional tool to determine whether DSBs resected by MRX are processed by PRR. In 
addition to the helicases and nucleases discussed here, evidence has suggested that the 
heterodimer Ku regulates HR through inhibition of DNA end processing (Clerici et al., 
2008; Lee et al., 1998; Zhang et al., 2007). Furthermore, evidence indicates that DSB 
resection by Exo1 could be repressed by Ku (Wasko et al., 2009). Exo1 performs 
resection at telomeric regions in the absence of Ku (Maringele and Lydall, 2002), and 
deletion of Ku suppresses the hypersensitivity of mre11 and rad50 mutants to DSBs in an 
Exo1-dependent manner (Tomita et al., 2003). In addition, we found that deletion of 
EXO1 specifically compromises the relative level of diubiquitinated PCNA without 
affecting its monoubiquitination. Therefore, the question becomes: is the function of 
Exo1 in relation to PRR affected by the heterodimer Ku? It is possible that if we utilize 
the PCNA ubiquitination assay, as previously described, with a ku mutant, we would see 
an increase in the relative level of diubiquitinated PCNA, compared to wild-type, as Exo1 
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would no longer be inhibited by Ku. However, it may not be possible to achieve, or 
detect, higher than wild-type levels of diubiquitination, even in a mutant strain. 
Therefore, it might be more relevant to overexpress Ku in a wild-type background to 
determine if the overexpression of Ku is sufficient to decrease diubiquitinated PCNA. If 
this is indeed the case, it would suggest that Ku plays a critical role in mediating DNA 
lesion bypass by PRR.  
 
6.2.6 – A Search for the PCNA Deubiquitination Enzyme 
 Ubiquitination of PCNA has been shown in this body of work, and previously, to 
be vital for PRR and cell survival in S. cerevisiae. However, ubiquitination of any 
substrate is a covalent modification, and thought to be short-lived. As PCNA is 
constantly ubiquitinated, and is therefore in a “turned on” state so to speak, a constant 
state of DNA repair or DNA damage tolerance would ensue. Therefore it seems vital that 
at some point the cell would need to deubiquitinate Lys63-linked polyubiquitinated 
PCNA to return to a “normal” state following DNA lesion bypass. The non-processive, 
low-fidelity DNA polymerases must be removed rapidly from the replication fork 
following their required function in bypassing DNA lesions to ensure additional errors 
are not incorporated into the DNA, and that genomic stability is preserved. The question 
therefore becomes how does this occur, and what proteins are involved in the 
deubiquitination of PCNA to “turn off” PRR? A recent review explored this issue 
(Gallego-Sanchez et al., 2010), and although USP1 has been shown to deubiquitinate 
PCNA in cultured human cells the same conclusion has remained elusive in yeast. There 
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are 17 known genes in budding yeast that code for ubiquitin-specific proteases, some of 
which have been well characterized, while others remain unknown (Gallego-Sanchez et 
al., 2010; Kvint et al., 2008; Wilkinson, 1997). Analysis of the 17 putative ubiquitin-
specific proteases has failed to locate a PIP (PCNA interacting protein) domain; however, 
this analysis assumes a direct interaction between PCNA and a putative ubiquitin-specific 
protease. Alternatively, analysis of PIP plain variant, which has been shown to be 
required for PCNA to interact with Eco1 (Moldovan et al., 2006), reveals such a domain 
in 4 of the 17 putative ubiquitin-specific proteases (Gallego-Sanchez et al., 2010). The 4 
putative ubiquitin-specific proteases are: Ubp3, Doa4/Ubp4, Ubp8 and Dot4/Ubp10. As 
none of these 4 putative ubiquitin-specific proteases are essential, yeast strains containing 
null mutations of these genes could be run through our ubiquitination assay, (as described 
in Chapter 2 and further explored in Chapter 4). I hypothesize that in the absence of a 
ubiquitin-specific protease, detection of PCNA ubiquitination following DNA damage 
would be enhanced. Enhancement could be shown as total quantity of mono- and 
diubiquitinated PCNA or, in the number of ubiquitin moieties attached to PCNA in the 
non-canonical Lys63 linked chains. Alternatively, candidate genes could be cloned into 
yeast overexpression vectors, and screened for their ability to virtually eliminate 
detectable PCNA ubiqutination following DNA damage. Therefore, by employing these 
methods, there would be no dependence on direct physical interaction between PCNA 
and a putative deubiquitinating enzyme, which may or may not be essential. Should these 
initial 4 candidates show a lack of involvement in PCNA-deubiquitinating function, the 
remaining 13 putative ubiquitin-specific enzymes could be tested in a similar manner.  
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6.2.7 – Roles of Rad18 Phosphorylation in PRR 
 A recent study showed that Rad18 is phosphorylated in a Cdc7-mediated manner 
in cultured human cells (Day et al., 2010). Rad18 is a highly conserved E3 ubiquitin 
ligase, and previous genetic studies have shown an interaction between Cdc7 and known 
members of the TLS pathway in S. cerevisiae (Pessoa-Brandao and Sclafani, 2004). 
CDC7 was initially assigned to the RAD6 epistasis group (Njagi and Kilbey, 1982), and 
subsequently shown to act with Dbf4 as a protein kinase required for DNA replication in 
eukaryotes from yeast to humans. In addition, Day et al. demonstrated that Cdc7-
dependent Rad18 phosphorylation promotes recruitment of Polto stalled replication 
forks after UV treatment (Day et al., 2010). In S. cerevisiae Pol is encoded for by the 
RAD30 gene (Andersen et al., 2008), and it is one of three DNA polymerases utilized for 
TLS lesion bypass, and all three (including Rev1 and Pol ζ ) have known human 
homologs (Reviewed in (Andersen et al., 2008) and most recently discussed in (Wiltrout 
and Walker, 2010)). Studies with knockout mice have demonstrated the importance of 
Pol in tumour suppression, as 100% of mice with pol-/- develop epithelial tumours 
(Lin et al., 2006). Therefore, the question becomes: is Rad18 phosphorylated in S. 
cerevisiae in order to recruit TLS polymerases? If so, is the phosphorylation of Rad18 
only required to recruit Rad30, or all three TLS polymerases? In order to test this 
hypothesis Rad18 could be examined for phosphorylation via western blot analysis with 
specific antibodies to either a genomic integrated tag or Rad18 following DNA damage. 
Should phosphorylated Rad18 be detected, determining the site of Rad18 
phosphorylation, by creating site specific mutations, could allow for further analysis to 
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determine the function of Rad18 phosphorylation. However, the serine residue that is 
phosphorylated in humans and conserved amongst orangutans, mice, dogs, rats, chickens 
and zebrafish (Gallego-Sanchez et al., 2010) is not conserved in S. cerevisiae thus 
making this study a little more challenging.   
S. cerevisiae has proven an excellent eukaryotic model to study DNA repair and 
mutagenesis. As many of the genes examined in this study have known human 
homologues, it is hopeful that gaining further insight into yeast PRR will guide our 
investigation into higher eukaryotes, including humans, for similar processes that 
function to maintain genomic stability and prevent the hallmark of genomic instability, 
cancer.  
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